ID	1.1.1.10
********************************************************************************
*                                                                              *
* Copyrighted by Dietmar Schomburg, Techn. University Braunschweig, GERMANY    *
* Distributed under the License as stated at http:/www.brenda-enzymes.org      *
*                                                                              *
********************************************************************************

PROTEIN
PR	#1# Cavia porcellus   (#1# SULT1A2 <1,2,6,7>) <1,2,6,7>
PR	#2# Mus musculus   <11,18,19>
PR	#3# Homo sapiens   <11,12,18,20,22>
PR	#4# Rattus norvegicus   <13,18,20>
PR	#5# Sus scrofa   <18>
PR	#6# Saccharomyces cerevisiae   <5>
PR	#7# Neurospora crassa   <21>
PR	#8# Aspergillus niger   <8,32>
PR	#9# Mesocricetus auratus   <16>
PR	#10# Meyerozyma guilliermondii   <30,31>
PR	#11# Kluyveromyces marxianus   <36>
PR	#12# Pantoea ananatis   <4>
PR	#13# Chlorella sorokiniana   <35>
PR	#14# Erwinia sp.   <3>
PR	#15# Scheffersomyces stipitis   <9,23,24,25,26,27,37>
PR	#16# Cricetinae   <10>
PR	#17# Candida tenuis   <28>
PR	#18# Homo sapiens Q7Z4W1 SwissProt <14,17,29>
PR	#19# Ambrosiozyma monospora Q70FD1 SwissProt <15>
PR	#20# Mus musculus Q91X52 SwissProt <14>
PR	#21# Rattus norvegicus Q920P0 SwissProt <14>
PR	#22# Cavia porcellus Q920N9 SwissProt <14>
PR	#23# Mesocricetus auratus Q91XV4 SwissProt <14>
PR	#24# Trichoderma reesei Q8NK50 UniProt <33>
PR	#25# Caenorhabditis elegans Q21929 UniProt <34>

RECOMMENDED_NAME
RN	L-xylulose reductase


SYSTEMATIC_NAME
SN	xylitol:NADP+ 4-oxidoreductase (L-xylulose-forming)


SYNONYMS
SY	 reductase, L-xylulose
SY	#10,15# xylose reductase <27,30,31>
SY	#11# NADP(H)-preferring xylitol dehydrogenase <36>
SY	#13# NADP+-linked xylitol dehydrogenase <35>
SY	#13,15# XDH <23,25,35,37>
SY	#15# xylitol dehydrogenase <9>
SY	#15# NADP(+)-dependent xylitol dehydrogenase <23>
SY	#15# NADP+-dependent xylitol dehydrogenase <37>
SY	#15,17# NAD(P)H-dependent xylose reductase <26,28>
SY	#18# P34H <14>
SY	#2,3,4,18,20,21,22,23# XR <11,12,13,14,17>
SY	#2,3,4,8# More (#8# xylitol:NAD+ 2-oxidoreductase, EC 1.1.1.9, is
	termed as xylitol dehydrogenase <8>; #2,3,4# enzyme belongs to the
	short-chain dehydrogenase/reductase family <11,13,17>) <8,11,13,17>
SY	#24# LXR3 (#24# gene name <33>) <33>
SY	#3,24# L-xylulose reductase <22,33>
SY	#9# P31h <16>
SY	#9,25# dicarbonyl/L-xylulose reductase <16,34>
SY	#9,25# DCXR <16,34>

REACTION
RE	xylitol + NADP+ = L-xylulose + NADPH + H+ (#16# probably identical with
	EC 1.1.1.5 diacetyl reductase <10>; #3# active site structure <12>; #3#
	active site residues are Cys138, Val143, His146, Trp191, and Met200,
	the catalytic tetrad is formed by Asn107, Ser136, Tyr149, and Lys153,
	substrate binding site structure, enzyme with dual function showing
	L-xylulose reductase activity and dicarbonyl reductase activity, EC
	1.1.1.5 <17>; #20,21,22,23# enzyme with dual function showing
	L-xylulose reductase and dicarbonyl reductase activities <14>; #2,3,18#
	enzyme with dual function showing L-xylulose reductase and dicarbonyl
	reductase activities, it is probably identical with sperm 34 kDa
	protein P34H and diacetyl reductase, EC 1.1.1.5 <11,14>; #4# enzyme
	with dual function showing L-xylulose reductase and dicarbonyl
	reductase activities, it is probably identical with sperm 34 kDa
	protein P34H and diacetyl reductase, EC 1.1.1.5, the amino acid
	residues Ser136, Tyr149, and Lys153 form the catalytic triad <13>; #9#
	immunological analysis revealed that the dicarbonyl/L-xylulose
	reductase is not identical with the sperm protein P26h <16>)

REACTION_TYPE
RT	redox reaction
RT	oxidation
RT	reduction

SOURCE_TISSUE
ST	#1,2,3,4,5,16,18,20,21,22,23# liver (#18,21,22,23# high content <14>)
	<1,2,6,7,10,14,18>
ST	#1,2,3,4,5,16,18,20,21,22,23# kidney (#18,20,21,22,23# high content
	<14>; #4# brush border <13>) <7,10,12,13,14,18,19>
ST	#13# cell culture <35>
ST	#13# more (#13# D-xylose utilization by the oleaginous microalga
	Chlorella sorokiniana <35>) <35>
ST	#18,20,21,22,23# heart (#18,20,21,23# low expression level <14>) <14>
ST	#18,20,21,22,23# spleen (#18,20,22,23# low expression level <14>) <14>
ST	#18,20,21,22,23# brain (#18,20,21,22,23# low expression level <14>) <14>
ST	#18,20,21,22,23# lung (#22# high content <14>; #18,21,23# low
	expression level <14>) <14>
ST	#18,20,21,22,23# testis (#18,20,21,22,23# low expression level <14>)
	<14>
ST	#25# intestine <34>
ST	#25# spermatid <34>
ST	#25# gonadal sheath cell <34>
ST	#25# uterine seam cell <34>
ST	#25# spermathecal-uterine valve <34>
ST	#3# MOLT-4 cell (#3# expression levels of L-xylulose reductase and its
	mRNA in the T lymphoma cells are markedly enhanced after the exposure
	to 9,10-phenanthrenequinone, and the induction is completely abolished
	by the ROS scavengers. L-Xylulose reductase is upregulated in the
	earlier step of the apoptosis and deteriorates the apoptotic signaling
	through the generation of ROS by the redox cycling of
	9,10-phenanthrenequinone <22>) <22>
ST	#9# epithelium (#9# epididymal <16>) <16>
ST	#9,18,20,21,22,23# epididymis (#20# high content <14>; #21,23# low
	expression level <14>; #9# from caput, corpus, and cauda, activity in
	descending order <16>) <14,16>

LOCALIZATION
LO	#22# cytosol <14>
LO	#25# plasma membrane (#25# of spermatids <34>) <34>
LO	#3# brush border <12>
LO	#3,4# membrane <12,13>
LO	#9# perinuclear space <16>

NATURAL_SUBSTRATE_PRODUCT
NSP	#13,24# xylitol + NADP+ = L-xylulose + NADPH + H+ {r} <33,35>
NSP	#13,24# xylitol + NADP+ = L-xylulose + NADPH + H+ <33,35>
NSP	#19# L-xylulose + NADH = L-xylitol + NAD+ (#19# part of the L-arabinose
	catabolism <15>) {r} <15>
NSP	#2,3,4,5,8# L-xylulose + NADPH + H+ = L-xylitol + NADP+ (#3# part of
	the glucuronic acid pathway, enzyme may be involved in water
	reabsorption and cellular osmoregulation <12>; #4# part of the uronate
	cycle, involved in osmoregulation in the kidney <13>; #3# the enzyme is
	involved in the uronate cycle of glucose metabolism <17>; #2,3,4,5#
	uronate cycle of glucose metabolism <18>) {r} <8,12,13,17,18>
NSP	#2,3,4,5,8# L-xylulose + NADPH + H+ = L-xylitol + NADP+ (#3# part of
	the glucuronic acid pathway, enzyme may be involved in water
	reabsorption and cellular osmoregulation <12>; #4# part of the uronate
	cycle, involved in osmoregulation in the kidney <13>; #3# the enzyme is
	involved in the uronate cycle of glucose metabolism <17>; #2,3,4,5#
	uronate cycle of glucose metabolism <18>) {} <8,12,13,17,18>
NSP	#2,3,4,5,8# L-xylulose + NADPH + H+ = L-xylitol + NADP+ (#3# part of
	the glucuronic acid pathway, enzyme may be involved in water
	reabsorption and cellular osmoregulation <12>; #4# part of the uronate
	cycle, involved in osmoregulation in the kidney <13>; #3# the enzyme is
	involved in the uronate cycle of glucose metabolism <17>; #2,3,4,5#
	uronate cycle of glucose metabolism <18>) <8,12,13,17,18>
NSP	#25# more = ? (#25# dicarbonyl/L-xylulose reductase is bifunctional
	<34>) {} <34>
NSP	#25# more = ? (#25# dicarbonyl/L-xylulose reductase is bifunctional
	<34>) {} <34>
NSP	#25# L-xylulose + NADPH + H+ = xylitol + NADP+ {ir} <34>
NSP	#25# L-xylulose + NADPH + H+ = xylitol + NADP+ {r} <34>
NSP	#4# diacetyl + NAD(P)H = acetoin + NAD(P)+ (#4# detoxification of
	alpha-dicarbonyl compounds <13>) {} <13>
NSP	#4# diacetyl + NAD(P)H = acetoin + NAD(P)+ (#4# detoxification of
	alpha-dicarbonyl compounds <13>) {r} <13>

SUBSTRATE_PRODUCT
SP	#1,2,3,4,5,7,8,10,15,16,17,18,20,21,22,23# L-xylulose + NADPH + H+ =
	L-xylitol + NADP+ (#16# also reduces 2,3-butadione <10>; #3# part of
	the glucuronic acid pathway, enzyme may be involved in water
	reabsorption and cellular osmoregulation <12>; #4# part of the uronate
	cycle, involved in osmoregulation in the kidney <13>; #3# the enzyme is
	involved in the uronate cycle of glucose metabolism <17>; #3,4#
	L-xylulose reductase activity <13,17>; #18,20,21,22,23# reductase
	activity <14>; #2,3,4,5# uronate cycle of glucose metabolism <18>; #15#
	xylulose reductase has about 50% higher activity during xylose
	consumption than during the coconsumption of glucose and xylose <27>)
	{r} <6,7,8,10,11,12,13,14,17,18,21,25,26,27,28,30,31,32>
SP	#1,2,3,4,5,7,8,10,15,16,17,18,20,21,22,23# L-xylulose + NADPH + H+ =
	L-xylitol + NADP+ (#16# also reduces 2,3-butadione <10>; #3# part of
	the glucuronic acid pathway, enzyme may be involved in water
	reabsorption and cellular osmoregulation <12>; #4# part of the uronate
	cycle, involved in osmoregulation in the kidney <13>; #3# the enzyme is
	involved in the uronate cycle of glucose metabolism <17>; #3,4#
	L-xylulose reductase activity <13,17>; #18,20,21,22,23# reductase
	activity <14>; #2,3,4,5# uronate cycle of glucose metabolism <18>; #15#
	xylulose reductase has about 50% higher activity during xylose
	consumption than during the coconsumption of glucose and xylose <27>)
	{} <6,7,8,10,11,12,13,14,17,18,21,25,26,27,28,30,31,32>
SP	#1,2,3,4,5,7,8,10,15,16,17,18,20,21,22,23# L-xylulose + NADPH + H+ =
	L-xylitol + NADP+ (#16# also reduces 2,3-butadione <10>; #3# part of
	the glucuronic acid pathway, enzyme may be involved in water
	reabsorption and cellular osmoregulation <12>; #4# part of the uronate
	cycle, involved in osmoregulation in the kidney <13>; #3# the enzyme is
	involved in the uronate cycle of glucose metabolism <17>; #3,4#
	L-xylulose reductase activity <13,17>; #18,20,21,22,23# reductase
	activity <14>; #2,3,4,5# uronate cycle of glucose metabolism <18>; #15#
	xylulose reductase has about 50% higher activity during xylose
	consumption than during the coconsumption of glucose and xylose <27>)
	<6,7,8,10,11,12,13,14,17,18,21,25,26,27,28,30,31,32>
SP	#1,3,4,8,12,13,14,15,16,24# xylitol + NADP+ = L-xylulose + NADPH + H+
	(#15# engineered enzyme with altered cofactor specificity <37>) |#12#
	strain DM101 and DM122, product identification is not exact, could also
	be D-xylulose <4>| {r} <1,2,3,4,6,7,8,9,10,20,33,35,37>
SP	#1,3,4,8,12,13,14,15,16,24# xylitol + NADP+ = L-xylulose + NADPH + H+
	(#15# engineered enzyme with altered cofactor specificity <37>) |#12#
	strain DM101 and DM122, product identification is not exact, could also
	be D-xylulose <4>| <1,2,3,4,6,7,8,9,10,20,33,35,37>
SP	#1,4,8,12,18,19,20,21,22,23,24,25# more = ? (#25# substrate
	specificity, overview <34>; #8# minimal reductive activity also with
	D-xylulose, D-erythrose and dihydroxyacetone <8>; #1# no activity in
	the mitochondrial fraction with D-xylulose, D-sorbose, L-sorbose,
	L-erythrulose, D-fructose, D-sorbitol, L-arabitol, D-gulitol, D-talitol
	<7>; #12# minimal oxidative activity with D-arabitol, mannitol,
	1,2-propanediol and 2,3-butanediol <4>; #19# NADH-linked enzyme form,
	no activity with NADPH and NADP+, no activity with L-arabinitol,
	adonitol or ribitol, dulcitol or galactitol, D-mannitol, and
	D-sorbitol, no activity with D-sorbose, L-sorbose, D-psicose, and
	D-fructose <15>; #18,20,21,22,23# substrate specificity for dicarbonyl
	reductase activity, overview <14>; #4# the size and hydrophobicity of
	the amino acid residues involved in substrate recognition, i.e. Q137,
	L143, H146, N190, and W191, is important, mutants N190V, N190V/W191S,
	Q137M/L143F/H146L, and N190V/W191S/Q137M/L143F/H146L show reductive
	activity with 4-nitroacetophenone, 5beta-androstane-3,17-dione,
	5beta-androstan-17beta-ol-3-one, and
	5beta-androstane-3alpha,17beta-diol, overview <13>; #8# no substrate:
	D-fructose, D-sorbose, L-sorbose, xylitol, D-arabitol, L-arabitol,
	ribitol, D-sorbitol and galactitol <32>; #25# dicarbonyl/L-xylulose
	reductase is bifunctional <34>; #24# substrate specificity, overview.
	No activity with L-xylo-3-hexulose, D-sorbose, D-ribitol, D-arabitol,
	or L-arabitol <33>) {} <4,7,8,13,14,15,32,33,34>
SP	#1,4,8,12,18,19,20,21,22,23,24,25# more = ? (#25# substrate
	specificity, overview <34>; #8# minimal reductive activity also with
	D-xylulose, D-erythrose and dihydroxyacetone <8>; #1# no activity in
	the mitochondrial fraction with D-xylulose, D-sorbose, L-sorbose,
	L-erythrulose, D-fructose, D-sorbitol, L-arabitol, D-gulitol, D-talitol
	<7>; #12# minimal oxidative activity with D-arabitol, mannitol,
	1,2-propanediol and 2,3-butanediol <4>; #19# NADH-linked enzyme form,
	no activity with NADPH and NADP+, no activity with L-arabinitol,
	adonitol or ribitol, dulcitol or galactitol, D-mannitol, and
	D-sorbitol, no activity with D-sorbose, L-sorbose, D-psicose, and
	D-fructose <15>; #18,20,21,22,23# substrate specificity for dicarbonyl
	reductase activity, overview <14>; #4# the size and hydrophobicity of
	the amino acid residues involved in substrate recognition, i.e. Q137,
	L143, H146, N190, and W191, is important, mutants N190V, N190V/W191S,
	Q137M/L143F/H146L, and N190V/W191S/Q137M/L143F/H146L show reductive
	activity with 4-nitroacetophenone, 5beta-androstane-3,17-dione,
	5beta-androstan-17beta-ol-3-one, and
	5beta-androstane-3alpha,17beta-diol, overview <13>; #8# no substrate:
	D-fructose, D-sorbose, L-sorbose, xylitol, D-arabitol, L-arabitol,
	ribitol, D-sorbitol and galactitol <32>; #25# dicarbonyl/L-xylulose
	reductase is bifunctional <34>; #24# substrate specificity, overview.
	No activity with L-xylo-3-hexulose, D-sorbose, D-ribitol, D-arabitol,
	or L-arabitol <33>) {} <4,7,8,13,14,15,32,33,34>
SP	#16# DL-threitol + NADP+ = D-erythrulose + NADPH (#16# probably
	identical with erythrulose reductase, EC 1.1.1.162 and diacetyl
	reductase,  EC 1.1.1.5 <10>) {r} <10>
SP	#18,20,21,22,23# 1,4-dibromo-2,3-butanedione + NAD(P)H = ? + NAD(P)+
	(#18,20,21,22,23# dicarbonyl reductase activity, best substrate, NADPH
	is the preferred cofactor, forward reaction is preferred <14>) {r} <14>
SP	#18,20,21,22,23# D-erythrose + NADPH = ? (#18,20,21,22,23# reductase
	activity <14>) {r} <14>
SP	#18,20,21,22,23# D-threose + NADPH = D-threitol + NADP+
	(#18,20,21,22,23# reductase activity <14>) {r} <14>
SP	#18,20,21,22,23# D-xylulose + NADPH + H+ = D-xylitol + NADP+
	(#18,20,21,22,23# reductase activity <14>) {r} <14>
SP	#18,20,21,22,23# DL-glyceraldehyde + NADPH = dihydroxyacetone + NADP+
	(#18,20,21,22,23# reductase activity, forward reaction is highly
	preferred <14>) {r} <14>
SP	#18,20,21,22,23# L-erythrulose + NADPH = ? (#18,20,21,22,23# reductase
	activity <14>) {r} <14>
SP	#18,20,21,22,23# L-threose + NADPH = L-threitol + NADP+
	(#18,20,21,22,23# reductase activity <14>) {r} <14>
SP	#19# L-xylulose + NADH = L-xylitol + NAD+ (#19# part of the L-arabinose
	catabolism <15>) {r} <15>
SP	#19# D-ribulose + NADH = D-arabinitol + NAD+ {r} <15>
SP	#2,3,4,18,20,21,22,23# diacetyl + NAD(P)H = acetoin + NAD(P)+ (#4#
	detoxification of alpha-dicarbonyl compounds <13>; #2,3,4# dicarbonyl
	reductase activity <11,13,17>; #18,20,21,22,23# dicarbonyl reductase
	activity, NADPH is the preferred cofactor <14>) {} <11,13,14,17>
SP	#2,3,4,18,20,21,22,23# diacetyl + NAD(P)H = acetoin + NAD(P)+ (#4#
	detoxification of alpha-dicarbonyl compounds <13>; #2,3,4# dicarbonyl
	reductase activity <11,13,17>; #18,20,21,22,23# dicarbonyl reductase
	activity, NADPH is the preferred cofactor <14>) {r} <11,13,14,17>
SP	#2,3,9,12# DL-threitol + NAD+ = D-threose + NADH {} <4,14>
SP	#2,3,9,12# DL-threitol + NAD+ = D-threose + NADH {r} <4,14>
SP	#24# D-sorbitol + NADP+ = D-sorbose + NADPH + H+ <33>
SP	#24# L-sorbose + NADPH + H+ = L-sorbitol + NADP+ (#24# low activity
	<33>) <33>
SP	#24# D-fructose + NADPH + H+ = ? + NADP+ (#24# low activity <33>) <33>
SP	#24# D-ribulose + NADPH + H+ = ? + NADP+ <33>
SP	#24,25# L-xylulose + NADPH + H+ = xylitol + NADP+ (#24# preferred
	substrate <33>) {ir} <33,34>
SP	#24,25# L-xylulose + NADPH + H+ = xylitol + NADP+ (#24# preferred
	substrate <33>) {r} <33,34>
SP	#24,25# D-xylulose + NADPH + H+ = xylitol + NADP+ (#24# low activity
	<33>) <33,34>
SP	#25# D-erythrose + NADPH + H+ = ? + NADP+ {ir} <34>
SP	#25# D-threose + NADPH + H+ = ? + NADP+ {ir} <34>
SP	#25# L-erythrulose + NADPH + H+ = ? + NADP+ {ir} <34>
SP	#25# L-ribulose + NADPH + H+ = ? + NADP+ (#25# low activity <34>) <34>
SP	#3# diacetyl + NADPH + H+ = acetoin + NADP+ <29>
SP	#3,19# D-xylulose + NADH + H+ = D-arabinitol + NAD+ (#19# about 100fold
	lower activity compared to L-xylulose <15>) {} <14,15>
SP	#3,19# D-xylulose + NADH + H+ = D-arabinitol + NAD+ (#19# about 100fold
	lower activity compared to L-xylulose <15>) {r} <14,15>
SP	#4# 1,4-dibromo-2,3-butanedione + NADPH = ? + NADP+ (#4# dicarbonyl
	reductase activity <13>) {r} <13>
SP	#7,18,20,21,22,23# D-ribulose + NADPH = D-ribitol + NADP+
	(#18,20,21,22,23# reductase activity <14>) <14,21>
SP	#7,18,20,21,22,23# D-ribulose + NADPH = D-ribitol + NADP+
	(#18,20,21,22,23# reductase activity <14>) {r} <14,21>
SP	#8# D-sorbitol + NADP+ = ? <8>
SP	#8# D-ribulose + NADPH + H+ = D-ribitol + NADP+ <32>

TURNOVER_NUMBER
TN	#18# 0.52 {DL-glyceraldehyde}  (#18# pH 7.0, 25°C <14>) <14>
TN	#18# 0.52 {D-ribulose}  (#18# pH 7.0, 25°C <14>) <14>
TN	#18# 0.52 {L-threose}  (#18# pH 7.0, 25°C <14>) <14>
TN	#18# 3.8 {NADH}  (#18# pH 7.0, 25°C <14>) <14>
TN	#18# 0.1 {D-xylulose}  (#18# pH 7.0, 25°C <14>) <14>
TN	#18# 1.5 {NADPH}  (#18# pH 7.0, 25°C <14>) <14>
TN	#18# 1.5 {NAD+}  (#18# pH 7.0, 25°C <14>) <14>
TN	#18# 1.6 {diacetyl}  (#18# pH 7.0, 25°C <14>) <14>
TN	#18# 0.65 {NADP+}  (#18# pH 7.0, 25°C <14>) <14>
TN	#18# 0.65 {L-xylulose}  (#18# pH 7.0, 25°C <14>) <14>
TN	#18# 0.65 {acetoin}  (#18# pH 7.0, 25°C <14>) <14>
TN	#18# 0.82 {D-threose}  (#18# pH 7.0, 25°C <14>) <14>
TN	#18# 0.6 {xylitol}  (#18# pH 7.0, 25°C <14>) <14>
TN	#18# 0.6 {L-erythrulose}  (#18# pH 7.0, 25°C <14>) <14>
TN	#18# 0.43 {D-erythrose}  (#18# pH 7.0, 25°C <14>) <14>
TN	#18# 0.48 {D-threitol}  (#18# pH 7.0, 25°C <14>) <14>
TN	#18# 0.23 {dihydroxyacetone}  (#18# pH 7.0, 25°C <14>) <14>
TN	#20# 3.3 {dihydroxyacetone}  (#20# pH 7.0, 25°C <14>) <14>
TN	#20# 15 {NADP+}  (#20# pH 7.0, 25°C <14>) <14>
TN	#20# 34 {NADPH}  (#20# pH 7.0, 25°C <14>) <14>
TN	#20# 3 {acetoin}  (#20# pH 7.0, 25°C <14>) <14>
TN	#20# 55 {NAD+}  (#20# pH 7.0, 25°C <14>) <14>
TN	#20# 7.4 {D-xylulose}  (#20# pH 7.0, 25°C <14>) <14>
TN	#20# 17 {xylitol}  (#20# pH 7.0, 25°C <14>) <14>
TN	#20# 41 {NADH}  (#20# pH 7.0, 25°C <14>) <14>
TN	#20# 41 {diacetyl}  (#20# pH 7.0, 25°C <14>) <14>
TN	#20# 26 {D-ribulose}  (#20# pH 7.0, 25°C <14>) <14>
TN	#20# 24 {DL-glyceraldehyde}  (#20# pH 7.0, 25°C <14>) <14>
TN	#20# 23 {L-erythrulose}  (#20# pH 7.0, 25°C <14>) <14>
TN	#20# 23 {D-threose}  (#20# pH 7.0, 25°C <14>) <14>
TN	#20,21# 18 {D-erythrose}  (#20,21# pH 7.0, 25°C <14>) <14>
TN	#20,21# 16 {L-threose}  (#20,21# pH 7.0, 25°C <14>) <14>
TN	#20,22# 37 {L-xylulose}  (#20,22# pH 7.0, 25°C <14>) <14>
TN	#20,23# 16 {D-threitol}  (#20,23# pH 7.0, 25°C <14>) <14>
TN	#21# 2-8 {D-threose}  (#21# pH 7.0, 25°C <14>) <14>
TN	#21# 18 {D-xylulose}  (#21# pH 7.0, 25°C <14>) <14>
TN	#21# 21 {DL-glyceraldehyde}  (#21# pH 7.0, 25°C <14>) <14>
TN	#21# 39 {L-xylulose}  (#21# pH 7.0, 25°C <14>) <14>
TN	#21# 10 {NADP+}  (#21# pH 7.0, 25°C <14>) <14>
TN	#21# 10 {xylitol}  (#21# pH 7.0, 25°C <14>) <14>
TN	#21# 25 {diacetyl}  (#21# pH 7.0, 25°C <14>) <14>
TN	#21# 19 {D-ribulose}  (#21# pH 7.0, 25°C <14>) <14>
TN	#21# 41 {NAD+}  (#21# pH 7.0, 25°C <14>) <14>
TN	#21# 12 {D-threitol}  (#21# pH 7.0, 25°C <14>) <14>
TN	#21# 5.1 {dihydroxyacetone}  (#21# pH 7.0, 25°C <14>) <14>
TN	#21# 23 {NADH}  (#21# pH 7.0, 25°C <14>) <14>
TN	#21,22,23# 6.9 {acetoin}  (#21,22,23# pH 7.0, 25°C <14>) <14>
TN	#21,23# 25 {L-erythrulose}  (#21,23# pH 7.0, 25°C <14>) <14>
TN	#22# 3.8 {dihydroxyacetone}  (#22# pH 7.0, 25°C <14>) <14>
TN	#22# 2-8 {D-erythrose}  (#22# pH 7.0, 25°C <14>) <14>
TN	#22# 15 {D-threitol}  (#22# pH 7.0, 25°C <14>) <14>
TN	#22# 27 {L-threose}  (#22# pH 7.0, 25°C <14>) <14>
TN	#22# 20 {xylitol}  (#22# pH 7.0, 25°C <14>) <14>
TN	#22# 20 {DL-glyceraldehyde}  (#22# pH 7.0, 25°C <14>) <14>
TN	#22# 76 {NADH}  (#22# pH 7.0, 25°C <14>) <14>
TN	#22# 19 {D-xylulose}  (#22# pH 7.0, 25°C <14>) <14>
TN	#22# 26 {NADPH}  (#22# pH 7.0, 25°C <14>) <14>
TN	#22# 24 {diacetyl}  (#22# pH 7.0, 25°C <14>) <14>
TN	#22# 24 {L-erythrulose}  (#22# pH 7.0, 25°C <14>) <14>
TN	#22# 23 {NADP+}  (#22# pH 7.0, 25°C <14>) <14>
TN	#22# 32 {D-threose}  (#22# pH 7.0, 25°C <14>) <14>
TN	#22# 7.8 {D-ribulose}  (#22# pH 7.0, 25°C <14>) <14>
TN	#23# 22 {DL-glyceraldehyde}  (#23# pH 7.0, 25°C <14>) <14>
TN	#23# 27 {NADPH}  (#23# pH 7.0, 25°C <14>) <14>
TN	#23# 8.7 {dihydroxyacetone}  (#23# pH 7.0, 25°C <14>) <14>
TN	#23# 30 {diacetyl}  (#23# pH 7.0, 25°C <14>) <14>
TN	#23# 44 {NAD+}  (#23# pH 7.0, 25°C <14>) <14>
TN	#23# 26 {NADP+}  (#23# pH 7.0, 25°C <14>) <14>
TN	#23# 31 {D-ribulose}  (#23# pH 7.0, 25°C <14>) <14>
TN	#23# 31 {D-threose}  (#23# pH 7.0, 25°C <14>) <14>
TN	#23# 6.9 {D-xylulose}  (#23# pH 7.0, 25°C <14>) <14>
TN	#23# 23 {D-erythrose}  (#23# pH 7.0, 25°C <14>) <14>
TN	#23# 23 {L-threose}  (#23# pH 7.0, 25°C <14>) <14>
TN	#24# 1 {xylitol}  (#24# pH 7.0, 30°C, recombinant enzyme <33>) <33>
TN	#24# 11.4 {L-xylulose}  (#24# pH 7.0, 30°C, recombinant enzyme <33>)
	<33>
TN	#24# 1.8 {D-sorbitol}  (#24# pH 7.0, 30°C, recombinant enzyme <33>) <33>
TN	#24# 7.75 {NADPH}  (#24# pH 7.0, 30°C, recombinant enzyme, with
	L-xylulose <33>) <33>
TN	#24# 8.24 {D-ribulose}  (#24# pH 7.0, 30°C, recombinant enzyme <33>)
	<33>
TN	#25# 2.32 {D-threose}  (#25# pH 7.0, temperature not specified in the
	publication <34>) <34>
TN	#25# 1.8 {D-erythrose}  (#25# pH 7.0, temperature not specified in the
	publication <34>) <34>
TN	#25# 1.22 {D-xylulose}  (#25# pH 7.0, temperature not specified in the
	publication <34>) <34>
TN	#25# 0.49 {L-ribulose}  (#25# pH 7.0, temperature not specified in the
	publication <34>) <34>
TN	#25# 3.32 {L-erythrulose}  (#25# pH 7.0, temperature not specified in
	the publication <34>) <34>
TN	#25# 4.98 {L-xylulose}  (#25# pH 7.0, temperature not specified in the
	publication <34>) <34>
TN	#3# 0.009 {diacetyl}  (#3# pH 7.0, 25°C, mutant N107D <17>) <17>
TN	#3# 0.0008 {diacetyl}  (#3# pH 7.0, 25°C, mutant N107L <17>) <17>
TN	#3# 1.57 {diacetyl}  (#3# pH 7.0, 25°C, wild-type enzyme <17>) <17>
TN	#4# 0.0005 {NADPH}  (#4# pH 7.0, 25°C, mutant K153M <13>) <13>
TN	#4# 9.5 {NADP+}  (#4# pH 7.0, 25°C, wild-type enzyme <13>) <13>
TN	#4# 0.0009 {NADPH}  (#4# pH 7.0, 25°C, mutant Y149F <13>) <13>
TN	#4# 0.0006 {NADPH}  (#4# pH 7.0, 25°C, mutant S136A <13>) <13>
TN	#4,21# 25 {NADPH}  (#21# pH 7.0, 25°C <14>; #4# pH 7.0, 25°C, wild-type
	enzyme <13>) <13,14>
TN	#7# 5.6 {xylitol}  <21>
TN	#7# 119 {D-ribulose}  <21>
TN	#9# 3-6 {L-xylulose}  (#9# pH 7.0, 25°C <14>) <14>
TN	#9# 2-8 {NADH}  (#9# pH 7.0, 25°C <14>) <14>
TN	#9# 2-8 {xylitol}  (#9# pH 7.0, 25°C <14>) <14>

KM_VALUE
KM	#1# 0.29 {L-xylulose}  <1>
KM	#12# 48 {xylitol}  <4>
KM	#14# 72 {xylitol}  <3>
KM	#18# 1.5 {acetoin}  (#18# pH 7.0, 25°C <14>) <14>
KM	#18# 2.5 {L-erythrulose}  (#18# pH 7.0, 25°C <14>) <14>
KM	#18# 5 {D-ribulose}  (#18# pH 7.0, 25°C <14>) <14>
KM	#18# 25 {xylitol}  (#18# pH 7.0, 25°C <14>) <14>
KM	#18# 18 {D-threitol}  (#18# pH 7.0, 25°C <14>) <14>
KM	#19# 4.7 {D-ribulose}  (#19# pH 7.0, 30°C, purified recombinant enzyme
	<15>) <15>
KM	#19# 2.7 {D-arabinitol}  (#19# pH 9.0, 30°C, purified recombinant
	enzyme <15>) <15>
KM	#19# 9.6 {L-xylulose}  (#19# pH 7.0, 30°C, purified recombinant enzyme
	<15>) <15>
KM	#19# 7.2 {L-xylitol}  (#19# pH 9.0, 30°C, purified recombinant enzyme
	<15>) <15>
KM	#2# 0.22 {NADH}  (#2# pH 7.0, 25°C <14>) <14>
KM	#2# 0.67 {diacetyl}  (#2# pH 7.0, 25°C <14>) <14>
KM	#2# 2.4 {D-threose}  (#2# pH 7.0, 25°C <14>) <14>
KM	#2# 5.7 {D-ribulose}  (#2# pH 7.0, 25°C <14>) <14>
KM	#2# 5.7 {D-erythrose}  (#2# pH 7.0, 25°C <14>) <14>
KM	#2# 4.8 {L-erythrulose}  (#2# pH 7.0, 25°C <14>) <14>
KM	#2# 5.6 {L-threose}  (#2# pH 7.0, 25°C <14>) <14>
KM	#2# 0.24 {L-xylulose}  (#2# pH 7.0, 25°C <14>) <14>
KM	#2# 0.99 {NAD+}  (#2# pH 7.0, 25°C <14>) <14>
KM	#2,22# 0.005 {NADPH}  (#2,22# pH 7.0, 25°C <14>) <14>
KM	#2,4,9# 0.003 {NADP+}  (#4# pH 7.0, 25°C, wild-type enzyme <13>;
	#2,4,9# pH 7.0, 25°C <14>) <13,14>
KM	#20# 9 {acetoin}  (#20# pH 7.0, 25°C <14>) <14>
KM	#20# 6 {DL-glyceraldehyde}  (#20# pH 7.0, 25°C <14>) <14>
KM	#20# 15 {xylitol}  (#20# pH 7.0, 25°C <14>) <14>
KM	#20# 37 {D-threitol}  (#20# pH 7.0, 25°C <14>) <14>
KM	#20# 47 {dihydroxyacetone}  (#20# pH 7.0, 25°C <14>) <14>
KM	#20,23# 12 {D-xylulose}  (#20,23# pH 7.0, 25°C <14>) <14>
KM	#21# 1.5 {NAD+}  (#21# pH 7.0, 25°C <14>) <14>
KM	#21# 4 {D-threose}  (#21# pH 7.0, 25°C <14>) <14>
KM	#21# 11 {xylitol}  (#21# pH 7.0, 25°C <14>) <14>
KM	#21# 16 {D-threitol}  (#21# pH 7.0, 25°C <14>) <14>
KM	#21# 6 {D-erythrose}  (#21# pH 7.0, 25°C <14>) <14>
KM	#21# 5.5 {L-erythrulose}  (#21# pH 7.0, 25°C <14>) <14>
KM	#21,22# 18 {D-xylulose}  (#21,22# pH 7.0, 25°C <14>) <14>
KM	#21,23# 60 {dihydroxyacetone}  (#21,23# pH 7.0, 25°C <14>) <14>
KM	#22# 0.05 {L-xylulose}  (#22# pH 7.0, 25°C <14>) <14>
KM	#22# 0.002 {NADP+}  (#22# pH 7.0, 25°C <14>) <14>
KM	#22# 2 {L-erythrulose}  (#22# pH 7.0, 25°C <14>) <14>
KM	#22# 2 {D-threose}  (#22# pH 7.0, 25°C <14>) <14>
KM	#22# 1.4 {DL-glyceraldehyde}  (#22# pH 7.0, 25°C <14>) <14>
KM	#22# 10 {xylitol}  (#22# pH 7.0, 25°C <14>) <14>
KM	#22# 0.59 {D-erythrose}  (#22# pH 7.0, 25°C <14>) <14>
KM	#22# 0.69 {NADH}  (#22# pH 7.0, 25°C <14>) <14>
KM	#22# 14 {D-threitol}  (#22# pH 7.0, 25°C <14>) <14>
KM	#22# 2.9 {L-threose}  (#22# pH 7.0, 25°C <14>) <14>
KM	#22# 0.52 {diacetyl}  (#22# pH 7.0, 25°C <14>) <14>
KM	#22# 36 {dihydroxyacetone}  (#22# pH 7.0, 25°C <14>) <14>
KM	#22# 13 {acetoin}  (#22# pH 7.0, 25°C <14>) <14>
KM	#22# 7.8 {D-ribulose}  (#22# pH 7.0, 25°C <14>) <14>
KM	#23# 40 {xylitol}  (#23# pH 7.0, 25°C <14>) <14>
KM	#23# 34 {D-threitol}  (#23# pH 7.0, 25°C <14>) <14>
KM	#24# 100 {xylitol}  (#24# pH 7.0, 30°C, recombinant enzyme <33>) <33>
KM	#24# 0.13 {NADPH}  (#24# pH 7.0, 30°C, recombinant enzyme, with
	L-xylulose <33>) <33>
KM	#24# 16 {L-xylulose}  (#24# pH 7.0, 30°C, recombinant enzyme <33>) <33>
KM	#24# 250 {D-sorbitol}  (#24# pH 7.0, 30°C, recombinant enzyme <33>) <33>
KM	#24# 105 {D-ribulose}  (#24# pH 7.0, 30°C, recombinant enzyme <33>) <33>
KM	#25# 0.17 {L-erythrulose}  (#25# pH 7.0, temperature not specified in
	the publication <34>) <34>
KM	#25# 0.18 {L-ribulose}  (#25# pH 7.0, temperature not specified in the
	publication <34>) <34>
KM	#25# 0.66 {L-xylulose}  (#25# pH 7.0, temperature not specified in the
	publication <34>) <34>
KM	#25# 0.27 {D-erythrose}  (#25# pH 7.0, temperature not specified in the
	publication <34>) <34>
KM	#25# 0.68 {D-threose}  (#25# pH 7.0, temperature not specified in the
	publication <34>) <34>
KM	#25# 2.58 {D-xylulose}  (#25# pH 7.0, temperature not specified in the
	publication <34>) <34>
KM	#3# 0.17 {NADH}  (#3# pH 7.0, 25°C <14>) <14>
KM	#3# 0.001 {NADP+}  (#3# pH 7.0, 25°C <14>) <14>
KM	#3# 0.21 {L-xylulose}  (#3# pH 7.0, 25°C <14>) <14>
KM	#3# 0.22 {diacetyl}  (#3# mutant enzyme C138A, in 10 mM potassium
	phosphate buffer <29>) <29>
KM	#3# 2.4 {D-erythrose}  (#3# pH 7.0, 25°C <14>) <14>
KM	#3# 1.2 {DL-glyceraldehyde}  (#3# pH 7.0, 25°C <14>) <14>
KM	#3# 1.9 {D-threose}  (#3# pH 7.0, 25°C <14>) <14>
KM	#3# 4.8 {D-xylulose}  (#3# pH 7.0, 25°C <14>) <14>
KM	#3# 0.85 {NAD+}  (#3# pH 7.0, 25°C <14>) <14>
KM	#3# 1.6 {dihydroxyacetone}  (#3# pH 7.0, 25°C <14>) <14>
KM	#3# 4.2 {L-threose}  (#3# pH 7.0, 25°C <14>) <14>
KM	#3# 26 {diacetyl}  (#3# pH 7.0, 25°C, mutant N107D <17>) <17>
KM	#3# 0.077 {diacetyl}  (#3# pH 7.0, 25°C, wild-type enzyme <17>; #3# pH
	7.0, 25°C <14>) <14,17>
KM	#3# 31 {diacetyl}  (#3# pH 7.0, 25°C, mutant N107L <17>) <17>
KM	#3# 95 {NADPH}  (#3# pH 7.0, 25°C, mutant N107D <17>) <17>
KM	#3# 97 {NADPH}  (#3# pH 7.0, 25°C, mutant N107L <17>) <17>
KM	#3# 0.0945 {diacetyl}  (#3# wild type enzyme, in 10 mM potassium
	phosphate buffer <29>) <29>
KM	#3,4# 0.002 {NADPH}  (#3# pH 7.0, 25°C, wild-type enzyme <17>; #3# pH
	7.0, 25°C <14>; #4# pH 7.0, 25°C, mutant Y149F <13>) <13,14,17>
KM	#4# 0.05 {1,4-dibromo-2,3-butanedione}  (#4# pH 7.0, 25°C, mutant S136A
	<13>) <13>
KM	#4# 0.1 {1,4-dibromo-2,3-butanedione}  (#4# pH 7.0, 25°C, mutant K153M
	<13>) <13>
KM	#4# 0.31 {L-xylulose}  (#4# pH 7.0, 25°C, mutant N190V <13>) <13>
KM	#4# 0.013 {L-xylitol}  (#4# pH 7.0, 25°C, mutant S136A <13>) <13>
KM	#4# 0.005 {1,4-dibromo-2,3-butanedione}  (#4# pH 7.0, 25°C, wild-type
	enzyme <13>) <13>
KM	#4# 0.0046 {NADPH}  (#4# pH 7.0, 25°C, mutant S136A <13>) <13>
KM	#4# 0.14 {L-xylulose}  (#4# pH 7.0, 25°C, wild-type enzyme and mutant
	L143F <13>) <13>
KM	#4# 0.78 {diacetyl}  (#4# pH 7.0, 25°C, wild-type enzyme <13>) <13>
KM	#4# 0.23 {L-xylulose}  (#4# pH 7.0, 25°C <14>) <14>
KM	#4# 0.011 {L-xylitol}  (#4# pH 7.0, 25°C, wild-type enzyme <13>) <13>
KM	#4# 1.2 {diacetyl}  (#4# pH 7.0, 25°C, mutant H146L <13>) <13>
KM	#4# 3 {diacetyl}  (#4# pH 7.0, 25°C, mutant Q137M <13>) <13>
KM	#4# 0.007 {NADPH}  (#4# pH 7.0, 25°C, wild-type enzyme <13>; #4# pH
	7.0, 25°C <14>) <13,14>
KM	#4# 0.085 {L-xylitol}  (#4# pH 7.0, 25°C, mutant K153M <13>) <13>
KM	#4# 0.33 {L-xylulose}  (#4# pH 7.0, 25°C, mutant Q137M <13>) <13>
KM	#4# 0.0013 {NADP+}  (#4# pH 7.0, 25°C, mutant Y149F <13>) <13>
KM	#4# 0.36 {NADH}  (#4# pH 7.0, 25°C <14>) <14>
KM	#4# 8.3 {L-threose}  (#4# pH 7.0, 25°C <14>) <14>
KM	#4# 1.1 {diacetyl}  (#4# pH 7.0, 25°C <14>) <14>
KM	#4# 2.7 {DL-glyceraldehyde}  (#4# pH 7.0, 25°C <14>) <14>
KM	#4# 2.7 {diacetyl}  (#4# pH 7.0, 25°C, mutant
	N190V/W191S/Q137M/L143F/H146L <13>) <13>
KM	#4# 11 {diacetyl}  (#4# pH 7.0, 25°C, mutant Q137M/L143F <13>) <13>
KM	#4# 0.053 {NADPH}  (#4# pH 7.0, 25°C, mutant K153M <13>) <13>
KM	#4# 16 {diacetyl}  (#4# pH 7.0, 25°C, mutant N190V/W191S <13>) <13>
KM	#4# 2.6 {diacetyl}  (#4# pH 7.0, 25°C, mutant N190V <13>) <13>
KM	#4# 0.092 {L-xylulose}  (#4# pH 7.0, 25°C, mutant H146L <13>) <13>
KM	#4# 3.6 {L-xylulose}  (#4# pH 7.0, 25°C, mutant Q137M/L143F <13>) <13>
KM	#4# 42 {diacetyl}  (#4# pH 7.0, 25°C, mutant W191S <13>) <13>
KM	#4# 9.6 {diacetyl}  (#4# pH 7.0, 25°C, mutant Q137M/L143F/H146L <13>)
	<13>
KM	#4# 5.2 {diacetyl}  (#4# pH 7.0, 25°C, mutant W191F <13>) <13>
KM	#4# 6.2 {diacetyl}  (#4# pH 7.0, 25°C, mutant L143F <13>) <13>
KM	#4# 7.2 {L-xylulose}  (#4# pH 7.0, 25°C, mutant W191F <13>) <13>
KM	#4# 0.0099 {L-xylitol}  (#4# pH 7.0, 25°C, mutant Y149F <13>) <13>
KM	#4# 0.139 {1,4-dibromo-2,3-butanedione}  (#4# pH 7.0, 25°C, mutant
	Y149F <13>) <13>
KM	#4# 0.117 {NADP+}  (#4# pH 7.0, 25°C, mutant K153M <13>) <13>
KM	#4# 6.9 {acetoin}  (#4# pH 7.0, 25°C <14>) <14>
KM	#4# 0.00067 {NADP+}  (#4# pH 7.0, 25°C, mutant S136A <13>) <13>
KM	#4,9# 6.3 {D-ribulose}  (#4,9# pH 7.0, 25°C <14>) <14>
KM	#7# 0.0026 {NADPH}  <21>
KM	#7# 150 {D-ribulose}  <21>
KM	#7# 0.153 {NADP+}  <21>
KM	#7# 1239 {xylitol}  <21>
KM	#8# 0.03 {NADPH}  <8>
KM	#8# 0.13 {NADP+}  <8>
KM	#8# 17 {L-xylulose}  <8>
KM	#8# 25 {L-xylulose}  (#8# pH 7.0, 22°C <32>) <32>
KM	#8# 925 {xylitol}  <8>
KM	#9# 0.26 {L-xylulose}  (#9# pH 7.0, 25°C <14>) <14>
KM	#9# 0.003 {NADPH}  (#9# pH 7.0, 25°C <14>) <14>
KM	#9# 0.2 {diacetyl}  (#9# pH 7.0, 25°C <14>) <14>
KM	#9# 0.12 {NADH}  (#9# pH 7.0, 25°C <14>) <14>
KM	#9# 3.3 {acetoin}  (#9# pH 7.0, 25°C <14>) <14>
KM	#9# 4.3 {L-threose}  (#9# pH 7.0, 25°C <14>) <14>
KM	#9# 2.7 {D-threose}  (#9# pH 7.0, 25°C <14>) <14>
KM	#9# 0.91 {NAD+}  (#9# pH 7.0, 25°C <14>) <14>
KM	#9# 3.9 {D-erythrose}  (#9# pH 7.0, 25°C <14>) <14>
KM	#9# 2.9 {L-erythrulose}  (#9# pH 7.0, 25°C <14>) <14>
KM	#9# 5.1 {DL-glyceraldehyde}  (#9# pH 7.0, 25°C <14>) <14>

PH_OPTIMUM
PHO	#1# 7.5 (#1# approximately <6>) <6>
PHO	#1,2,3,4,7,18,19,20,21,22,23,24,25# 7 (#2,3,4,18,20,21,22,23,25# assay
	at <11,13,14,17,34>; #24# reduction reaction <33>; #7# reductase
	activity <21>; #19# forward, reduction reaction <15>)
	<1,11,13,14,15,17,21,33,34>
PHO	#13# 8 <35>
PHO	#7,19,24# 9 (#24# oxidation reaction <33>; #7# oxidase activity <21>;
	#19# reverse, oxidation reaction <15>) <15,21,33>
PHO	#8# 6.5 (#8# reduction of L-xylulose <8>) <8>
PHO	#8# 10-11 (#8# oxidation of xylitol <8>) <8>

PH_RANGE
PHR	#13# 6-8 (#13# 92% of maximal activity at pH 6.0, 70% at pH 8.0, 60% at
	pH 9.0, and maximal activity at pH 8.0 <35>) <35>
PHR	#7# 4.5-8.5 (#7# pH 4.5: about 55% of maximal activity, pH 8.5: about
	70% of maximal activity, reductase activity <21>) <21>
PHR	#7# 7-10.5 (#7# pH 7.0: about 40% of maximal activity, pH 10.5: about
	60% of maximal activity, oxidase activity <21>) <21>
PHR	#8# 5-8.5 (#8# reduction of L-xylulose <8>) <8>
PHR	#8# 8-11.5 (#8# oxidation of xylitol <8>) <8>

SPECIFIC_ACTIVITY
SA	#12# 0.23 (#12# xylitol dehydrogenase activity <4>) <4>
SA	#13# 0.026 (#13# crude enzyme extract, induced cells, pH 8.0, 40°C
	<35>) <35>
SA	#15# 14.11 (#15# recombinant strains harboring genes Xr and mutated
	XDH, pH and temperature not specified in the publication <37>) <37>
SA	#22# 143.0 (#22# purified native enzyme, L-xylulose reductase activity
	<14>) <14>
SA	#23# 642.0 (#23# purified native enzyme, L-xylulose reductase activity
	<14>) <14>
SA	#8# 1.4 (#8# substrate ribulose, pH 7.0, 22°C <32>) <32>
SA	#8# 1.0 (#8# substrate xylitol, pH 7.0, 22°C <32>) <32>
SA	#8# 200.0 (#8# L-xylulose reduction, NADPH <8>) <8>
SA	#8# 1.8 (#8# substrate L-xylulose, pH 7.0, 22°C <32>) <32>
SA	#8# 33.0 (#8# xylitol oxidation, NADP+ <8>) <8>

TEMPERATURE_OPTIMUM
TO	#13# 50 <35>
TO	#19# 30 (#19# assay at <15>) <15>
TO	#2,3,4,18,20,21,22,23# 25 (#2,3,4,18,20,21,22,23# assay at
	<11,13,14,17>) <11,13,14,17>
TO	#7# 37 (#7# reductase activity <21>) <21>

TEMPERATURE_RANGE
TR	#13# 40-70 (#13# about 40% of maximal activity at 40°C, 7% at 70°C, and
	maximal activity at 50°C <35>) <35>
TR	#7# 15-55 (#7# 15°C: about 65% of maximal activity, 55°C: about 60% of
	maximal activity, reductase activity <21>) <21>

COFACTOR
CF	#1,2,3,4,6,7,8,13,15,18,20,21,22,23,24# NADP+ (#13# specific for <35>;
	#1# B-specific hydrogen transfer from xylitol to NADP+ <2>; #1# much
	more effective than NAD+ <6>; #3# binding structure determination <17>;
	#18,20,21,22,23# preferred cofactor, reverse reaction <14>; #15#
	engineered enzyme with altered cofactor specificity <37>)
	<2,5,6,8,11,13,14,17,20,21,33,35,37>
CF	#1,6,8,12,15,18,19,20,21,22,23# NAD+ (#1# much less effective than
	NADP+ <6>; #1,15# preference for, coenzyme-binding domain is a
	beta-alpha-beta-fold typical for NAD+ dehydrogenases <2,9>; #8# no
	activity with <8>; #19# specific for, no activity with NADP+ <15>)
	<2,4,5,6,8,9,14,15>
CF	#1,7,8,13,25# more (#25# no activity with NADH <34>; #8# determination
	of Ki of NADP+ and NADPH in competition with each other <8>; #13# no
	activity with NAD+ <35>; #7# the enzyme does not accept NAD+ <21>; #8#
	no activitiy with NADH <32>) <1,8,21,32,34,35>
CF	#18,19,20,21,22,23# NADH (#19# specific for no activity with NADPH
	<15>) <14,15>
CF	#2,3,4,5,8,10,15,17,18,20,21,22,23,24,25# NADPH (#10# dependent on
	<30,31>; #8# preference for <8>; #3# binding structure determination
	<17>; #18,20,21,22,23# preferred cofactor, forward reaction <14>; #15#
	has a higher affinity for NADPH than for NADH <26>)
	<8,11,12,13,14,17,18,20,25,26,27,28,29,30,31,32,33,34>

INHIBITORS
IN	#1# p-chloromercuribenzoate <1>
IN	#1# phosphate buffer <7>
IN	#1# iodoacetate (#1# not inhibitory <1>; #1# complete inhibition of
	L-xylulose reductive activity at 5 mM <6>) <1,6>
IN	#1# fluoride (#1# 50 mM <7>) <7>
IN	#1# aminopyrine (#1# 70 mM <7>) <7>
IN	#1,3,10,18,20,21,23# more (#1# not: EDTA <1>; #23# acetic acid is a
	poor inhibitor <14>; #20# acetic acid, acetoacetic acid, 3-OH-butyric
	acid, and octanoic acid are poor inhibitors <14>; #21# acetic acid,
	oxaloacetic acid, and octanoic acid are poor inhibitors <14>; #18#
	acetic acid, threonic acid, and octanoic acid are poor inhibitors <14>;
	#3# modelling of structure-based inhibitor binding into the active site
	<12>; #10# the level of xylose reductase decreases when the initial
	xylose concentration is increased from 30 to 70 g/l <31>) <1,12,14,31>
IN	#18,20,21,23# pentanoic acid (#21# 50% inhibition at 0.5 mM <14>; #18#
	50% inhibition at 0.15 mM <14>; #23# 50% inhibition at 0.20 mM <14>;
	#20# 50% inhibition at 0.38 mM <14>) <14>
IN	#18,20,21,23# Pyruvic acid (#20# 50% inhibition at 1.5 mM <14>; #18#
	50% inhibition at 0.50 mM <14>; #23# 50% inhibition at 0.88 mM <14>;
	#21# 50% inhibition at 1.0 mM <14>) <14>
IN	#18,20,21,23# heptanoic acid (#21# 50% inhibition at 2.5 mM <14>; #23#
	50% inhibition at 1.4 mM <14>; #18# 50% inhibition at 0.38 mM <14>;
	#20# 50% inhibition at 2.0 mM <14>) <14>
IN	#18,20,21,23# propionic acid (#23# 50% inhibition at 0.096 mM <14>;
	#21# 50% inhibition at 0.13 mM <14>; #20# 50% inhibition at 0.17 mM
	<14>; #18# 50% inhibition at 0.38 mM <14>) <14>
IN	#18,20,21,23# hexanoic acid (#18# 50% inhibition at 0.10 mM <14>; #23#
	50% inhibition at 0.40 mM <14>; #21# 50% inhibition at 0.42 mM <14>;
	#20# 50% inhibition at 1.1 mM <14>) <14>
IN	#18,20,23# oxaloacetic acid (#20,23# 50% inhibition at 2.5 mM <14>;
	#18# 50% inhibition at 0.91 mM <14>) <14>
IN	#18,21,23# acetoacetic acid (#21# 50% inhibition at 2.5 mM <14>; #23#
	50% inhibition at 1.8 mM <14>; #18# 50% inhibition at 0.63 mM <14>) <14>
IN	#18,21,23# 3-hydroxybutyric acid (#23# 50% inhibition at 1.0 mM <14>;
	#18# 50% inhibition at 1.1 mM <14>; #21# 50% inhibition at 2.0 mM <14>)
	<14>
IN	#20,21,23# threonic acid (#20# 50% inhibition at 1.5 mM <14>; #23# 50%
	inhibition at 0.75 mM <14>; #21# 50% inhibition at 1.9 mM <14>) <14>
IN	#23# octanoic acid (#23# 50% inhibition at 2.5 mM <14>) <14>
IN	#3# cysteine (#3# the addition of cysteine (more than 2 mM) inactivates
	human L-xylulose reductase and is accompanied by a 10fold decrease in
	catalytic efficiency, the activity of the cysteine-inactivated enzyme
	is not recovered by the addition of 10 mM dithiothreitol and
	2-mercaptoethanol <29>) <29>
IN	#3# potassium phosphate (#3# when the purified enzyme containing 2 mM
	2-mercaptoethanol is diluted with 10 mM potassium phosphate pH 7.0, its
	diacetyl reductase activity is gradually decreased <29>) <29>
IN	#3,4# 4-methyl-[1,2,3]-thiadiazole-5-carboxylic acid benzyloxyamide
	(#4# IC50: 0.00023 mM for wild-type enzyme, 0.0019 mM for mutant enzyme
	L143F, 0.0018 mM for mutant enzyme H146L, 0.0029 mM for mutant enzyme
	W191S, 0.00079 mM for mutant enzyme W191F <20>) <20>
IN	#3,4,18,20,21,23# n-butyric acid (#20# 50% inhibition at 0.05 mM <14>;
	#23# 50% inhibition at 0.026 mM <14>; #21# 50% inhibition at 0.052 mM
	<14>; #18# 50% inhibition at 0.064 mM <14>; #3# binds to the active
	site of the enzyme, complex structure determination and analysis <12>;
	#4# specific, binds to the enzyme-NADP+ complex, the mutant enzymes
	show altered sensitivity to inhibition, overview <13>) <12,13,14>
IN	#4# 4-methylthiophene-2-carboxylic acid
	N'-(2,3,3-trichloroacryloyl)-hydrazide (#4# IC50: 0.0003 mM for
	wild-type enzyme, 0.00056 mM for mutant enzyme L143F, 0.002 mM for
	mutant enzyme H146L, 0.0002 mM for mutant enzyme W191S, 0.0022 mM for
	mutant enzyme W191F <20>) <20>

METALS_IONS
ME	#1,19# Mg2+ <6,15>

MOLECULAR_WEIGHT
MW	#12# 136000 (#12# non-denaturing PAGE <4>) <4>
MW	#14# 102000 (#14# 4D2P, nondenaturing PAGE <3>) <3>
MW	#16# 40000 (#16# 4 * 40000, about, sequence calculation <10>) <10>
MW	#4# 26500 (#4# x * 26500 <13>) <13>
MW	#8# 250000 (#8# gel filtration <8>) <8>
MW	#8# 32000 (#8# 8 * 32000, SDS-PAGE <8>) <8>
MW	#9,24# 31000 (#9# x * 31000, SDS-PAGE <16>; #24# x * 31000 <33>) <16,33>

SUBUNITS
SU	#2# More (#2# the dimeric form is inactive <11>) <11>
SU	#2,3,4,5,16# tetramer (#16# 4 * 40000, about, sequence calculation
	<10>; #2,3# amino acid residues Trp242, Glu238, Arg203, and Cys244 are
	important for tetramer formation <11>) <10,11,18,20>
SU	#3# dimer (#3# x-ray crystallography <29>) <29>
SU	#4,9,24# ? (#9# x * 31000, SDS-PAGE <16>; #24# x * 31000 <33>; #4# x *
	26500 <13>) <13,16,33>
SU	#8# octamer (#8# 8 * 32000, SDS-PAGE <8>) <8>

APPLICATION
AP	#13# synthesis (#13# the microalga Chlorella sorokiniana and provide a
	target for genetic engineering to improve D-xylose utilization for
	microalgal lipid production <35>) <35>
AP	#3# pharmacology (#3# enzyme is a target for design and development of
	potent and specific structure-based inhibitors binding in the active
	site <12>) <12>

ENGINEERING
EN	#11,15,24,25# more (#15# several mutants per site-directed mutagenesis
	to change the coenzyme binding specificity, mutants showed reduced NAD+
	specificity <9>; #24# deletion of gene lxr3 leads to a significant
	reduction in NADPH specific LXR activity after replacement to both
	media containing L-arabinose <33>; #25# library screening and isolation
	of a dhs-21 deletion mutant <34>; #11# engineering of strain YZJ088 for
	ethanol production via the NADP(H)-preferring xylose reductase-xylitol
	dehydrogenase pathway in the thermotolerant yeast Kluyveromyces
	marxianus, method overview <36>; #15# enzyme XDH is changed from
	NAD+-dependent to NADP+-dependent, xylitol accumulation is reduced and
	ethanol production improved using protein engineering for reversing the
	dependency of XDH from NAD+ to NADP+. Construction of a set of
	recombinant Saccharomyces cerevisiae carrying a mutated strictly
	NADPH-dependent XR and NADP+-dependent XDH genes with overexpression of
	endogenous xylulokinase (XK), effects of complete NADPH/NADP+ recycling
	on ethanol fermentation and xylitol accumulation, overview. The mutated
	strains demonstrate 0% and 10% improvement in ethanol production, and
	reduced xylitol accumulation, ranging 34.4-54.7% compared with the
	control strain <37>) <9,33,34,36,37>
EN	#15# S96C/S99C/Y102C/D207A/I208R/F209S (#15# mutation produces a
	further 4fold improvement in the kcat/Km for NADP+ compared to mutant
	enzyme D207/I208R/F209S <24>) <24>
EN	#15# D207/I208R/F209S (#15# kcat/Km of mutant enzyme for NAD+ dropps
	15fold compared with the native enzyme, kcat/Km for NADP+ increases up
	to 4100fold <24>) <24>
EN	#2# D238E (#2# site-directed mutagenesis, mutant exists in dimeric form
	at low temperature like the wild-type enzyme resulting in cold
	inactivation <11>) <11>
EN	#2# L242W (#2# site-directed mutagenesis, mutation leads to partial
	prevention of cold inactivation, mutant exists in dimeric and
	tetrameric form at low temperature <11>) <11>
EN	#2# T244C (#2# site-directed mutagenesis, mutant exists in dimeric form
	at low temperature like the wild-type enzyme resulting in cold
	inactivation <11>) <11>
EN	#2# D238E/L242W (#2# site-directed mutagenesis, mutation leads to
	complete prevention of cold inactivation, mutant exists in tetrameric
	form at low temperature <11>) <11>
EN	#2# L242W/T244C (#2# site-directed mutagenesis, double mutation leads
	to partial prevention of cold inactivation, mutant exists in dimeric
	and tetrameric form at low temperature <11>) <11>
EN	#2# D238E/L242W/T244C (#2# site-directed mutagenesis, double mutation
	leads to partial prevention of cold inactivation, mutant exists in
	dimeric and tetrameric form at low temperature <11>) <11>
EN	#3# N107L (#3# site-directed mutagenesis, active site residue mutant,
	inactive <17>) <17>
EN	#3# N107D (#3# site-directed mutagenesis, active site residue mutant,
	inactive <17>) <17>
EN	#4# Y149F (#4# site-directed mutagenesis, active site mutant, complete
	loss of activity <13>) <13>
EN	#4# K153M (#4# site-directed mutagenesis, active site mutant, complete
	loss of activity <13>) <13>
EN	#4# W191F (#4# site-directed mutagenesis, altered activity <13>; #4#
	IC50-value for 4-methyl-[1,2,3]-thiadiazole-5-carboxylic acid
	benzyloxyamide is 3.4fold higher than wild-type value, IC50-value for
	4-methylthiophene-2-carboxylic acid
	N-(2,3,3-trichloroacryloyl)-hydrazide is 7.3fold higher than wild-type
	value <20>) <13,20>
EN	#4# S136A (#4# site-directed mutagenesis, active site mutant, complete
	loss of activity <13>) <13>
EN	#4# N190V/W191S (#4# site-directed mutagenesis, almost complete loss of
	L-xylulose reductase activity <13>) <13>
EN	#4# Q137M/L143F (#4# site-directed mutagenesis, increased Km for
	L-xylulose compared to the wild-type <13>) <13>
EN	#4# Q137M/L143F/H146L (#4# site-directed mutagenesis, almost complete
	loss of L-xylulose reductase activity, mutant shows 3-ketosteroid
	reductase activity <13>) <13>
EN	#4# N190V/W191S/Q137M/L143F/H146L (#4# site-directed mutagenesis,
	almost complete loss of L-xylulose reductase activity, mutant shows
	high 3-ketosteroid reductase activity <13>) <13>
EN	#4# Q137M (#4# site-directed mutagenesis, altered activity, stable
	against cold inactivation <13>) <13>
EN	#4# Q137M/F241L (#4# site-directed mutagenesis, altered activity,
	sensitive to cold inactivation like the wild-type enzyme <13>) <13>
EN	#4# L143F (#4# site-directed mutagenesis, altered activity <13>; #4#
	IC50-value for 4-methyl-[1,2,3]-thiadiazole-5-carboxylic acid
	benzyloxyamide is 8.3fold higher than wild-type value, IC50-value for
	4-methylthiophene-2-carboxylic acid
	N-(2,3,3-trichloroacryloyl)-hydrazide is 1.9fold higher than wild-type
	value <20>) <13,20>
EN	#4# H146L (#4# site-directed mutagenesis, altered activity <13>; #4#
	IC50-value for 4-methyl-[1,2,3]-thiadiazole-5-carboxylic acid
	benzyloxyamide is 7.8fold higher than wild-type value, IC50-value for
	4-methylthiophene-2-carboxylic acid
	N-(2,3,3-trichloroacryloyl)-hydrazide is 6.7fold higher than wild-type
	value <20>) <13,20>
EN	#4# N190V (#4# site-directed mutagenesis, altered activity <13>) <13>
EN	#4# W191S (#4# site-directed mutagenesis, altered activity <13>; #4#
	IC50-value for 4-methyl-[1,2,3]-thiadiazole-5-carboxylic acid
	benzyloxyamide is 13fold higher than wild-type value, IC50-value for
	4-methylthiophene-2-carboxylic acid
	N-(2,3,3-trichloroacryloyl)-hydrazide is 1.5fold lower than wild-type
	value <20>) <13,20>

CLONED
CL	#2# (expression of wild-type and mutant enzymes in Escherichia coli
	strain BL21(DE3)) <11>
CL	#2# (transgenic mice over-expressing dicarbonyl/L-xylulose reductase
	gene crossed with KK-A(y) diabetic model mice serve as an animal model
	for the metabolism of renal carbonyl compounds) <19>
CL	#3# (expression of wild-type and mutant enzymes in Escherichia coli)
	<17>
CL	#3# (expressed in Escherichia coli BL21 (DE3) cells) <29>
CL	#4# (expression of wild-type and mutant enzymes in Escherichia coli)
	<13>
CL	#7# (expressed in Escherichia coli as a His6 tag fusion protein) <21>
CL	#8# (expression in Saccharomyces cerevisiae) <32>
CL	#12# (Tn5 transposon transfer) <4>
CL	#15# (expressed in Saccharomyces cerevisiae) <27>
CL	#15# (a recombinant Saccharomyces cerevisiae strain D-XR/ARSdR/XK, in
	which protein engineered NADP+-dependent XDH is expressed, shows 40%
	increased ethanol production and 23% decrease in xylitol excretion as
	compared with the reference strain D-XR/XDH/XK expressing the wild-type
	XDH) <23>
CL	#15# (expression of Pichia stipitis mutated XYL2 (D207/I208R/F209S or
	XYL2 S96C/S99C/Y102C/D207A/I208R/F209S) in Saccharomyces cerevisiae)
	<24>
CL	#15# (expressed in Saccharomyces cerevisiae strain MA-R4) <25>
CL	#15# (expressed in Saccharomyces cerevisiae strains MA-N2, MA-N3,
	MA-N4, and MA-N5) <26>
CL	#15# (recombinant overexpression of strictly NADPH-dependent XR with
	mutated strictly NADP+-dependent XDH leading to increased bioethanol
	production and decreased xylitol accumulation in Saccharomyces
	cerevisiae strain D452-2 resulting in mutant strains SK-N1 to SK-N4)
	<37>
CL	#17# (expressed in Saccharomyces cerevisiae) <28>
CL	#19# (construction of a cDNA library, DNA sequence determination and
	analysis, subcloning in Escherichia coli DH5alpha, overexpression as
	His-tagged enzyme in Saccharomyces cerevisiae strain CEN.PK2) <15>
CL	#22# (DNA sequence determination and analysis, expression in
	Escherichia coli strain BL21(DE3)) <14>
CL	#24# (gene lxr3, phylogenetic analysis, cloning in Escherichia coli
	strain JM109, expression of N-terminal His-tagged in Saccharomyces
	cerevisiae strain CEN.PK2-1D) <33>
CL	#25# (gene dhs-21, DNA and amino acid sequence determination and
	analysis, the dhs-21 gene is physically mapped to the cosmid R11D1
	between the sma-1 and mes-4genes on chromosome V, expression of
	His6-tagged enzyme. Spatial and temporal expression pattern of the
	DHS-21-GFP construct in transgenic worms, overview) <34>
CL	#274945# (DNA sequence determination and analysis, expression in
	Escherichia coli strain BL21(DE3)) <14>

CRYSTALLIZATION
CR	#2# <18>
CR	#3# <18>
CR	#3# (structure of the biological tetramer of human L-xylulose reductase
	in complex with NADP+ and the competitive inhibitor
	4-methyl-[1,2,3]-thiadiazole-5-carboxylic acid benzyloxyamide, vapor
	diffusion method) <20>
CR	#3# (vapour diffusion method, using 15% PEG 8000, 0.05 M potassium
	phosphate and 0.1 M MES buffer, pH 6.5) <29>
CR	#18# (18 mg/ml purified enzyme complexed with NADPH, in 10 mM Tris-HCl,
	pH 7.5, 2 mM 2-mercaptoethanol, 20% glycerol, replacement buffer is 10
	mM Tris-HCl, pH 7.5, 2 mM 2-mercaptoethanol, mixed with 12.9 mM NADPH,
	in a molar ratio of enzyme and cofactor of 1:8, equal volume of 0.003
	ml of enzyme complex mixture and well solution, containing 15% PEG
	8000, 50 mM potassium phosphate, and 0.1 M MES, pH 6.5, 1 week, X-ray
	diffraction structure determination and analysis, molecular replacement
	method, 1.96 A resolution, molecular modeling) <17>
CR	#18# (crystal structure analysis and modelling) <11>

PURIFICATION
PU	#1# (partial) <1>
PU	#2# (recombinant wild-type and mutant enzymes from Escherichia coli)
	<11>
PU	#3# <29>
PU	#7# (recombinant enzyme) <21>
PU	#8# <8>
PU	#9# (recombinant enzyme from Escherichia coli, native from liver) <14>
PU	#12# (partial from strain DM101) <4>
PU	#14# (strain 4D2P, partial) <3>
PU	#16# <10>
PU	#19# (recombinant His-tagged enzyme from Saccharomyces cerevisiae by
	nickel affinity chromatography) <15>
PU	#22# (recombinant enzyme from Escherichia coli, native from liver) <14>
PU	#24# (recombinant N-terminal His-tagged enzyme from Saccharomyces
	cerevisiae strain CEN.PK2-1D by nickel affinity chromatography) <33>
PU	#274945# (recombinant enzyme from Escherichia coli) <14>

GENERAL_STABILITY
GS	#1# (inactivation during dialysis) <6>

PH_STABILITY
PHS	#1# 9 (#1# room temperature, several h stable <6>) <6>
PHS	#1# 4 (#1# 2°C, 2 h stable <6>) <6>

STORAGE_STABILITY
SS	#1# (2°C, aqueous solution, many weeks) <6>
SS	#1# (frozen, ammonium sulfate precipitate, several days) <1>
SS	#1# (0°C, mitochondria, 0.15 M KCl- 0.01 M NaHCO3, minimum 2 days) <7>
SS	#8# (4°C, Tris-HCl 20 mM, pH 7.0, at leat several weeks) <8>

TEMPERATURE_STABILITY
TS	#1# 50 (#1# 20 min stable <6>) <6>
TS	#2,3,4,5# -999 (#2# dissociation into inactive dimers at low
	temperatures <11>; #3# stable at low temperatures <11>; #2,4,5# rapidly
	dissociates into the inactive dimeric form at low temperature <18>)
	<11,18>

REFERENCE
RF	<1> Hickman, J.; Ashwell, G.: A sensitive and stereospecific enzymatic
	assay for xylulose. J. Biol. Chem. (1959) 234, 758-761.
	{Pubmed:13654257} (c)
RF	<2> Alizade, M.A.; Brendel, K.; Gaede, K.: Chirality of
	xylitol-oxidizing enzymes from mammalian liver. FEBS Lett. (1976) 67,
	41-44. {Pubmed:8339} (c)
RF	<3> Doten, R.C.; Mortlock, R.P.: Inducible xylitol dehydrogenases in
	enteric bacteria. J. Bacteriol. (1985) 162, 845-848. {Pubmed:3886639}
	(c)
RF	<4> Doten, R.C.; Mortlock, R.P.: Characterization of xylitol-utilizing
	mutants of Erwinia uredovora. J. Bacteriol. (1985) 161, 529-533.
	{Pubmed:2981816}
RF	<5> Lowe, C.R.; Mosbach, K.; Dean, P.D.G.: Some applications of
	insolubilised cofactors to the purification of pyridine
	nucleotide-dependent dehydrogenases. Biochem. Biophys. Res. Commun.
	(1972) 48, 1004-1010. {Pubmed:4404621}
RF	<6> Hollmann, S.; Touster, O.: The L-xylulose-xylitol enzyme and other
	polyol dehydrogenases of guinea pig liver mitochondria. J. Biol. Chem.
	(1957) 225, 87-102. {Pubmed:13416220}
RF	<7> Touster, O.; Reynolds, V.H.; Hutcheson, R.M.: The reduction of
	L-xylulose to xylitol by guinea pig liver mitochondria. J. Biol. Chem.
	(1954) 221, 697-709. {Pubmed:13357463}
RF	<8> Witteveen, C.F.B.; Weber, F.; Busink, R.; Visser, J.: Isolation and
	characterization of two xylitol dehydrogenases from Aspergillus niger.
	Microbiology (1994) 140, 1679-1685. {Pubmed:}
RF	<9> Metzger, M.H.; Hollenberg, C.P.: Amino acid substitutions in the
	yeast Pichia stipitis xylitol dehydrogenase coenzyme-binding domain
	affect the coenzyme specificity. Eur. J. Biochem. (1995) 228, 50-54.
	{Pubmed:7883010}
RF	<10> Ishikura, S.; Isaji, T.; Usami, N.; Kitahara, K.; Nakagawa, J.;
	Hara, A.: Molecular cloning, expression and tissue distribution of
	hamster diacetyl reductase. Identity with L-xylulose reductase. Chem.
	Biol. Interact. (2001) 130-132, 879-889. {Pubmed:11306103}
RF	<11> Ishikura, S.; Usami, N.; El-Kabbani, O.; Hara, A.: Structural
	determinant for cold inactivation of rodent L-xylulose reductase.
	Biochem. Biophys. Res. Commun. (2003) 308, 68-72. {Pubmed:12890481}
RF	<12> Carbone, V.; Darmanin, C.; Ishikura, S.; Hara, A.; El-Kabbani, O.:
	Structure-based design of inhibitors of human L-xylulose reductase
	modelled into the active site of the enzyme. Bioorg. Med. Chem. Lett.
	(2003) 13, 1469-1474. {Pubmed:12668014}
RF	<13> Ishikura, S.; Isaji, T.; Usami, N.; Nakagawa, J.; El-Kabbani, O.;
	Hara, A.: Identification of amino acid residues involved in substrate
	recognition of L-xylulose reductase by site-directed mutagenesis. Chem.
	Biol. Interact. (2003) 143-144, 543-550. {Pubmed:12604240}
RF	<14> Nakagawa, J.; Ishikura, S.; Asami, J.; Isaji, T.; Usami, N.; Hara,
	A.; Sakurai, T.; Tsuritani, K.; Oda, K.; Takahashi, M.; Yoshimoto, M.;
	Otsuka, N.; Kitamura, K.: Molecular characterization of mammalian
	dicarbonyl/L-xylulose reductase and its localization in kidney. J.
	Biol. Chem. (2002) 277, 17888-17891. {Pubmed:11882650}
RF	<15> Verho, R.; Putkonen, M.; Londesborough, J.; Penttilä, M.; Richard,
	P.: A novel NADH-linked L-xylulose reductase in the L-arabinose
	catabolic pathway of yeast. J. Biol. Chem. (2004) 279, 14746-14751.
	{Pubmed:14736891}
RF	<16> Saint-Cyr, A.; Legare, C.; Frenette, G.; Gaudreault, C.; Sullivan,
	R.: P26h and dicarbonyl/L-xylulose reductase are two distinct proteins
	present in the hamster epididymis. Mol. Reprod. Dev. (2004) 69,
	137-145. {Pubmed:15293214}
RF	<17> El-Kabbani, O.; Ishikura, S.; Darmanin, C.; Carbone, V.; Chung,
	R.P.T.; Usami, N.; Hara, A.: Crystal structure of human L-xylulose
	reductase holoenzyme: probing the role of Asn107 with site-directed
	mutagenesis. Proteins (2004) 55, 724-732. {Pubmed:15103634}
RF	<18> Matsunaga, T.; Shintani, S.; Hara, A.: Multiplicity of mammalian
	reductases for xenobiotic carbonyl compounds. Drug Metab.
	Pharmacokinet. (2006) 21, 1-18. {Pubmed:16547389}
RF	<19> Sudo, T.; Ishii, A.; Asami, J.; Uematsu, Y.; Saitoh, M.; Nakamura,
	A.; Tada, N.; Ohnuki, T.; Komurasaki, T.; Nakagawa, J.: Transgenic mice
	over-expressing dicarbonyl/L-xylulose reductase gene crossed with
	KK-A(y) diabetic model mice: an animal model for the metabolism of
	renal carbonyl compounds. Exp. Anim. (2005) 54, 385-394.
	{Pubmed:16365515}
RF	<20> El-Kabbani, O.; Carbone, V.; Darmanin, C.; Ishikura, S.; Hara, A.:
	Structure of the tetrameric form of human L-xylulose reductase: probing
	the inhibitor-binding site with molecular modeling and site-directed
	mutagenesis. Proteins (2005) 60, 424-432. {Pubmed:15906319}
RF	<21> Nair, N.; Zhao, H.: Biochemical characterization of an L-Xylulose
	reductase from Neurospora crassa. Appl. Environ. Microbiol. (2007) 73,
	2001-2004. {Pubmed:17261518}
RF	<22> Matsunaga, T.; Kamiya, T.; Sumi, D.; Kumagai, Y.; Kalyanaraman,
	B.; Hara, A.: L-Xylulose reductase is involved in
	9,10-phenanthrenequinone-induced apoptosis in human T lymphoma cells.
	Free Radic. Biol. Med. (2008) 44, 1191-1202. {Pubmed:18206670}
RF	<23> Matsushika, A.; Watanabe, S.; Kodaki, T.; Makino, K.; Sawayama,
	S.: Bioethanol production from xylose by recombinant Saccharomyces
	cerevisiae expressing xylose reductase, NADP(+)-dependent xylitol
	dehydrogenase, and xylulokinase. J. Biosci. Bioeng. (2008) 105,
	296-299. {Pubmed:18397783}
RF	<24> Hou, J.; Shen, Y.; Li, X.P.; Bao, X.M.: Effect of the reversal of
	coenzyme specificity by expression of mutated Pichia stipitis xylitol
	dehydrogenase in recombinant Saccharomyces cerevisiae. Lett. Appl.
	Microbiol. (2007) 45, 184-189. {Pubmed:17651216}
RF	<25> Matsushika, A.; Inoue, H.; Watanabe, S.; Kodaki, T.; Makino, K.;
	Sawayama, S.: Efficient bioethanol production by a recombinant
	flocculent Saccharomyces cerevisiae strain with a genome-integrated
	NADP+-dependent xylitol dehydrogenase gene. Appl. Environ. Microbiol.
	(2009) 75, 3818-3822. {Pubmed:19329659}
RF	<26> Matsushika, A.; Watanabe, S.; Kodaki, T.; Makino, K.; Inoue, H.;
	Murakami, K.; Takimura, O.; Sawayama, S.: Expression of protein
	engineered NADP+-dependent xylitol dehydrogenase increases ethanol
	production from xylose in recombinant Saccharomyces cerevisiae. Appl.
	Microbiol. Biotechnol. (2008) 81, 243-255. {Pubmed:18751695}
RF	<27> Hou, J.; Vemuri, G.N.; Bao, X.; Olsson, L.: Impact of
	overexpressing NADH kinase on glucose and xylose metabolism in
	recombinant xylose-utilizing Saccharomyces cerevisiae. Appl. Microbiol.
	Biotechnol. (2009) 82, 909-919. {Pubmed:19221731}
RF	<28> Krahulec, S.; Klimacek, M.; Nidetzky, B.: Engineering of a matched
	pair of xylose reductase and xylitol dehydrogenase for xylose
	fermentation by Saccharomyces cerevisiae. Biotechnol. J. (2009) 4,
	684-694. {Pubmed:19452479}
RF	<29> Zhao, H.T.; Endo, S.; Ishikura, S.; Chung, R.; Hogg, P.J.; Hara,
	A.; El-Kabbani, O.: Structure/function analysis of a critical disulfide
	bond in the active site of L-xylulose reductase. Cell. Mol. Life Sci.
	(2009) 66, 1570-1579. {Pubmed:19337691}
RF	<30> Branco, R.; dos Santos, J.; Sarrouh, B.; Rivaldi, J.; Pessoa Jr.,
	A.; da Silva, S.: Profiles of xylose reductase, xylitol dehydrogenase
	and xylitol production under different oxygen transfer volumetric
	coefficient values. J. Chem. Technol. Biotechnol. (2009) 84, 326-330.
	{Pubmed:}
RF	<31> Gurpilhares, D.B.; Hasmann, F.A.; Pessoa, A.; Roberto, I.C.: The
	behavior of key enzymes of xylose metabolism on the xylitol production
	by Candida guilliermondii grown in hemicellulosic hydrolysate. J. Ind.
	Microbiol. Biotechnol. (2009) 36, 87-93. {Pubmed:18830730}
RF	<32> Mojzita, D.; Vuoristo, K.; Koivistoinen, O.M.; Penttilae, M.;
	Richard, P.: The true L-xylulose reductase of filamentous fungi
	identified in Aspergillus niger. FEBS Lett. (2010) 584, 3540-3544.
	{Pubmed:20654618}
RF	<33> Metz, B.; Mojzita, D.; Herold, S.; Kubicek, C.P.; Richard, P.;
	Seiboth, B.: A novel L-xylulose reductase essential for L-arabinose
	catabolism in Trichoderma reesei. Biochemistry (2013) 52, 2453-2460.
	{Pubmed:23506391}
RF	<34> Son, l.e..T.; Ko, K.M.; Cho, J.H.; Singaravelu, G.; Chatterjee,
	I.; Choi, T.W.; Song, H.O.; Yu, J.R.; Park, B.J.; Lee, S.K.; Ahnn, J.:
	DHS-21, a dicarbonyl/L-xylulose reductase (DCXR) ortholog, regulates
	longevity and reproduction in Caenorhabditis elegans. FEBS Lett. (2011)
	585, 1310-1316. {Pubmed:21477590}
RF	<35> Zheng, Y.; Yu, X.; Li, T.; Xiong, X.; Chen, S.: Induction of
	D-xylose uptake and expression of NAD(P)H-linked xylose reductase and
	NADP+-linked xylitol dehydrogenase in the oleaginous microalga
	Chlorella sorokiniana. Biotechnol. Biofuels (2014) 7, 125.
	{Pubmed:25342968}
RF	<36> Zhang, B.; Zhang, J.; Wang, D.; Gao, X.; Sun, L.; Hong, J.: Data
	for rapid ethanol production at elevated temperatures by engineered
	thermotolerant Kluyveromyces marxianus via the NADP(H)-preferring
	xylose reductase-xylitol dehydrogenase pathway. Data Brief (2015) 5,
	179-186. {Pubmed:26543879}
RF	<37> Khattab, S.M.; Saimura, M.; Kodaki, T.: Boost in bioethanol
	production using recombinant Saccharomyces cerevisiae with mutated
	strictly NADPH-dependent xylose reductase and NADP+-dependent xylitol
	dehydrogenase. J. Biotechnol. (2013) 165, 153-156. {Pubmed:23578809}

KI_VALUE
KI	#3# 0.00037 {4-methyl-[1,2,3]-thiadiazole-5-carboxylic acid
	benzyloxyamide}  (#3# competitive with respect to xylitol <20>) <20>
KI	#3# 0.00044 {4-methyl-[1,2,3]-thiadiazole-5-carboxylic acid
	benzyloxyamide}  (#3# uncompetitive with respect to NADPH <20>) <20>

IC50_VALUE
IC50	#4# 0.0003 {4-methylthiophene-2-carboxylic acid
	N'-(2,3,3-trichloroacryloyl)-hydrazide}  (#4# IC50: 0.0003 mM for
	wild-type enzyme, 0.00056 mM for mutant enzyme L143F, 0.002 mM for
	mutant enzyme H146L, 0.0002 mM for mutant enzyme W191S, 0.0022 mM for
	mutant enzyme W191F <20>) <20>
IC50	#4# 0.00023 {4-methyl-[1,2,3]-thiadiazole-5-carboxylic acid
	benzyloxyamide}  (#4# IC50: 0.00023 mM for wild-type enzyme, 0.0019 mM
	for mutant enzyme L143F, 0.0018 mM for mutant enzyme H146L, 0.0029 mM
	for mutant enzyme W191S, 0.00079 mM for mutant enzyme W191F <20>) <20>

KCAT_KM_VALUE
KKM	#25# 7.55 (#25# pH 7.0, temperature not specified in the publication
	<34>) <34>
KKM	#25# 0.36 (#25# pH 7.0, temperature not specified in the publication
	<34>) <34>
KKM	#25# 0.47 (#25# pH 7.0, temperature not specified in the publication
	<34>) <34>
KKM	#25# 3.42 (#25# pH 7.0, temperature not specified in the publication
	<34>) <34>
KKM	#25# 6.75 (#25# pH 7.0, temperature not specified in the publication
	<34>) <34>
KKM	#25# 19.03 (#25# pH 7.0, temperature not specified in the publication
	<34>) <34>

EXPRESSION
EXP	#25# down (#25# knock-down of daf-16 and elt-2 transcription factors
	affects dhs-21 expression <34>) <34>
EXP	#8,13,24# up (#8# expression is upregulated upon growth on L-arabinose
	<32>; #24# transcription of lxr3 is specifically induced by L-arabinose
	and L-arabitol <33>; #13# D-xylose uptake induces the enzyme, together
	with the D-xylose reductase, EC 1.1.1.307 <35>) <32,33,35>

GENERAL_INFORMATION
GI	#13# more (#13# the transportation of D-xylose across the cell membrane
	of Chlorella sorokiniana is realized by an inducible hexose symporter.
	The uptake of D-xylose subsequently activates the expression of key
	catalytic enzymes that enables D-xylose entering central metabolism
	<35>) <35>
GI	#15,24,25# metabolism (#25# dicarbonyl/L-xylulose reductase converts
	L-xylulose into xylitol, and reduces various alpha-dicarbonyl
	compounds, performing a dual role in carbohydrate metabolism and
	detoxification <34>; #24# the enzyme catalyzes the NADPH-dependent
	reduction of L-xylulose to xylitol in L-arabinose and glucuronic acid
	catabolism <33>; #15# the redox balance between xylose reductase (XR)
	and xylitol dehydrogenase (XDH) is thought to be an important factor in
	effective xylose fermentation <37>) <33,34,37>
GI	#24# evolution (#24# L-xylulose reductases belong to the superfamily of
	short chain dehydrogenases and reductases (SDRs) <33>) <33>
GI	#24,25# malfunction (#24# deletion of lxr3 affects growth on
	L-arabinose and L-arabitol and reduces total NADPH-dependent LXR
	activity in cell free extracts <33>; #25# dhs-21 null mutants show
	defects in longevity, reproduction and egg-laying <34>) <33,34>
GI	#8,15,24,25# physiological function (#8# deletion results in a strain
	lacking the NADPH-specific L-xylulose reductase activity and having
	reduced growth on L-arabinose <32>; #25# the enzyme is essential for
	normal life span and reproduction <34>; #24# the L-xylulose reductase
	is essential for L-arabinose catabolism in Trichoderma reesei <33>;
	#15# strictly NADPH-dependent XR with mutated strict NADP+-dependent
	XDH are more effective in increasing bioethanol production and
	decreasing xylitol accumulation than the wild-type, overview <37>)
	<32,33,34,37>

///
ID	1.1.1.100
********************************************************************************
*                                                                              *
* Copyrighted by Dietmar Schomburg, Techn. University Braunschweig, GERMANY    *
* Distributed under the License as stated at http:/www.brenda-enzymes.org      *
*                                                                              *
********************************************************************************

PROTEIN
PR	#1# Salmonella enterica subsp. enterica serovar Typhimurium   <19,48>
PR	#2# Gallus gallus   <54>
PR	#3# Staphylococcus aureus   <46,48>
PR	#4# Bacillus subtilis   <13>
PR	#5# Escherichia coli   <1,4,5,14,16,19,22,27,32,33,44,48>
PR	#6# Homo sapiens   <53,62>
PR	#7# Saccharomyces cerevisiae   <45,47>
PR	#8# Euglena gracilis   <9>
PR	#9# Spinacia oleracea   <1,8,10>
PR	#10# Pisum sativum   <8>
PR	#11# Arabidopsis thaliana   <39>
PR	#12# Enterobacter cloacae   <48>
PR	#13# Klebsiella aerogenes   <48>
PR	#14# Pseudomonas aeruginosa   <20,28,32,46,48>
PR	#15# Lactococcus lactis   <18>
PR	#16# Brassica napus   <3,6,15,16>
PR	#17# Acinetobacter calcoaceticus   <48>
PR	#18# Haloferax volcanii   <41>
PR	#19# Serratia marcescens   <48>
PR	#20# Streptococcus pneumoniae   <24,46>
PR	#21# Proteus vulgaris   <48>
PR	#22# Caenorhabditis elegans   <45>
PR	#23# Klebsiella pneumoniae   <48>
PR	#24# Mycobacterium tuberculosis   <21,25,31,47,52>
PR	#25# Staphylococcus epidermidis   <32,48>
PR	#26# Plasmodium falciparum   <26,29,34,43,49>
PR	#27# Persea americana   (#27# gene xyn11F63 <3>) <3,7,8,11>
PR	#28# Salmonella enterica subsp. enterica serovar Typhi   <48>
PR	#29# Vibrio cholerae serotype O1   <60>
PR	#30# Brassica juncea   <8>
PR	#31# Carthamus tinctorius   <2,8>
PR	#32# Cuphea lanceolata   <12>
PR	#33# Streptococcus sp.   <46>
PR	#34# Shigella sonnei   <48>
PR	#35# Shigella dysenteriae   <48>
PR	#36# Cuphea lutea   <8>
PR	#37# Shigella flexneri   <48>
PR	#38# synthetic construct   <46>
PR	#39# Enterococcus sp.   <48>
PR	#40# Haloarcula hispanica   <41>
PR	#41# Pseudomonas sp. Q4AE87 SwissProt <22>
PR	#42# Plasmodium falciparum Q86RB1 SwissProt <23>
PR	#43# Aquifex aeolicus VF5   <30>
PR	#44# Bacillus anthracis Q81JG6 SwissProt <37,50>
PR	#45# Pseudomonas putida A5HIF6 UniProt <38>
PR	#46# Synechococcus elongatus PCC 7942 = FACHB-805 Q31QF3 UniProt <40>
PR	#47# Mycobacterium tuberculosis P9WGT3 UniProt <47>
PR	#48# Mycobacterium tuberculosis O53665 UniProt <47,57>
PR	#49# Plasmodium falciparum K1   <35>
PR	#50# Plasmodium falciparum Q965D6 Uniprot <17>
PR	#51# Brassica napus Q949M3 Uniprot <36>
PR	#52# Escherichia coli P0AEK2 Uniprot <42>
PR	#53# Rickettsia prowazekii P50941 UniProt <51>
PR	#54# Pseudomonas aeruginosa O54438 UniProt <55>
PR	#55# Cupriavidus necator P14697 UniProt <56>
PR	#56# Homo sapiens Q92506 UniProt <61>
PR	#57# Saccharomyces cerevisiae P35731 UniProt <59>
PR	#58# Mycolicibacterium smegmatis A0R723 UniProt <58>

RECOMMENDED_NAME
RN	3-oxoacyl-[acyl-carrier-protein] reductase


SYSTEMATIC_NAME
SN	(3R)-3-hydroxyacyl-[acyl-carrier protein]:NADP+ oxidoreductase


SYNONYMS
SY	 reductase, 3-oxoacyl-[acyl carrier protein]
SY	 beta-ketoacyl-[acyl-carrier protein] (ACP) reductase
SY	 beta-ketoacyl acyl carrier protein (ACP) reductase
SY	 beta-ketoacyl thioester reductase
SY	 3-ketoacyl acyl carrier protein reductase
SY	 NADPH-specific 3-oxoacyl-[acylcarrier protein]reductase
SY	 3-oxoacyl-[ACP]reductase
SY	#1,3,5,12,13,14,17,18,19,20,21,23,24,25,26,28,33,34,35,37,38,39,40,49
	58# beta-ketoacyl-ACP reductase <24,27,29,35,41,42,44,46,48,49,52,58>
SY	#1,3,5,12,13,14,17,19,20,21,23,25,26,28,29,33,34,35,37,38,39,41,42,45
	49,53,54,57,58# FabG (#53# gene name <51>)
	<17,19,20,22,23,26,27,29,35,38,42,43,44,46,48,49,51,55,58,59,60>
SY	#1,5,24# beta-ketoacyl-acyl carrier protein reductase <19,25>
SY	#11# KCR1 <39>
SY	#11# KCR2 <39>
SY	#14# RhlG <28>
SY	#14,26# beta-ketoacyl acyl carrier protein reductase <20,26,43>
SY	#15,18,40,47# FabG1 <18,41,47>
SY	#18,40# polyhydroxyalkanoate-specific acetoacetyl coenzyme A reductase
	<41>
SY	#18,40# PHA-specific acetoacetyl-CoA reductase <41>
SY	#18,40,55# PhaB <41,56>
SY	#20# KACPR <24>
SY	#24# 3-ketoacyl-ACP(CoA) reductase <21>
SY	#24# ACP reductase <25>
SY	#24# MabA <25,52>
SY	#29# beta-ketoacyl-(acyl carrier protein) reductase <60>
SY	#42# OAR <23>
SY	#44# 3-oxoacyl-(acyl carrier protein) reductase <50>
SY	#45# 3-ketoacyl-ACP reductase <38>
SY	#46# 3-ketoacyl-[acyl-carrier-protein] reductase <40>
SY	#47,48# 3-oxoacyl-AcpM reductase <47>
SY	#5# beta-ketoacyl-[acyl carrier protein] reductase <42>
SY	#5,16# BKR <14,15,16>
SY	#5,41,45# 3-ketoacyl-acyl carrier protein reductase <22,38>
SY	#53# 3-ketoacyl-(acyl-carrier-protein) reductase <51>
SY	#54# 3-oxo-acyl-ACP reductase <55>
SY	#55# NADPH-dependent acetoacetyl coenzyme A reductase <56>
SY	#56# KAR <61>
SY	#56# 3-ketoacyl-ACP reductase/3R-hydroxyacyl-CoA dehydrogenase <61>
SY	#56# 3-ketoacyl-thioester reductase <61>
SY	#57# OAR1 <59>
SY	#57# 3-oxoacyl-(acyl-carrier-protein) reductase <59>
SY	#58# ketoacyl-acyl carrier protein reductase <58>
SY	#58# MSMEG_6753 (#58# gene name <58>) <58>
SY	#6,11,14,48# beta-ketoacyl reductase <28,39,57,62>
SY	#7# Oar1p <45>
SY	#7,22,24# 3-oxoacyl-thioester reductase <45,47>
SY	#7,24,48# fabG4 <47,57>
SY	#7,42,57# 3-oxoacyl-ACP reductase <23,45,59>

REACTION
RE	a (3R)-3-hydroxyacyl-[acyl-carrier protein] + NADP+ = a
	3-oxoacyl-[acyl-carrier protein] + NADPH + H+ (#16# belongs to family
	of short-chain alcohol dehydrogenases (SDR) with catalytic triad
	Ser154, Tyr167 and Lys171, catalytic mechanism <16>; #24# chemical and
	kinetic mechanism <25>; #26# cofactor and substrate binding kinetics,
	allosteric regulation mechanism, overview <26>; #42# ordered bi bi
	kinetic mechanism, [acyl-carrier protein] recognition mechanism <23>;
	#20# reaction mechanism, random bi bi kinetic mechanism <24>; #24#
	positive cooperativity in binding of NADPH to enzyme, no cooperativity
	in binding of acetoacyl-CoA. Pre-existing equilibrium of two forms of
	free MabA in solution followed by a bimolecular association process
	<31>)

REACTION_TYPE
RT	redox reaction
RT	oxidation
RT	reduction

SOURCE_TISSUE
ST	#11# embryo (#11# KCR1 and KCR2 <39>) <39>
ST	#11# inflorescence (#11# KCR1 and KCR2 present in inflorescence stem
	<39>) <39>
ST	#11# silique (#11# KCR1 and KCR2 <39>) <39>
ST	#11,32# root (#11# only KCR1 <39>) <12,39>
ST	#11,32# flower (#11# KCR1 and KCR2 <39>) <12,39>
ST	#2# liver <54>
ST	#27# mesocarp <3,7,11>
ST	#27,30,31,32,36# seed <2,8,12>
ST	#45# cell culture (#45# strain KCTC1639 <38>) <38>
ST	#6# MDA-MB-231 cell <53>
ST	#6# U-251 cell <53>
ST	#9,10,11,32# leaf (#11# KCR1 and KCR2 <39>) <1,8,10,12,39>

LOCALIZATION
LO	#11# endoplasmic reticulum (#11# KCR1 and KCR2 <39>) <39>
LO	#7,22,57# mitochondrion <45,59>
LO	#7,24,26# soluble (#26# recombinant enzyme from Escherichia coli <17>)
	<17,47>

NATURAL_SUBSTRATE_PRODUCT
NSP	#1,5# beta-ketoacyl-[acyl-carrier protein] + NADPH =
	beta-hydroxyacyl-[acyl-carrier protein] + NADP+ (#1,5# first reductive
	step in the elongation cycle of fatty acid biosynthesis <19>) <19>
NSP	#20# acetoacetyl-CoA + NADPH = 3-hydroxybutyryl-CoA + NADP+ <24>
NSP	#20# acetoacetyl-CoA + NADPH = 3-hydroxybutyryl-CoA + NADP+ {r} <24>
NSP	#24,26# 3-oxoacyl-[acyl-carrier protein] + NADPH =
	3-hydroxyacyl-[acyl-carrier protein] + NADP+ {r} <25,26>
NSP	#29# 3-oxoacyl-[acyl-carrier protein] + NADPH + H+ =
	(3R)-3-hydroxyacyl-[acyl-carrier protein] + NADP+ <60>
NSP	#45# (3R)-3-hydroxyacyl-[acyl-carrier protein] + NADP+ =
	3-oxoacyl-[acyl-carrier protein] + NADPH + H+ (#45# beta-oxidation
	pathway <38>) <38>
NSP	#5,14,15,45# more = ? (#5# catalyzes also the reduction of the
	beta-keto group of unsaturated acyl chains during biosynthesis of
	unsaturated fatty acids <16>; #15# FabG1 is responsible for the first
	reductive step of the fatty acid synthetic cycle. FabG2 is inactive in
	fatty acid synthesis <18>; #14# the beta-ketoacyl acyl carrier protein
	reductase activity of the fatty acid biosynthetic pathway is a
	determining factor of 3-oxo-homoserine lactone acyl chain lengths <20>;
	#14# the enzyme is essential in the rhamnolipid biosynthetic pathway of
	Pseudomonas aeruginosa <28>; #45# fabG overexpression tends to depress
	the biosynthesis of medium-chain-length polyhydroxyalkanoate due to the
	reversible conversion of (R)-3-hydroxyalkanoate monomer units into
	3-ketoacyl-CoA <38>) {} <16,18,20,28,38>
NSP	#5,14,15,45# more = ? (#5# catalyzes also the reduction of the
	beta-keto group of unsaturated acyl chains during biosynthesis of
	unsaturated fatty acids <16>; #15# FabG1 is responsible for the first
	reductive step of the fatty acid synthetic cycle. FabG2 is inactive in
	fatty acid synthesis <18>; #14# the beta-ketoacyl acyl carrier protein
	reductase activity of the fatty acid biosynthetic pathway is a
	determining factor of 3-oxo-homoserine lactone acyl chain lengths <20>;
	#14# the enzyme is essential in the rhamnolipid biosynthetic pathway of
	Pseudomonas aeruginosa <28>; #45# fabG overexpression tends to depress
	the biosynthesis of medium-chain-length polyhydroxyalkanoate due to the
	reversible conversion of (R)-3-hydroxyalkanoate monomer units into
	3-ketoacyl-CoA <38>) {} <16,18,20,28,38>
NSP	#5,9,16,27,31# 3-oxoacyl-[acyl-carrier protein] + NADPH =
	(3R)-3-hydroxyacyl-[acyl-carrier protein] + NADP+ (#16# enzyme is part
	of the dissociable fatty acid synthase type II multienzyme complex for
	de novo synthesis of fatty acids from acetyl-CoA and malonyl-CoA <16>;
	#5,16,27# first reduction step of fatty acid synthase <3,4>; #9,16,31#
	enzyme in fatty acid synthesis <2,10,16>) <2,3,4,10,16>
NSP	#5,9,16,27,31# 3-oxoacyl-[acyl-carrier protein] + NADPH =
	(3R)-3-hydroxyacyl-[acyl-carrier protein] + NADP+ (#16# enzyme is part
	of the dissociable fatty acid synthase type II multienzyme complex for
	de novo synthesis of fatty acids from acetyl-CoA and malonyl-CoA <16>;
	#5,16,27# first reduction step of fatty acid synthase <3,4>; #9,16,31#
	enzyme in fatty acid synthesis <2,10,16>) {r} <2,3,4,10,16>
NSP	#5,9,16,27,31# 3-oxoacyl-[acyl-carrier protein] + NADPH =
	(3R)-3-hydroxyacyl-[acyl-carrier protein] + NADP+ (#16# enzyme is part
	of the dissociable fatty acid synthase type II multienzyme complex for
	de novo synthesis of fatty acids from acetyl-CoA and malonyl-CoA <16>;
	#5,16,27# first reduction step of fatty acid synthase <3,4>; #9,16,31#
	enzyme in fatty acid synthesis <2,10,16>) {} <2,3,4,10,16>
NSP	#55# acetoacetyl-CoA + NADPH + H+ = 3-hydroxybutyryl-CoA + NADP+ <56>
NSP	#58# beta-ketoacyl-[acyl-carrier protein] + NADPH + H+ =
	beta-hydroxyacyl-[acyl-carrier protein] + NADP+ <58>
NSP	#6,57# a 3-oxoacyl-[acyl-carrier protein] + NADPH + H+ = a
	(3R)-3-hydroxyacyl-[acyl-carrier protein] + NADP+ <59,62>

SUBSTRATE_PRODUCT
SP	#1,5# beta-ketoacyl-[acyl-carrier protein] + NADPH =
	beta-hydroxyacyl-[acyl-carrier protein] + NADP+ (#1,5# first reductive
	step in the elongation cycle of fatty acid biosynthesis <19>) <19>
SP	#1,5,9,16,26,27,32# acetoacetyl-CoA + NADPH = D-beta-hydroxybutyryl-CoA
	+ NADP+ <1,3,5,6,7,12,16,17,19,42>
SP	#1,5,9,16,26,27,32# acetoacetyl-CoA + NADPH = D-beta-hydroxybutyryl-CoA
	+ NADP+ {r} <1,3,5,6,7,12,16,17,19,42>
SP	#1,5,9,16,26,27,32# acetoacetyl-CoA + NADPH = D-beta-hydroxybutyryl-CoA
	+ NADP+ {} <1,3,5,6,7,12,16,17,19,42>
SP	#15# beta-ketobutyryl-CoA + NADPH = beta-hydroxybutyryl-CoA + NADP+
	(#15# complementation of Escherichia coli fabG mutant with
	Lactobacillus lactis fabG genes shows that fabG1 encodes a functional
	beta-ketoacyl ACP reductase and fabG2 encodes an enzyme that has
	activity with the model substrate beta-ketobutyryl-CoA, but lacks the
	ability to support fatty acid synthesis both in vivo and in vitro <18>)
	{} <18>
SP	#24# acetoacetyl-CoA + NADPH = D-3-hydroxybutyryl-CoA + NADP+ <52>
SP	#24,26# 3-oxoacyl-[acyl-carrier protein] + NADPH =
	3-hydroxyacyl-[acyl-carrier protein] + NADP+ (#26# cooperative
	transitions in the enzyme due to cofactor and [acyl-carrier-protein]
	binding <26>) {r} <25,26>
SP	#26# acetoacetyl-CoA + NADPH = ? + NADP+ (#26# wild-type shows less
	activity with acetoacetyl-CoA than with acetoacetyl-[acyl-carrier
	protein] <43>) <43>
SP	#29# 3-oxoacyl-[acyl-carrier protein] + NADPH + H+ =
	(3R)-3-hydroxyacyl-[acyl-carrier protein] + NADP+ <60>
SP	#29,56,57,58# acetoacetyl-CoA + NADPH + H+ = ? (#56# low activity with
	NADPH <61>) <58,59,60,61>
SP	#45# (3R)-3-hydroxyacyl-[acyl-carrier protein] + NADP+ =
	3-oxoacyl-[acyl-carrier protein] + NADPH + H+ (#45# beta-oxidation
	pathway <38>) <38>
SP	#46# propiophenone + NADPH = ? + NADP+ (#46# 123% relative activity
	compared to acetophenone <40>) <40>
SP	#46# 1,1,1-trifluoroacetone + NADPH = ? + NADP+ (#46# 792% relative
	activity compared to acetophenone <40>) <40>
SP	#46# 2',3',4',5',6'-pentafluoroacetophenone + NADPH = ? + NADP+ (#46#
	3023% relative activity compared to acetophenone <40>) <40>
SP	#46# 2-octanone + NADPH = ? + NADP+ (#46# 15% relative activity
	compared to acetophenone <40>) <40>
SP	#46# 3'-fluoroacetophenone + NADPH = ? + NADP+ (#46# 100% relative
	activity compared to acetophenone <40>) <40>
SP	#46# 4'-chloroacetophenone + NADPH = ? + NADP+ (#46# 115% relative
	activity compared to acetophenone <40>) <40>
SP	#46# 4'-fluoroacetophenone + NADPH = ? + NADP+ (#46# 62% relative
	activity compared to acetophenone <40>) <40>
SP	#46# acetophenone + NADPH = ? + NADP+ (#46# 100% relative activity
	<40>) <40>
SP	#46# alpha-chloroacetophenone + NADPH = ? + NADP+ (#46# 1885% relative
	activity compared to acetophenone <40>) <40>
SP	#46# ethyl 4-chloroacetoacetate + NADPH = ? + NADP+ (#46# 29454%
	relative activity compared to acetophenone <40>) <40>
SP	#46# ethylbenzoylacetate + NADPH = ? + NADP+ (#46# 892% relative
	activity compared to acetophenone <40>) <40>
SP	#48# 3-oxohexanoyl-CoA + NADH + H+ = (3R)-3-hydroxyhexanoyl-CoA + NAD+
	<57>
SP	#5# ethyl acetoacetate + NADPH = ? + NADP+ <48>
SP	#5# methyl acetoacetate + NADPH = ? + NADP+ (#5# is not a good
	substrate as ethyl acetoacetate <44>) <44>
SP	#5# propyl acetoacetate + NADPH = ? + NADP+ (#5# as substrate it is
	limited to its weak solubility <44>) <44>
SP	#5,16,27# acetoacetyl-N-cysteamine + NADPH =
	D-3-hydroxybutyryl-N-cysteamine + NADP+ <3,6,7,16>
SP	#5,20,24,26,41,42,49# acetoacetyl-CoA + NADPH = 3-hydroxybutyryl-CoA +
	NADP+ <22,23,24,25,26,27,29,35,49>
SP	#5,20,24,26,41,42,49# acetoacetyl-CoA + NADPH = 3-hydroxybutyryl-CoA +
	NADP+ {r} <22,23,24,25,26,27,29,35,49>
SP	#5,38# ethyl acetoacetate + NADPH = ethyl 3-hydroxybutyrate + NADP+
	<44,46>
SP	#5,41# 3-oxodecanoyl-CoA + NADPH = (R)-3-hydroxydecanoyl-CoA + NADP+
	<22>
SP	#5,41# 3-oxododecanoyl-CoA + NADPH = (R)-3-hydroxydodecanoyl-CoA +
	NADP+ <22>
SP	#5,41# 3-oxohexanoyl-CoA + NADPH = (R)-3-hydroxyhexanoyl-CoA + NADP+
	<22>
SP	#5,41# 3-oxooctanoyl-CoA + NADPH = (R)-3-hydroxyoctanoyl-CoA + NADP+
	<22>
SP	#5,8,9,10,16,26,27,30,31,36# 3-oxoacyl-[acyl-carrier protein] + NADPH =
	(3R)-3-hydroxyacyl-[acyl-carrier protein] + NADP+ (#16# belongs to
	family of short-chain alcohol dehydrogenases (SDR) with catalytic
	triade Ser154, Tyr167 and Lys171, catalytic mechanism <16>; #5# pH
	6.0-7.0, equilibrium almost completely favors formation of the
	beta-hydroxyacyl ACP derivatives <5>; #16# enzyme is part of the
	dissociable fatty acid synthase type II multienzyme complex for de novo
	synthesis of fatty acids from acetyl-CoA and malonyl-CoA <16>;
	#5,16,27# first reduction step of fatty acid synthase <3,4>; #9,16,31#
	enzyme in fatty acid synthesis <2,10,16>) |#5# product is the
	D-(-)-stereoisomer <5>| <1,2,3,4,5,6,7,8,9,10,11,14,15,16,49>
SP	#5,8,9,10,16,26,27,30,31,36# 3-oxoacyl-[acyl-carrier protein] + NADPH =
	(3R)-3-hydroxyacyl-[acyl-carrier protein] + NADP+ (#16# belongs to
	family of short-chain alcohol dehydrogenases (SDR) with catalytic
	triade Ser154, Tyr167 and Lys171, catalytic mechanism <16>; #5# pH
	6.0-7.0, equilibrium almost completely favors formation of the
	beta-hydroxyacyl ACP derivatives <5>; #16# enzyme is part of the
	dissociable fatty acid synthase type II multienzyme complex for de novo
	synthesis of fatty acids from acetyl-CoA and malonyl-CoA <16>;
	#5,16,27# first reduction step of fatty acid synthase <3,4>; #9,16,31#
	enzyme in fatty acid synthesis <2,10,16>) |#5# product is the
	D-(-)-stereoisomer <5>| {r} <1,2,3,4,5,6,7,8,9,10,11,14,15,16,49>
SP	#5,8,9,10,16,26,27,30,31,36# 3-oxoacyl-[acyl-carrier protein] + NADPH =
	(3R)-3-hydroxyacyl-[acyl-carrier protein] + NADP+ (#16# belongs to
	family of short-chain alcohol dehydrogenases (SDR) with catalytic
	triade Ser154, Tyr167 and Lys171, catalytic mechanism <16>; #5# pH
	6.0-7.0, equilibrium almost completely favors formation of the
	beta-hydroxyacyl ACP derivatives <5>; #16# enzyme is part of the
	dissociable fatty acid synthase type II multienzyme complex for de novo
	synthesis of fatty acids from acetyl-CoA and malonyl-CoA <16>;
	#5,16,27# first reduction step of fatty acid synthase <3,4>; #9,16,31#
	enzyme in fatty acid synthesis <2,10,16>) |#5# product is the
	D-(-)-stereoisomer <5>| {} <1,2,3,4,5,6,7,8,9,10,11,14,15,16,49>
SP	#5,9,14,15,16,27,41,45,47,58# more = ? (#58# no activity with NADH
	<58>; #5# only D-(-) isomer is oxidized <4>; #5# beta-ketoacyl
	thioesters of CoA and pantetheine metabolized at slower rates <4>;
	#16,27# animals, yeast and Mycobacteria have fatty acid synthetase
	containing all the individual activities on one or two multifunctional
	polypeptide chains, plants and most bacterial systems, including E.
	coli, possess individual monofunctional enzymes and a separate acyl
	carrier protein <3>; #5# equally active on beta-ketoacyl-ACP
	derivatives of C4 to C16 <4>; #5# broad specificity for chain length of
	substrates <4,5>; #5,9# L-isomer completely inactive <1,4>; #5#
	catalyzes also the reduction of the beta-keto group of unsaturated acyl
	chains during biosynthesis of unsaturated fatty acids <16>; #15# FabG1
	is responsible for the first reductive step of the fatty acid synthetic
	cycle. FabG2 is inactive in fatty acid synthesis <18>; #14# the
	beta-ketoacyl acyl carrier protein reductase activity of the fatty acid
	biosynthetic pathway is a determining factor of 3-oxo-homoserine
	lactone acyl chain lengths <20>; #14# the enzyme is essential in the
	rhamnolipid biosynthetic pathway of Pseudomonas aeruginosa <28>; #5,41#
	FabG substrate specificity overview <22>; #45# fabG overexpression
	tends to depress the biosynthesis of medium-chain-length
	polyhydroxyalkanoate due to the reversible conversion of
	(R)-3-hydroxyalkanoate monomer units into 3-ketoacyl-CoA <38>; #47#
	FabG1 is able to act on shorter (C4) acyl substrates <47>) {}
	<1,3,4,5,16,18,20,22,28,38,47,58>
SP	#5,9,14,15,16,27,41,45,47,58# more = ? (#58# no activity with NADH
	<58>; #5# only D-(-) isomer is oxidized <4>; #5# beta-ketoacyl
	thioesters of CoA and pantetheine metabolized at slower rates <4>;
	#16,27# animals, yeast and Mycobacteria have fatty acid synthetase
	containing all the individual activities on one or two multifunctional
	polypeptide chains, plants and most bacterial systems, including E.
	coli, possess individual monofunctional enzymes and a separate acyl
	carrier protein <3>; #5# equally active on beta-ketoacyl-ACP
	derivatives of C4 to C16 <4>; #5# broad specificity for chain length of
	substrates <4,5>; #5,9# L-isomer completely inactive <1,4>; #5#
	catalyzes also the reduction of the beta-keto group of unsaturated acyl
	chains during biosynthesis of unsaturated fatty acids <16>; #15# FabG1
	is responsible for the first reductive step of the fatty acid synthetic
	cycle. FabG2 is inactive in fatty acid synthesis <18>; #14# the
	beta-ketoacyl acyl carrier protein reductase activity of the fatty acid
	biosynthetic pathway is a determining factor of 3-oxo-homoserine
	lactone acyl chain lengths <20>; #14# the enzyme is essential in the
	rhamnolipid biosynthetic pathway of Pseudomonas aeruginosa <28>; #5,41#
	FabG substrate specificity overview <22>; #45# fabG overexpression
	tends to depress the biosynthesis of medium-chain-length
	polyhydroxyalkanoate due to the reversible conversion of
	(R)-3-hydroxyalkanoate monomer units into 3-ketoacyl-CoA <38>; #47#
	FabG1 is able to act on shorter (C4) acyl substrates <47>) {}
	<1,3,4,5,16,18,20,22,28,38,47,58>
SP	#5,9,16,26,27,31# acetoacetyl-[acyl-carrier protein] + NADPH =
	D-beta-hydroxybutyryl-[acyl-carrier protein] + NADP+ (#16,27# much
	greater specificity for acetoacetyl-ACP than for either of the model
	substrates acetoacetyl-CoA or acetoacetyl-N-acetylcysteamine <3>; #26#
	Arg187 and Arg230 are critical residues for the FabG-acyl-carrier
	protein interactions, significance of the positively
	charged/hydrophobic patch located adjacent to the active site cavities
	of FabG for interactions with acyl carrier protein <43>)
	<1,2,3,5,6,7,10,16,43>
SP	#5,9,16,26,27,31# acetoacetyl-[acyl-carrier protein] + NADPH =
	D-beta-hydroxybutyryl-[acyl-carrier protein] + NADP+ (#16,27# much
	greater specificity for acetoacetyl-ACP than for either of the model
	substrates acetoacetyl-CoA or acetoacetyl-N-acetylcysteamine <3>; #26#
	Arg187 and Arg230 are critical residues for the FabG-acyl-carrier
	protein interactions, significance of the positively
	charged/hydrophobic patch located adjacent to the active site cavities
	of FabG for interactions with acyl carrier protein <43>) {r}
	<1,2,3,5,6,7,10,16,43>
SP	#5,9,16,26,27,31# acetoacetyl-[acyl-carrier protein] + NADPH =
	D-beta-hydroxybutyryl-[acyl-carrier protein] + NADP+ (#16,27# much
	greater specificity for acetoacetyl-ACP than for either of the model
	substrates acetoacetyl-CoA or acetoacetyl-N-acetylcysteamine <3>; #26#
	Arg187 and Arg230 are critical residues for the FabG-acyl-carrier
	protein interactions, significance of the positively
	charged/hydrophobic patch located adjacent to the active site cavities
	of FabG for interactions with acyl carrier protein <43>) {}
	<1,2,3,5,6,7,10,16,43>
SP	#54# 3-hydroxydecanoyl-N-acetylcysteamine + NADP+ =
	3-oxodecanoyl-N-acetylcysteamine + NADPH + H+ <55>
SP	#54,55# acetoacetyl-CoA + NADPH + H+ = 3-hydroxybutyryl-CoA + NADP+
	<55,56>
SP	#56# 9,10-phenanthrene quinone + NADH + H+ = ? <61>
SP	#56# 9,10-phenanthrene quinone + NADPH + H+ = ? (#56# low activity with
	NADPH <61>) <61>
SP	#56# acetoacetyl-CoA + NADH + H+ = ? <61>
SP	#58# beta-ketoacyl-[acyl-carrier protein] + NADPH + H+ =
	beta-hydroxyacyl-[acyl-carrier protein] + NADP+ <58>
SP	#6,57# a 3-oxoacyl-[acyl-carrier protein] + NADPH + H+ = a
	(3R)-3-hydroxyacyl-[acyl-carrier protein] + NADP+ <59,62>

TURNOVER_NUMBER
TN	#20# 11 {NADPH}  (#20# pH 7.6, 30°C <24>) <24>
TN	#20# 11 {acetoacetyl-CoA}  (#20# pH 7.6, 30°C <24>) <24>
TN	#24# 7 {NADPH}  (#24# pH 7.6, 30°C <25>) <25>
TN	#24# 7 {acetoacetyl-CoA}  (#24# pH 7.0, 25°C <25>) <25>
TN	#26# 250 {NADPH}  (#26# without urea, pH 7.0, 25°C <49>) <49>
TN	#26# 0.014 {acetoacetyl-CoA}  (#26# pH 7.5 <17>) <17>
TN	#26# 259 {NADPH}  (#26# pH 6.8, 22°C, recombinant enzyme <26>) <26>
TN	#26# 259 {acetoacetyl-CoA}  (#26# pH 6.8, 22°C, recombinant enzyme
	<26>) <26>
TN	#26# 344.7 {NADPH}  (#26# in the presence of 1 M urea, pH 7.0, 25°C
	<49>) <49>
TN	#26# 187.3 {NADPH}  (#26# in the presence of 1.5 M urea, pH 7.0, 25°C
	<49>) <49>
TN	#26# 148.6 {NADPH}  (#26# in the presence of 4 M urea, pH 7.0, 25°C
	<49>) <49>
TN	#42# 265 {NADPH}  (#42# pH 6.8, 25°C, recombinant enzyme <23>) <23>
TN	#42# 265 {acetoacetyl-CoA}  (#42# pH 6.8, 25°C, recombinant enzyme
	<23>) <23>
TN	#5# 0.3 {ethyl acetoacetate}  <44>
TN	#5# 0.59 {NADPH}  <44>
TN	#55# 361 {NADPH}  (#55# mutant enzyme Q47L, at pH 8.0 and 30°C <56>)
	<56>
TN	#55# 361 {acetoacetyl-CoA}  (#55# mutant enzyme Q47L, at pH 8.0 and
	30°C <56>) <56>
TN	#55# 102 {NADPH}  (#55# wild type enzyme, at pH 8.0 and 30°C <56>) <56>
TN	#55# 102 {acetoacetyl-CoA}  (#55# wild type enzyme, at pH 8.0 and 30°C
	<56>) <56>
TN	#55# 249 {NADPH}  (#55# mutant enzyme Q47L, at pH 8.0 and 30°C <56>)
	<56>
TN	#55# 249 {acetoacetyl-CoA}  (#55# mutant enzyme Q47L, at pH 8.0 and
	30°C <56>) <56>
TN	#57# 91.4 {NADPH}  (#57# mutant enzyme S40A, at pH 8.0 and 25°C <59>)
	<59>
TN	#57# 91.4 {acetoacetyl-CoA}  (#57# mutant enzyme S40A, at pH 8.0 and
	25°C <59>) <59>
TN	#57# 117.5 {NADPH}  (#57# wild type enzyme, at pH 8.0 and 25°C <59>)
	<59>
TN	#57# 117.5 {acetoacetyl-CoA}  (#57# wild type enzyme, at pH 8.0 and
	25°C <59>) <59>
TN	#57# 108.2 {NADPH}  (#57# mutant enzyme S36A, at pH 8.0 and 25°C <59>)
	<59>
TN	#57# 108.2 {acetoacetyl-CoA}  (#57# mutant enzyme S36A, at pH 8.0 and
	25°C <59>) <59>

KM_VALUE
KM	#15# 0.29 {beta-ketobutyryl-CoA}  (#15# pH 7.0, 30°C, FabG1 <18>) <18>
KM	#15# 4.06 {beta-ketobutyryl-CoA}  (#15# pH 7.0, 30°C, FabG2 <18>) <18>
KM	#16# 0.003 {acetoacetyl-[acyl-carrier protein]}  <6>
KM	#16# 0.023 {NADPH}  (#16# + acetoacetyl-[acyl-carrier-protein] <6>) <6>
KM	#16# 0.035 {N-(2-sulfanylethyl)acetamide}  <6>
KM	#16# 0.261 {acetoacetyl-CoA}  <6>
KM	#20# 0.4 {NADPH}  (#20# pH 7.6, 30°C <24>) <24>
KM	#20# 2.2 {acetoacetyl-CoA}  (#20# pH 7.6, 30°C <24>) <24>
KM	#24# 0.026 {NADPH}  (#24# pH 7.6, 30°C <25>) <25>
KM	#24# 0.165 {acetoacetyl-CoA}  (#24# pH 7.6, 30°C <25>) <25>
KM	#26# 0.45 {acetoacetyl-CoA}  (#26# mutant R187A <43>) <43>
KM	#26# 0.49 {acetoacetyl-CoA}  (#26# mutant R230E <43>) <43>
KM	#26# 0.43 {acetoacetyl-CoA}  (#26# wild-type <43>; #26# pH 6.8, 22°C,
	recombinant enzyme <26>) <26,43>
KM	#26# 0.58 {acetoacetyl-CoA}  (#26# mutant R187E/R230E <43>) <43>
KM	#26# 0.075 {acetoacetyl-CoA}  (#26# pH 7.5 <17>) <17>
KM	#26# 0.44 {acetoacetyl-CoA}  (#26# mutant R230A <43>) <43>
KM	#26# 0.043 {NADPH}  (#26# pH 6.8, 22°C, recombinant enzyme <26>) <26>
KM	#26# 0.0461 {NADPH}  (#26# without urea, pH 7.0, 25°C <49>) <49>
KM	#26# 0.0434 {NADPH}  (#26# in the presence of 1 M urea, pH 7.0, 25°C
	<49>) <49>
KM	#26# 0.0412 {NADPH}  (#26# in the presence of 1.5 M urea, pH 7.0, 25°C
	<49>) <49>
KM	#26# 0.4553 {NADPH}  (#26# in the presence of 4 M urea, pH 7.0, 25°C
	<49>) <49>
KM	#26,27# 0.47 {acetoacetyl-CoA}  (#26# mutant R187A/R230A <43>; #26#
	mutant R187E <43>) <7,43>
KM	#27# 48 {acetoacetyl-N-acetylcysteamine}  <7>
KM	#27# 0.0093 {NADPH}  <7>
KM	#27# 0.0079 {acetoacetyl-[acyl-carrier protein]}  <7>
KM	#31# 0.009 {acetoacetyl-[acyl-carrier protein]}  <2>
KM	#31# 0.016 {NADPH}  <2>
KM	#42# 0.51 {acetoacetyl-CoA}  (#42# pH 6.8, 25°C, recombinant enzyme
	<23>) <23>
KM	#42# 0.0475 {NADPH}  (#42# pH 6.8, 25°C, recombinant enzyme <23>) <23>
KM	#46# 1.92 {ethylbenzoylacetate}  (#46# with 4 mM NADPH, in 0.1 M sodium
	phosphate buffer, pH 7.0 <40>) <40>
KM	#46# 6.03 {propiophenone}  (#46# with 4 mM NADPH, in 0.1 M sodium
	phosphate buffer, pH 7.0 <40>) <40>
KM	#46# 2.71 {alpha-chloroacetophenone}  (#46# with 4 mM NADPH, in 0.1 M
	sodium phosphate buffer, pH 7.0 <40>) <40>
KM	#46# 5.72 {2',3',4',5',6'-pentafluoroacetophenone}  (#46# with 4 mM
	NADPH, in 0.1 M sodium phosphate buffer, pH 7.0 <40>) <40>
KM	#46# 8.31 {ethyl 4-chloroacetoacetate}  (#46# with 4 mM NADPH, in 0.1 M
	sodium phosphate buffer, pH 7.0 <40>) <40>
KM	#46# 7.38 {3'-fluoroacetophenone}  (#46# with 4 mM NADPH, in 0.1 M
	sodium phosphate buffer, pH 7.0 <40>) <40>
KM	#46# 46.92 {acetophenone}  (#46# with 4 mM NADPH, in 0.1 M sodium
	phosphate buffer, pH 7.0 <40>) <40>
KM	#46# 14.34 {4'-chloroacetophenone}  (#46# with 4 mM NADPH, in 0.1 M
	sodium phosphate buffer, pH 7.0 <40>) <40>
KM	#46# 12.29 {4'-fluoroacetophenone}  (#46# with 4 mM NADPH, in 0.1 M
	sodium phosphate buffer, pH 7.0 <40>) <40>
KM	#46# 89.2 {1,1,1-trifluoroacetone}  (#46# with 4 mM NADPH, in 0.1 M
	sodium phosphate buffer, pH 7.0 <40>) <40>
KM	#5# 0.01 {NADPH}  <44>
KM	#5# 0.127 {ethyl acetoacetate}  <44>
KM	#54# 1 {acetoacetyl-CoA}  (#54# pH and temperature not specified in the
	publication <55>) <55>
KM	#54# 0.29 {NADPH}  (#54# with acetoacetyl-CoA as cosubstrate, pH and
	temperature not specified in the publication <55>) <55>
KM	#54# 0.29 {NADP+}  (#54# with 3-hydroxydecanoyl-N-acetylcysteamine as
	cosubstrate, pH and temperature not specified in the publication <55>)
	<55>
KM	#55# 0.0057 {acetoacetyl-CoA}  (#55# wild type enzyme, at pH 8.0 and
	30°C <56>) <56>
KM	#55# 0.149 {NADPH}  (#55# wild type enzyme, at pH 8.0 and 30°C <56>)
	<56>
KM	#55# 0.617 {NADPH}  (#55# mutant enzyme Q47L, at pH 8.0 and 30°C <56>)
	<56>
KM	#55# 0.0136 {acetoacetyl-CoA}  (#55# mutant enzyme Q47L, at pH 8.0 and
	30°C <56>) <56>
KM	#55# 0.0159 {acetoacetyl-CoA}  (#55# mutant enzyme Q47L, at pH 8.0 and
	30°C <56>) <56>
KM	#55# 0.289 {NADPH}  (#55# mutant enzyme Q47L, at pH 8.0 and 30°C <56>)
	<56>
KM	#57# 0.0205 {NADPH}  (#57# wild type enzyme, at pH 8.0 and 25°C <59>)
	<59>
KM	#57# 0.0264 {NADPH}  (#57# mutant enzyme S36A, at pH 8.0 and 25°C <59>)
	<59>
KM	#57# 0.0571 {NADPH}  (#57# mutant enzyme S40A, at pH 8.0 and 25°C <59>)
	<59>
KM	#57# 0.8158 {acetoacetyl-CoA}  (#57# wild type enzyme, at pH 8.0 and
	25°C <59>) <59>
KM	#57# 0.8871 {acetoacetyl-CoA}  (#57# mutant enzyme S36A, at pH 8.0 and
	25°C <59>) <59>
KM	#57# 0.9913 {acetoacetyl-CoA}  (#57# mutant enzyme S40A, at pH 8.0 and
	25°C <59>) <59>
KM	#9# 0.015 {NADPH}  <10>
KM	#9# 0.025 {NADPH}  <1>
KM	#9# 0.25 {acetoacetyl-CoA}  <1>
KM	#9# 0.017 {acetoacetyl-[acyl-carrier protein]}  <10>
KM	#9# 0.0037 {acetoacetyl-[acyl-carrier protein]}  <1>
KM	#9,20,24,26,27,42# -999 {more}  (#26# cooperativity kinetics, binding
	constants of substrates and cofactors <26>; #24# detailed kinetic and
	thermodynamic analysis, solvent and multiple kinetic isotope effects,
	kinetic mechanism <25>; #20# detailed steady-state kinetic analysis,
	solvent and multiple kinetic isotope effects, random bi bi kinetic
	mechanism <24>; #42# kinetic analysis of the recombinant enzyme,
	kinetic mechanism <23>) <10,11,23,24,25,26>

PH_OPTIMUM
PHO	#20# 7.6 <24>
PHO	#24# -999 (#24# increase in alpha-secondary deuterium kinetic isotope
	effect values measured at pH 10 as compared to those obtained at pH 7
	points to isotope- and pH-sensitive steps occurring concomitantly <31>)
	<31>
PHO	#26# 7.5 (#26# assay at <29>) <29>
PHO	#26,42# 6.8 (#26# assay at <26>) <23,26>
PHO	#27# 6.5 <11>
PHO	#5# 6-7 <5>
PHO	#5,24,38# 7 (#5,24# assay at <25,27,52>; #38# assay conditions <46>)
	<25,27,46,52>
PHO	#5,41,46# 8 (#5,41# assay at <22>) <22,40,44>
PHO	#9# 5.7-6.2 <10>

PH_RANGE
PHR	#20# 5.5-9.5 (#20# pH profile, detailed mechanistic pH-dependence
	analysis, overview <24>) <24>
PHR	#24# 5.8-10 (#24# pH profile, pH-dependence analysis, overview <25>)
	<25>
PHR	#27# 5.5-8.5 (#27# about 50% of activity maximum at pH 5.5 and 8.5
	<11>) <11>
PHR	#46# 4-10 (#46# pH 4: about 60% of maximal activity, pH 10: about 75%
	of maximal activity <40>) <40>
PHR	#9# 6-8.7 (#9# both reaction directions <1>) <1>

SPECIFIC_ACTIVITY
SA	#10# 0.0132 <8>
SA	#16# 136000.0 (#16# purified enzyme, protein determination by
	calculation from absorption at 280 nm <6>) <6>
SA	#26# 6.9 (#26# mutant R187A, acyl-carrier protein-dependent
	spectroscopic assay <43>) <43>
SA	#26# 45.6 (#26# mutant R187A/R230A, acyl-carrier protein-independent
	spectroscopic assay <43>) <43>
SA	#26# 3.0 (#26# mutant R187A/R230A, acyl-carrier protein-dependent
	spectroscopic assay <43>) <43>
SA	#26# 4.0 (#26# mutant R230E, acyl-carrier protein-dependent
	spectroscopic assay <43>) <43>
SA	#26# 59.8 (#26# purified recombinant enzyme <26>; #26# wild-type,
	acyl-carrier protein-independent spectroscopic assay <43>) <26,43>
SA	#26# 55.3 (#26# mutant R230A, acyl-carrier protein-independent
	spectroscopic assay <43>) <43>
SA	#26# 6.1 (#26# mutant R230A, acyl-carrier protein-dependent
	spectroscopic assay <43>) <43>
SA	#26# 54.2 (#26# mutant R230E, acyl-carrier protein-independent
	spectroscopic assay <43>) <43>
SA	#26# 0.0019 (#26# recombinant soluble enzyme <29>) <29>
SA	#26# 54.5 (#26# mutant R187E, acyl-carrier protein-independent
	spectroscopic assay <43>) <43>
SA	#26# 57.9 (#26# mutant R187A, acyl-carrier protein-independent
	spectroscopic assay <43>) <43>
SA	#26# 0.0017 (#26# recombinant refolded enzyme <29>) <29>
SA	#26# 42.6 (#26# mutant R187E/R230E, acyl-carrier protein-independent
	spectroscopic assay <43>) <43>
SA	#26# 70.6 (#26# wild-type, acyl-carrier protein-dependent spectroscopic
	assay <43>) <43>
SA	#26,56# 2.0 (#26# mutant R187E/R230E, acyl-carrier protein-dependent
	spectroscopic assay <43>; #56# mutant enzyme Y169A, with
	acetoacetyl-CoA and NADPH, pH 7.4 and 25°C <61>) <43,61>
SA	#26,56# 6.3 (#26# mutant R187E, acyl-carrier protein-dependent
	spectroscopic assay <43>; #56# mutant enzyme R168E, with
	acetoacetyl-CoA and NADPH, pH 7.4 and 25°C <61>) <43,61>
SA	#27# 280.0 (#27# acetoacetyl-N-acetylcysteamine <7>) <7>
SA	#27# 450.0 (#27# acetoacetyl-CoA <7>) <7>
SA	#27# 530.0 (#27# acetoacteyl-ACP <7>) <7>
SA	#27# 9401.0 (#27# purified enzyme, protein determination by amino acid
	analysis <7>) <7>
SA	#30# 0.0366 <8>
SA	#31# 0.0197 <2>
SA	#31# 0.0189 <8>
SA	#32# 3839.0 (#32# recombinant protein, cosubstrate NADH, pH 7.0,
	phosphate buffer <12>) <12>
SA	#32# 180400.0 (#32# recombinant protein, cosubstrate NADPH, pH 7.0,
	phosphate buffer <12>) <12>
SA	#32# 83140.0 (#32# cosubstrate NADPH, pH 8.35, carbonate buffer <12>)
	<12>
SA	#36# 0.0168 <8>
SA	#45# -999.0 (#45# the intrinsic NADPH dependent 3-ketoacyl-CoA
	reductase activity in the transformant Pseudomonas putida with
	overexpressed fabG gene increased about 1.6-fold from 0.87 to 1.39
	units/mg protein, indicating successful overexpression of the fabGJ
	genes in Pseudomonas putida KCTC1639. <38>) <38>
SA	#46# 0.08 (#46# with 4-fluoroacetophenone as substrate, 4 mM NADPH, in
	0.1 M sodium phosphate buffer, pH 7.0 <40>) <40>
SA	#46# 0.15 (#46# with 4-chloroacetophenone as substrate, 4 mM NADPH, in
	0.1 M sodium phosphate buffer, pH 7.0 <40>) <40>
SA	#46# 2.45 (#46# with alpha-chloroacetophenone as substrate, 4 mM NADPH,
	in 0.1 M sodium phosphate buffer, pH 7.0 <40>) <40>
SA	#46# 0.16 (#46# with propiophenone as substrate, 4 mM NADPH, in 0.1 M
	sodium phosphate buffer, pH 7.0 <40>) <40>
SA	#46# 1.03 (#46# with 1,1,1-trifluoroacetone as substrate, 4 mM NADPH,
	in 0.1 M sodium phosphate buffer, pH 7.0 <40>) <40>
SA	#46# 0.02 (#46# with 2-octanone as substrate, 4 mM NADPH, in 0.1 M
	sodium phosphate buffer, pH 7.0 <40>) <40>
SA	#46# 1.16 (#46# with ethylbenzoylacetate as substrate, 4 mM NADPH, in
	0.1 M sodium phosphate buffer, pH 7.0 <40>) <40>
SA	#46# 0.13 (#46# with 3-fluoroacetophenone as substrate, 4 mM NADPH, in
	0.1 M sodium phosphate buffer, pH 7.0 <40>; #46# with acetophenone as
	substrate, 4 mM NADPH, in 0.1 M sodium phosphate buffer, pH 7.0 <40>)
	<40>
SA	#46# 3.93 (#46# with 2,3,4,5,6-pentafluoroacetophenone as substrate, 4
	mM NADPH, in 0.1 M sodium phosphate buffer, pH 7.0 <40>) <40>
SA	#46# 38.29 (#46# with ethyl 4-chloroacetoacetate as substrate, 4 mM
	NADPH, in 0.1 M sodium phosphate buffer, pH 7.0 <40>) <40>
SA	#5# 0.0032 <1>
SA	#5# 4930.0 (#5# purified enzyme <5>) <5>
SA	#56# 1.2 (#56# mutant enzyme K173A, with 9,10-phenanthrene quinone and
	NAD+, pH 7.4 and 25°C <61>) <61>
SA	#56# 0.06 (#56# mutant enzyme K173A, with acetoacetyl-CoA and NADH, pH
	7.4 and 25°C <61>) <61>
SA	#56# 2.4 (#56# mutant enzyme K173A, with acetoacetyl-CoA and NADPH, pH
	7.4 and 25°C <61>) <61>
SA	#56# 3.5 (#56# wild type enzyme, with acetoacetyl-CoA and NADPH, pH 7.4
	and 25°C <61>) <61>
SA	#56# 4.5 (#56# mutant enzyme K173A, with 9,10-phenanthrene quinone and
	NADP+, pH 7.4 and 25°C <61>) <61>
SA	#56# 0.85 (#56# mutant enzyme Y169A, with 9,10-phenanthrene quinone and
	NAD+, pH 7.4 and 25°C <61>) <61>
SA	#56# 7.9 (#56# mutant enzyme R168E, with 9,10-phenanthrene quinone and
	NAD+, pH 7.4 and 25°C <61>) <61>
SA	#56# 1.7 (#56# mutant enzyme Q126E/K169E, with 9,10-phenanthrene
	quinone and NADP+, pH 7.4 and 25°C <61>) <61>
SA	#56# 1.3 (#56# mutant enzyme K169E, with 9,10-phenanthrene quinone and
	NADP+, pH 7.4 and 25°C <61>) <61>
SA	#56# 20.0 (#56# mutant enzyme D42A, with acetoacetyl-CoA and NADPH, pH
	7.4 and 25°C <61>) <61>
SA	#56# 22.0 (#56# mutant enzyme K152A, with acetoacetyl-CoA and NADH, pH
	7.4 and 25°C <61>) <61>
SA	#56# 31.8 (#56# mutant enzyme Q126E/K169E, with acetoacetyl-CoA and
	NADH, pH 7.4 and 25°C <61>) <61>
SA	#56# 5.4 (#56# mutant enzyme D42A, with 9,10-phenanthrene quinone and
	NADP+, pH 7.4 and 25°C <61>) <61>
SA	#56# 2.6 (#56# wild type enzyme, with 9,10-phenanthrene quinone and
	NADP+, pH 7.4 and 25°C <61>) <61>
SA	#56# 1.6 (#56# mutant enzyme R168E, with 9,10-phenanthrene quinone and
	NADP+, pH 7.4 and 25°C <61>) <61>
SA	#56# 0.5 (#56# mutant enzyme Q126E/R168E/K169E, with acetoacetyl-CoA
	and NADPH, pH 7.4 and 25°C <61>) <61>
SA	#56# 21.7 (#56# mutant enzyme R168E, with acetoacetyl-CoA and NADH, pH
	7.4 and 25°C <61>) <61>
SA	#56# 0.65 (#56# mutant enzyme Y169A, with acetoacetyl-CoA and NADH, pH
	7.4 and 25°C <61>) <61>
SA	#56# 20.8 (#56# wild type enzyme, with 9,10-phenanthrene quinone and
	NAD+, pH 7.4 and 25°C <61>) <61>
SA	#56# 21.0 (#56# mutant enzyme R34A, with acetoacetyl-CoA and NADH, pH
	7.4 and 25°C <61>) <61>
SA	#56# 14.8 (#56# mutant enzyme Q126E/R168E/K169E, with acetoacetyl-CoA
	and NADH, pH 7.4 and 25°C <61>) <61>
SA	#56# 25.5 (#56# mutant enzyme K152A, with 9,10-phenanthrene quinone and
	NAD+, pH 7.4 and 25°C <61>) <61>
SA	#56# 7.3 (#56# mutant enzyme D42A, with acetoacetyl-CoA and NADH, pH
	7.4 and 25°C <61>) <61>
SA	#56# 4.3 (#56# mutant enzyme Q126E/K169E, with acetoacetyl-CoA and
	NADPH, pH 7.4 and 25°C <61>) <61>
SA	#56# 8.4 (#56# mutant enzyme Q126E/R168E/K169E, with 9,10-phenanthrene
	quinone and NAD+, pH 7.4 and 25°C <61>) <61>
SA	#56# 20.5 (#56# wild type enzyme, with acetoacetyl-CoA and NADH, pH 7.4
	and 25°C <61>) <61>
SA	#56# 20.7 (#56# mutant enzyme R34A, with 9,10-phenanthrene quinone and
	NAD+, pH 7.4 and 25°C <61>) <61>
SA	#56# 15.7 (#56# mutant enzyme K169E, with 9,10-phenanthrene quinone and
	NAD+, pH 7.4 and 25°C <61>) <61>
SA	#56# 17.4 (#56# mutant enzyme Q126E/K169E, with 9,10-phenanthrene
	quinone and NAD+, pH 7.4 and 25°C <61>) <61>
SA	#56# 0.44 (#56# mutant enzyme R34A, with 9,10-phenanthrene quinone and
	NADP+, pH 7.4 and 25°C <61>; #56# mutant enzyme R34A, with
	acetoacetyl-CoA and NADPH, pH 7.4 and 25°C <61>) <61>
SA	#56# 3.1 (#56# mutant enzyme Y169A, with 9,10-phenanthrene quinone and
	NADP+, pH 7.4 and 25°C <61>) <61>
SA	#56# 5.5 (#56# mutant enzyme K169E, with acetoacetyl-CoA and NADPH, pH
	7.4 and 25°C <61>) <61>
SA	#56# 0.46 (#56# mutant enzyme K152A, with 9,10-phenanthrene quinone and
	NADP+, pH 7.4 and 25°C <61>) <61>
SA	#56# 19.3 (#56# mutant enzyme K169E, with acetoacetyl-CoA and NADH, pH
	7.4 and 25°C <61>) <61>
SA	#56# 74.6 (#56# mutant enzyme D42A, with 9,10-phenanthrene quinone and
	NAD+, pH 7.4 and 25°C <61>) <61>
SA	#9# 0.005 <1>
SA	#9# 0.0192 <8>
SA	#9# 7.95 <1>

TEMPERATURE_OPTIMUM
TO	#20,45# 30 (#20,45# assay at <24,38>) <24,38>
TO	#24,42# 25 (#24,42# assay at <23,25,52>) <23,25,52>
TO	#46# 44 <40>
TO	#5# 45 <44>
TO	#5# 37 (#5# assay at <27>) <27>
TO	#5,26,41# 22 (#5,26,41# assay at room temperature <22,26>) <22,26>

TEMPERATURE_RANGE
TR	#24# 15-37 (#24# temperature profile <25>) <25>
TR	#46# 30-55 (#46# 30°C: about 55% of maximal activity, 55°C: about 65%
	of maximal activity <40>) <40>

COFACTOR
CF	#1,5,6,8,9,10,14,16,20,24,26,27,29,30,31,32,36,38,40,41,42,49,56,57,58#
	NADPH (#40# dependent on <41>; #5,16,27# absolute specificity for NADPH
	<3,5,16>; #9# much more effective than NADH <10>; #26# exhibits
	negative cooperativity for its interaction with the enzyme <17>; #42#
	cofactor binding structure and mechanism <23>; #26# cooperative
	transitions in the enzyme due to cofactor and [acyl-carrier-protein]
	binding, cooperative allosteric cofactor binding in presence of
	[acyl-carrier-protein] <26>; #24# positive cooperativity in binding to
	enzyme <31>; #26# 3fold enhancement in acyl-carrier protein binding to
	wild-type in the presence of NADPH <43>; #56# low activity with NADPH
	<61>)
	<1,2,3,4,5,6,7,8,9,10,11,12,16,17,19,20,22,23,24,25,26,27,29,31,35,41
	42,43,44,46,48,49,58,59,60,61,62>
CF	#5,9,24,26,45,54,55# NADP+ (#26# cooperative transitions in the enzyme
	due to cofactor and [acyl-carrier-protein] binding, cooperative
	cofactor binding <26>) <1,14,25,26,38,55,56>
CF	#8,27# more (#8,27# NADH is used by NADH-dependent 3-oxoacyl
	[ACP]-reductase, EC 1.1.1.121 <9,11>) <9,11>
CF	#9,48,56# NADH (#9# NADPH is much more effective than NADH <1,10>)
	<1,10,57,61>

ACTIVATING_COMPOUND
AC	#26,46# more (#26# affinity of acyl-carrier protein for FabG is
	increased by 3fold in the presence of 1 M urea <49>; #46# variation of
	the buffer molarity between 25 mM and 200 mM or addition of NaCl up to
	500 mM has no significant effect on enzyme activity <40>) <40,49>

INHIBITORS
IN	#1,3,5,12,13,14,17,19,21,23,25,28,34,35,37,39# Tannic acid (#3,25#
	displays very strong inhibition <48>; #5# strongest inhibition on FabG,
	shows time-dependent irreversible inhibition <48>) <48>
IN	#1,3,5,9,12,13,14,17,19,20,21,23,25,28,33,34,35,37,38,39,42# more (#9#
	not: N-ethylmaleimide, arsenite <1>; #42# no inhibition by triclosan
	<23>; #5# cinnamic acid derivatives can be accommodated in the
	substrate-binding region of the active site, above the nicotinamide
	moiety of the NADPH cofactor <42>; #38# FabG is inhibited by extract of
	galangal (rhizome of Alpinia officinarum), strongest inhibition with
	40% ethanol extract of galangal. Inhibition is consisted of both
	reversible and irreversible inhibition. Inhibits FabG in a competitive
	pattern against NADPH, irreversible inhibition presents two phases
	(slow and fast one) <46>; #20# FabG is inhibited by extract of galangal
	(rhizome of Alpinia officinarum). Minimum inhibitory concentration is
	0.01-0.02 mM <46>; #33# FabG is inhibited by extract of galangal
	(rhizome of Alpinia officinarum). Minimum inhibitory concentration is
	0.025-0.05 mM <46>; #3# FabG is inhibited by extract of galangal
	(rhizome of Alpinia officinarum). Minimum inhibitory concentration is
	0.32-0.64 mM <46>; #14# FabG is inhibited by extract of galangal
	(rhizome of Alpinia officinarum). Minimum inhibitory concentration is
	above 1.28 mM <46>; #1,3,5,12,13,14,17,19,23,34,37,39# inhibition by
	leaf extracts from Acer platanoides, Acer campestre, Acer rubrum, Acer
	saccharum and Acer truncatum Bunge <48>; #25# inhibition by leaf
	extracts from Acer platanoides, Acer campestre, Acer rubrum, Acer
	saccharum and Acer truncatum Bunge, except strain 04-5 <48>; #21,28,35#
	inhibition by leaf extracts from Acer platanoides, Acer campestre, Acer
	rubrum, Acer saccharum and Acer truncatum Bunge. Is inhibited by the
	leaf extracts from all five kinds of maples more effectively than are
	other Gram-negative bacteria strains <48>; #5# inhibition by leaf
	extracts from Acer platanoides, Acer campestre, Acer rubrum, Acer
	saccharum and Acer truncatum Bunge. Leaf extracts of Acer saccharum and
	Acer truncatum Bunge display time-dependent irreversible inhibition of
	FabG, whereas leaf extracts of Acer platanoides, Acer campestre and
	Acer rubrum show reversible inhibition <48>) <1,23,42,46,48>
IN	#11# RNAi (#11# suppresses KCR activity, which results in a reduction
	of cuticular wax load and affects very-long-chain fatty acid
	composition of sphingolipids, seed triacylglycerols, and root
	glycerolipids. RNAi-suppressed Arabidopsis KCR1 plants display fused
	vegetative and reproductive organs, an abnormal root morphology and
	have abnormal trichome and epidermal cell morphology <39>) <39>
IN	#15# Acyl carrier protein (#15# beta-ketobutyryl-CoA reductase activity
	of FabG1 is inhibited, activity of FabG2 is unaffected <18>) <18>
IN	#2# resveratrol (#2# inhibits the overall reaction and beta-ketoacyl
	reductase reaction of FAS with IC50 values of 11.1 microg/ml and 21.9
	microg/ml, respectively. In 3 T3-L1 preadipocytes, resveratrol reduces
	lipid accumulation remarkably <54>) <54>
IN	#2# grape skin extract (#2# inhibits the overall reaction and
	beta-ketoacyl reductase reaction of FAS with IC50 values of 4.61
	microg/ml and 20.3 microg/ml, respectively. Inhibits the overall
	reaction of FAS competitively with acetyl-CoA, noncompetitively with
	malonyl-CoA and in a mixed manner with NADPH <54>) <54>
IN	#20# DL-3-hydroxybutyryl-CoA (#20# competitive product inhibition <24>)
	<24>
IN	#24,42# 3-hydroxybutyryl-CoA (#42# competitive product inhibition <23>;
	#24# noncompetitive product inhibition pattern <25>) <23,25>
IN	#26# Guanidinium chloride (#26# FabG is fully unfolded at 4 M,
	approximately 90% of the enzyme activity can be recovered on dialyzing
	the denaturant. In presence of NADPH, there is no stabilization of FabG
	in case of equilibrium unfolding with guanidinium chloride <49>) <49>
IN	#26# Urea (#26# FabG is fully unfolded at 6 M, approximately 90% of the
	enzyme activity can be recovered on dialyzing the denaturant. Two
	states in the reversible unfolding process of FabG in presence of
	NADPH, one is an activity-enhanced state and the other, an inactive
	state in case of equilibrium unfolding with urea <49>) <49>
IN	#26# acyl-carrier protein (#26# inhibition of wild-type with increasing
	concentrations <43>) <43>
IN	#27,32# Phenylglyoxal (#27# with NADPH 45% remaining activity, without
	total loss of activity <7>) <7,12>
IN	#38# kaempferol <46>
IN	#42# bromochlorophen (#42# an anthelmintic agent, over 75% inhibition
	at 0.02 mM, IC50: 0.0154 mM <23>) <23>
IN	#42# Hexachlorophene (#42# an anthelmintic and antimicrobial agent,
	over 75% inhibition at 0.02 mM, IC50: 0.002 mM <23>) <23>
IN	#42# di-resorcinol sulfide (#42# over 75% inhibition at 0.02 mM, IC50:
	0.0038 mM <23>) <23>
IN	#42# bithionol (#42# over 75% inhibition at 0.02 mM, IC50: 0.010 mM
	<23>) <23>
IN	#49# anthecotulide (#49# linear sesquiterpene lactone from Anthemis
	auriculata <35>) <35>
IN	#49# 4-hydroxyanthecotulide (#49# linear sesquiterpene lactone from
	Anthemis auriculata <35>) <35>
IN	#49# 4-acetoxyanthecotulide (#49# most active linear sesquiterpene
	lactone from Anthemis auriculata against FabG <35>) <35>
IN	#5# epigallocatechin gallate <44>
IN	#5# (E)-4-cyanophenyl 3-(benzo[d][1,3]dioxol-5-yl)acrylate <42>
IN	#5# (E)-2-nitrophenyl cinnamate <42>
IN	#5# chlorogenic acid (#5# IC50: 0.881-0.948 mM <27>) <27>
IN	#5# (E)-3-phenoxybenzyl 3-(benzo[d][1,3]dioxol-5-yl)acrylate (#5# 61%
	residual activity <42>) <42>
IN	#5# (E)-phenyl 3-(benzo[d][1,3]dioxol-5-yl)acrylate (#5# 69% residual
	activity <42>) <42>
IN	#5# N-(1,3-dioxoisoindolin-2-yl)-2-oxo-2H-chromene-3-carboxamide (#5#
	69% residual activity <42>) <42>
IN	#5# (E)-benzyl 3-(benzo[d][1,3]dioxol-5-yl)acrylate (#5# 71% residual
	activity <42>) <42>
IN	#5# (E)-1-(4-methylpiperidin-1-yl)-3-phenylprop-2-en-1-one (#5# 80%
	residual activity <42>) <42>
IN	#5,20,24# NADP+ (#5,20# competitive product inhibition <24,27>; #24#
	noncompetitive product inhibition pattern <25>) <24,25,27>
IN	#5,38# quercetin <46,48>
IN	#5,6,14,25# 1,2,3,4,6-penta-O-galloyl-beta-D-glucose (#14# minimal
	inhibitory concentration 0.125 mg/ml <32>; #25# minimal inhibitory
	concentration 0.25 mg/ml <32>; #5# mixed type of inhibition. IC50 value
	0.9 microgramm per ml, Ki value 0.21 microgramm per ml <32>; #6#
	compound is transported across cancer cell membrane to further
	down-regulate FAS and activate caspase-3 in MDA-MB-231 cells. Compared
	with other FAS inhibitors, including catechin gallate and morin,
	1,2,3,4,6-penta-O-galloyl-beta-D-glucose involves a higher reversible
	fast-binding inhibition with an irreversible slow-binding inhibition,
	i.e. saturation kinetics with a dissociation constant of 0.59 microM
	and a limiting rate constant of 0.16 per min. The major reacting site
	of PGG is on the beta-ketoacyl reduction domain of FAS. Compound
	exhibits different types of inhibitions against the three substrates in
	the FAS overall reaction <53>) <32,53>
IN	#9# p-chloromercuribenzoate <1>

METALS_IONS
ME	#42# more (#42# the enzyme activity is maximal at a ionic strength of
	325 mM <23>) <23>

MOLECULAR_WEIGHT
MW	#11# 35000 (#11# sequence analysis, KCR2 <39>) <39>
MW	#14# 116000 (#14# recombinant enzyme, analytical ultracentrifugation,
	tetrameric at higher enzyme concentrations <28>) <28>
MW	#14# 29000 (#14# 2 * 29000, recombinant enzyme, SDS-PAGE <28>; #14# 4 *
	29000, SDS-PAGE, tetrameric at higher enzyme concentrations <28>) <28>
MW	#14# 50400 (#14# recombinant enzyme, gel filtration <28>) <28>
MW	#14# 58400 (#14# recombinant enzyme, analytical ultracentrifugation
	<28>) <28>
MW	#15,29# 25000 (#15# x * 25000, recombinant methionine-labelled FabG1,
	SDS-PAGE <18>) <18,60>
MW	#16# 120000 (#16# gel filtration <6>) <6>
MW	#26# 110000 (#26# gel filtration, wild-type and mutants <43>) <43>
MW	#26# 31000 (#26# 4 * 31000, SDS-PAGE, wild-type and mutants <43>) <43>
MW	#26,27# 28000 (#26# x * 28000, SDS-PAGE <17>; #27# 4 * 28000, SDS-PAGE
	<7>) <7,17>
MW	#27# 130000 (#27# gel filtration <7>) <7>
MW	#27# 40000-46000 (#27# gel filtration, sucrose density gradient
	centrifugation <11>) <11>
MW	#32# 27000 (#32# ? * 27000, DNA sequence calculation <12>) <12>
MW	#4,15# 24000 (#4# ? * 24000, SDS-PAGE <13>; #15# x * 24000, recombinant
	methionine-labelled FabG2, SDS-PAGE <18>) <13,18>
MW	#45,46# 25500 (#45# derived from amino acid sequence containing 246
	amino acids <38>; #46# 4 * 25500, SDS-PAGE <40>) <38,40>
MW	#46# 102000 (#46# gel filtration <40>) <40>
MW	#58# 100000 (#58# x * 100000, SDS-PAGE <58>) <58>
MW	#8# 44000 (#8# gel filtration <9>) <9>
MW	#9# 97000 (#9# gel filtration <1>) <1>
MW	#9# 64000 (#9# gel filtration <10>) <10>
MW	#9# 24200 (#9# 4 * 24200, SDS-PAGE <1>) <1>

POSTTRANSLATIONAL_MODIFICATION
PM	#42# more (#42# the enzyme contains a signal peptide <23>) <23>

SUBUNITS
SU	#14# dimer (#14# 2 * 29000, recombinant enzyme, SDS-PAGE <28>) <28>
SU	#16,27# More (#16,27# animals, yeast and Mycobacteria have fatty acid
	synthetases containing all the individual activities on one or two
	multifunctional polypeptide chains, plants and most bacterial systems,
	including Escherichia coli, possess individual monofunctional enzymes
	and a separate acyl carrier protein <3>) <3>
SU	#26# homotetramer (#26# 4 * 31000, SDS-PAGE, wild-type and mutants
	<43>) <43>
SU	#29# homodimer or homotetramer (#29# 2 or 4 * 25000, SDS-PAGE <60>) <60>
SU	#4,15,26,32,58# ? (#58# x * 100000, SDS-PAGE <58>; #26# x * 28000,
	SDS-PAGE <17>; #32# ? * 27000, DNA sequence calculation <12>; #4# ? *
	24000, SDS-PAGE <13>; #15# x * 24000, recombinant methionine-labelled
	FabG2, SDS-PAGE <18>; #15# x * 25000, recombinant methionine-labelled
	FabG1, SDS-PAGE <18>) <12,13,17,18,58>
SU	#56# heterotetramer <61>
SU	#57# homodimer (#57# x-ray crystallography <59>) <59>
SU	#9,14,16,26,27,42,44,46# tetramer (#27# 4 * 28000, SDS-PAGE <7>; #9# 4
	* 24200, SDS-PAGE <1>; #16# 4 * 20000-30000, SDS-PAGE <3,6>; #46# 4 *
	25500, SDS-PAGE <40>; #44# crystallization data <37>; #44#
	crystallography <50>; #14# 4 * 29000, SDS-PAGE, tetrameric at higher
	enzyme concentrations <28>; #42# crystal structure and ultrafiltration,
	quarternary structure analysis, monomer interactions, conformations in
	absence and presence of cofactor NADP+ <23>; #26# cross-linking of
	native and up to 1 M urea-treated FabG <49>) <1,3,6,7,23,28,37,40,49,50>

PI_VALUE
PI	#45# 5.9 (#45# predicted <38>) <38>

APPLICATION
AP	#1,3,5,12,13,14,17,19,20,21,23,25,26,28,33,34,35,37,38,39# drug
	development (#26# the enzyme has no isoforms and thus is a good target
	for inhibitor design <26>;
	#1,3,5,12,13,14,17,19,21,23,25,28,34,35,37,39# FabG is the antibacteria
	target of maple leaf extracts and tannic acid, and both reversible and
	irreversible inhibitions of FabG are important for the antibacterial
	effect <48>; #3,14,20,33,38# galangal extract inhibits FabG, thereby
	displaying antibacterial ability <46>) <26,46,48>
AP	#5# synthesis (#5# coexpression with fabH mutant F87T and
	polyhydroxyalkanoate synthase genes enhances the production of short
	chain length-medium chain length polyhydroxyalkanoate copolymer from
	both related and unrelated carbon sources. Analysis of
	polyhydroxyalkanoate accumulation and physical characterization of
	copolymer <33>) <33>

ENGINEERING
EN	#1# M125I/S233T (#1# temperature-sensitive mutant enzyme does not allow
	growth of Escherichia coli at 42°C in complementation assay <19>) <19>
EN	#1,5# E233K (#1# temperature-sensitive mutant enzyme does not allow
	growth of Escherichia coli at 42°C in complementation assay <19>; #5#
	temperature-sensitive phenoptype, reductase activity is much more
	thermolabile than the activity of the wild-type strain <19>) <19>
EN	#24# S140A (#24# mutant shows no enzymatic activity. S140A mutant does
	not bind to NADPH <52>) <52>
EN	#24# S140T (#24# mutant shows no enzymatic activity. Mutant S140T shows
	impaired NADPH binding <52>) <52>
EN	#26# R187A (#26# kinetic constants (Km and acyl-carrier
	protein-independent specific activities) remain largely unchanged with
	respect to wild-type. Exhibits very poor activity in the acyl-carrier
	protein-dependent spectroscopic assay. No inhibition by increasing
	concentrations of acyl-carrier protein. 3fold decreased affinity
	binding to acyl-carrier protein with respect to wild-type <43>) <43>
EN	#26# R230A (#26# kinetic constants (Km and acyl-carrier
	protein-independent specific activities) remain largely unchanged with
	respect to wild-type. Exhibits very poor activity in the acyl-carrier
	protein-dependent spectroscopic assay. No inhibition by increasing
	concentrations of acyl-carrier protein. 5fold decreased affinity
	binding to acyl-carrier protein with respect to wild-type <43>) <43>
EN	#26# R187E (#26# kinetic constants (Km and acyl-carrier
	protein-independent specific activities) remain largely unchanged with
	respect to wild-type. Exhibits very poor activity in the acyl-carrier
	protein-dependent spectroscopic assay. No inhibition by increasing
	concentrations of acyl-carrier protein. 4fold decreased affinity
	binding to acyl-carrier protein with respect to wild-type <43>) <43>
EN	#26# R230E (#26# kinetic constants (Km and acyl-carrier
	protein-independent specific activities) remain largely unchanged with
	respect to wild-type. Exhibits very poor activity in the acyl-carrier
	protein-dependent spectroscopic assay. No inhibition by increasing
	concentrations of acyl-carrier protein. 41fold decreased affinity
	binding to acyl-carrier protein with respect to wild-type <43>) <43>
EN	#26# R187A/R230A (#26# kinetic constants (Km and acyl-carrier
	protein-independent specific activities) remain largely unchanged with
	respect to wild-type. Exhibits very poor activity in the acyl-carrier
	protein-dependent spectroscopic assay. 5fold decreased affinity binding
	to acyl-carrier protein with respect to wild-type <43>) <43>
EN	#26# R187E/R230E (#26# kinetic constants (Km and acyl-carrier
	protein-independent specific activities) remain largely unchanged with
	respect to wild-type. Exhibits very poor activity in the acyl-carrier
	protein-dependent spectroscopic assay. 80fold decreased affinity
	binding to acyl-carrier protein with respect to wild-type <43>) <43>
EN	#26# R187K (#26# no decreased affinity binding to acyl-carrier protein
	with respect to wild-type <43>) <43>
EN	#29# Y155F (#29# the mutant shows less than 3% of wild type activity
	<60>) <60>
EN	#29# G92D (#29# the mutant shows less than 5% of wild type activity
	<60>) <60>
EN	#29# G141A (#29# the mutant shows less than 5% of wild type activity
	<60>) <60>
EN	#29# G92A (#29# the mutant shows less than 60% of wild type activity
	<60>) <60>
EN	#29# Q152A (#29# the mutant shows less than 10% of wild type activity
	<60>) <60>
EN	#5# A154T/E233K (#5# temperature-sensitive phenoptype, reductase
	activity is much more thermolabile than the activity of the wild-type
	strain <19>) <19>
EN	#5# A154T (#5# similar thermal stability as wild-type enzyme <19>) <19>
EN	#5# F87T (#5# coexpression with fabH mutant F87T and
	polyhydroxyalkanoate synthase genes enhances the production of short
	chain length-medium chain length polyhydroxyalkanoate copolymer from
	both related and unrelated carbon sources <33>) <33>
EN	#55# Q47L (#55# the mutant with increased specific activity exhibits a
	kcat value that is 2.4fold higher than that of the wild type enzyme
	<56>) <56>
EN	#55# T173S (#55# the mutant with increased specific activity exhibits a
	kcat value that is 3.5fold higher than that of the wild type enzyme
	<56>) <56>
EN	#56# K173A (#56# the mutant shows 0.3% activity with acetoacetyl-CoA
	and NADH, 2.4% activity with acetoacetyl-CoA and NADPH, 6% activity
	with 9,10-phenanthrene and NAD+, and 22% activity with
	9,10-phenanthrene and NADP+, compared to the wild type enzyme,
	respectively <61>) <61>
EN	#56# D42A (#56# the mutant shows 36% activity with acetoacetyl-CoA and
	NADH, 20% activity with acetoacetyl-CoA and NADPH, 4% activity with
	9,10-phenanthrene and NAD+, and 26% activity with 9,10-phenanthrene and
	NADP+, compared to the wild type enzyme, respectively <61>) <61>
EN	#56# K152A (#56# the mutant shows 109% activity with acetoacetyl-CoA
	and NADH, no activity with acetoacetyl-CoA and NADPH, 123% activity
	with 9,10-phenanthrene and NAD+, and 2.2% activity with
	9,10-phenanthrene and NADP+, compared to the wild type enzyme,
	respectively <61>) <61>
EN	#56# Y169A (#56# the mutant shows 3% activity with acetoacetyl-CoA and
	NADH, 2% activity with acetoacetyl-CoA and NADPH, 4% activity with
	9,10-phenanthrene and NAD+, and 15% activity with 9,10-phenanthrene and
	NADP+, compared to the wild type enzyme, respectively <61>) <61>
EN	#56# R34A (#56# the mutant shows 102% activity with acetoacetyl-CoA and
	NADH, 100% activity with acetoacetyl-CoA and NADPH, 40.44% activity
	with 9,10-phenanthrene and NAD+, and 2.1% activity with
	9,10-phenanthrene and NADP+, compared to the wild type enzyme,
	respectively <61>) <61>
EN	#56# R168E (#56# the mutant shows 106% activity with acetoacetyl-CoA
	and NADH, 6.3% activity with acetoacetyl-CoA and NADPH, 38% activity
	with 9,10-phenanthrene and NAD+, and 8% activity with 9,10-phenanthrene
	and NADP+, compared to the wild type enzyme, respectively <61>) <61>
EN	#56# K169E (#56# the mutant shows 95% activity with acetoacetyl-CoA and
	NADH, 5.5% activity with acetoacetyl-CoA and NADPH, 76% activity with
	9,10-phenanthrene and NAD+, and 6% activity with 9,10-phenanthrene and
	NADP+, compared to the wild type enzyme, respectively <61>) <61>
EN	#56# Q126E/K169E (#56# the mutant shows 156% activity with
	acetoacetyl-CoA and NADH, 4.3% activity with acetoacetyl-CoA and NADPH,
	84% activity with 9,10-phenanthrene and NAD+, and 8% activity with
	9,10-phenanthrene and NADP+, compared to the wild type enzyme,
	respectively <61>) <61>
EN	#56# Q126E/R168E/K169E (#56# the mutant shows 72% activity with
	acetoacetyl-CoA and NADH, 0.5% activity with acetoacetyl-CoA and NADPH,
	40% activity with 9,10-phenanthrene and NAD+, and no activity with
	9,10-phenanthrene and NADP+, compared to the wild type enzyme,
	respectively <61>) <61>
EN	#57# S36A (#57# the mutant shows reduced activity compared to the wild
	type enzyme <59>) <59>
EN	#57# R14A (#57# inactive <59>) <59>
EN	#57# S40A (#57# the mutant shows reduced activity compared to the wild
	type enzyme <59>) <59>
EN	#7,11,16,32# more (#32# glutathione-S-transferase fusion protein
	without transit peptide, expressed in Escherichia coli <12>; #16#
	transformation with 3-oxoacyl-[acyl-carrier-protein] reductase in
	antisense orientation, driven by either the cauliflower mosaic virus
	35S promoter or a seed-specific acyl carrier protein promoter. In
	plants with altered reductase activity, total seed yield is reduced in
	all cases. In less severely affected plant lines, seeds have a normal
	appearance and composition but the yield of seeds is reduced by
	approximately 50%. In more severely affected lines, reductions in both
	seed fatty acid content and the number of seeds produced per plant are
	evident, resulting in a 90% reduction in fatty acid synthesized per
	plant. Phenotypes are independent of the promoter used. In severely
	affected lines, a large proportion of seeds show precocious
	germination, and these have a reduced oleate content and increased
	levels of polyunsaturated 18-carbon fatty acids, compared with normal
	seeds of the same line <36>; #11# insertional mutants in KCR1 and KCR2
	<39>; #7# mutant cells lacking the homologous mitochondrial FASII
	enzyme 3-oxoacyl-ACP reductase Oar1p <45>; #7# oar1-DELTA mutants, lack
	3-oxoacyl-ACP reductase acitivity, expression of FabG4 gene of
	Mycobacterium tuberculosis <47>) <12,36,39,45,47>

CLONED
CL	#4# (expression in Escherichia coli) <13>
CL	#5# (overexpression of fabG gene in Escherichia coli strain BL21 (DE3))
	<14>
CL	#5# (gene fabG, expression of N-terminally His-tagged enzyme in
	Escherichia coli strain BL21(DE3)) <27>
CL	#5# (gene fabG, overexpression of His-tagged enzyme in strain
	BL21(DE3)) <22>
CL	#5# (coexpression in Escherichia coli LS5218 with fabH mutant F87T and
	polyhydroxyalkanoate synthase genes) <33>
CL	#5# (His-tagged FabG expressed in Escherichia coli strain BL21 (DE3))
	<48>
CL	#5# (NH2-terminally His-tagged FabG expressed in Escherichia coli
	strain BL21(DE3)) <44>
CL	#5# (pET15b-fabG vector construct transformed into the Escherichia coli
	BL21 DE3 strain) <42>
CL	#11# (YFP-KCR1 and CFP-KCR2 fusion constructs transiently expressed in
	tobacco under the control of the 35S promoter or in Arabidopsis. KCR1
	and KCR2 expressed in the yeast ybr159DELTA mutant) <39>
CL	#14# (gene rhlG, expression of His-tagged enzyme in Escherichia coli
	strain BL21(DE3) or, as selenomethionine-labeled variant in Escherichia
	coli strain B834 in minimal medium) <28>
CL	#15# (complementation of Escherichia coli fabG mutant with
	Lactobacillus lactis fabG genes shows that fabG1 encodes a functional
	beta-ketoacyl ACP reductase and fabG2 encodes an enzyme that has
	activity with the model substrate beta-ketobutyryl-CoA, but lacks the
	ability to support fatty acid synthesis both in vivo and in vitro) <18>
CL	#16# (overexpression in Escherichia coli strain BL21 (DE3)) <15>
CL	#16# (transformation with 3-oxoacyl-[acyl-carrier-protein] reductase in
	antisense orientation, driven by either the cauliflower mosaic virus
	35S promoter or a seed-specific acyl carrier protein promoter) <36>
CL	#18# (heterologous coexpression of the polyhydroxyalkanoate synthase
	genes phaEC together with Haloarcula hispanica fabG1 reconstructs the
	polyhydroxyalkanoate biosynthetic pathway) <41>
CL	#22# (expression in Saccharomyces cerevisae mutant cells lacking the
	homologous mitochondrial FASII enzyme 3-oxoacyl-ACP reductase Oar1p)
	<45>
CL	#24# (expression in Escherichia coli) <31>
CL	#24# (expressed in Escherichia coli) <52>
CL	#24# (selection of an Escherichia coli, BL21(DE3)NH host that stably
	expresses mutant forms of 3-ketoacyl-ACP(CoA) reductase) <21>
CL	#24# (expression in Streptomyces cerevisiae cells lacking 3-oxoacyl-ACP
	reductase) <47>
CL	#26# (expression in Escherichia coli) <17>
CL	#26# (gene fabG, DNA and amino acid sequence determination and
	analysis, expression of C-terminally His-tagged enzyme in Escherichia
	coli strain BL21(DE3)) <26>
CL	#26# (overexpression of His-tagged enzyme in Escherichia coli strain
	BL21(DE3) in inclusion bodies) <29>
CL	#26# (into pET-28a vector and expressed in Escherichia coli BL21 (DE3)
	codon plus) <49>
CL	#26# (wild-type and mutants cloned into the pET-28a(+) vector and
	expressed in Escherichia coli BL21 (DE3) codon plus) <43>
CL	#29# (expressed in Escherichia coli BL21-CodonPlus(DE3)-RIPL cells) <60>
CL	#32# (expression of protein without transit peptide in Escherichia
	coli) <12>
CL	#38# (overexpressed in Escherichia coli BL21 (DE3)) <46>
CL	#40# (heterologous coexpression of the polyhydroxyalkanoate synthase
	genes phaEC together with fabG1 in Haloferax volcanii) <41>
CL	#41# (gene fabG, overexpression of His-tagged enzyme in strain
	BL21(DE3), recombinant expression in Escherichia coli strain JM109
	leads to enhanced production of polyhydroxyalkanoate, PHA, copolymer
	from glucose, PHA composition, overview) <22>
CL	#42# (gene fabG, DNA and amino acid sequence determination and
	analysis, expression of His10-tagged enzyme in Escherichia coli) <23>
CL	#43# (expression in Escherichia coli) <30>
CL	#44# (expression in Escherichia coli) <37>
CL	#44# (PCR product recombined with pDONR221 and insert from this vector
	transferred in the LR reaction to the expression vector pET15g which
	adds a histidine tag and a 3C protease cleavage site, expressed in
	Escherichia coli B834(DE3) cells) <50>
CL	#45# (Recombinant Escherichia coli (strain DH5alpha) co-expresses the
	fabG gene. The fabG gene is PCR-cloned using primers derived from the
	up and down-stream regions of the Pseudomonas putida KT2440 genome.)
	<38>
CL	#46# (transformation of the fabG gene encoding
	3-ketoacyl-[acyl-carrier-protein] reductase in fusion with a
	His6-MBP-tag (ligated into vector pETM-41) into Escherichia coli XL-10
	Gold. After isolation from XL-10 cells and DNA sequencing, transformed
	into Escherichia coli Tuner (DE3) cells) <40>
CL	#47# (FabG1 expressed from vector pPLM189 as mitochondrial protein in
	the Saccharomyces cerevisiae oar1DELTA mutant strain. FabG1 can restore
	respiratory growth of Saccharomyces cerevisiae oar1DELTA cells and
	renews lipoic acid production) <47>
CL	#48# (FabG4 expressed from vector pPLM192 as mitochondrial protein in
	the Saccharomyces cerevisiae oar1DELTA mutant strain. FabG4 can restore
	respiratory growth of Saccharomyces cerevisiae oar1DELTA cells and
	renews lipoic acid production) <47>
CL	#53# (expressed in Escherichia coli as a His-tagged fusion protein) <51>
CL	#55# (expressed in Escherichia coli BL21(DE3) cells and in
	Corynebacterium glutamicum) <56>
CL	#56# (expressed in Escherichia coli BL21 (RARE) cells) <61>
CL	#57# (expressed in Escherichia coli BL21(DE3) cells) <59>
CL	#58# (expressed in Escherichia coli BL21 Rosetta 2 (DE3) pLysS cells)
	<58>

CRYSTALLIZATION
CR	#5# <14>
CR	#14# (purified native and selenomethionine-labeled recombinant enzyme,
	hanging drop vapour diffusion method, 18°C, 2.5 mg/ml protein in 50 mm
	HEPES, pH 7.0, 5 mM Tris, pH 8.0, 0.15 mM ammonium sulfate, 6% PEG
	4000, 0.1 M NaCl, 0.5 mM EDTA, and 0.5 mM DTT, mixed with reservoir
	solution containing 1 M HEPES, pH 7.0, 0.3 M ammonium sulfate, and 12%
	PEG 4000, plus 1 mM NADPH, X-ray diffraction structure determination
	and analysis at 2.3 A resolution) <28>
CR	#16# <15>
CR	#16# (structure determination and similarities within short-chain
	alcohol dehydrogenase family, catalytic mechanism) <16>
CR	#29# (hanging drop vapor diffusion method, using 2.0-2.7 M ammonium
	sulfate and 0.1 M Tris (pH 9.0)) <60>
CR	#42# (purified recombinant enzyme, vapour diffusion method, 10 mg/ml
	protein in 20 mM HEPES, pH 6.8, 0.5 M NaCl, 1 mM DTT, and 0.5 mM EDTA,
	is mixed with an equal volume of reservoir solution containing 0.1 M
	MES, pH 6.0, 35% v/v 2-methyl-2,4-pentanediol, and 0.2 M LiSO4,
	equilibration against 1 ml of mother liquor, room temperature, 6 weeks,
	X-ray diffraction structure determination and analysis at 1.9 A
	resolution) <23>
CR	#43# (diffraction to 1.8 A, determinantion of initial phases by
	molecular replacement) <30>
CR	#44# (diffraction to 2.4 A. Final model contains two tetramers
	displaying 222 symmetry and 575 water molecules in the crystallographic
	asymmetric unit, but no bound cofactors or substrates) <37>
CR	#44# (at 2.4 A resolution, space group P21 with unit-cell parameters a
	= 70.6, b = 120.7, c = 136.4 and beta = 104.4. The structure contains
	two tetramers displaying 222 symmetry (all chains are completely
	traced, although for some chains the electron density for residues
	189-203 is poor) and 575 water molecules in the crystallographic
	asymmetric unit, but no bound cofactors or substrates) <50>
CR	#48# (in complex with hexanoyl-CoA, hanging drop vapor diffusion
	method, using) <57>
CR	#53# (crystalized at a resolution of 2.25 A) <51>
CR	#55# (vapor diffusion method, using 0.1 M MES (pH 7.1), 1.6 M ammonium
	sulfate, and 10% (w/v) 1,4-dioxane) <56>
CR	#56# (sitting drop vapor diffusion method, using 15-18% (w/v) PEG3350
	and 0.4 M ammonium acetate in sodium acetate buffer at pH 5.0) <61>
CR	#57# (apo-form complexed with NADPH, vapor diffusion method, using 10%
	(w/v) polyethylene glycol 4000, 10% (v/v) 2-propanol, 0.1 M HEPES pH
	7.0 and 30% (v/v) jeffamine ED2001, 0.1 M HEPES pH 7.5) <59>
CR	#58# (hanging drop vapor diffusion method, apoenzyme is crystallized by
	using 100 mM Na-HEPES (pH 7.5), 30% (w/v) PEG 400 and 200 mM magnesium
	chloride hexahydrate, while the complex with NADP+ is crystallized by
	using 200 mM sodium citrate tribasic dehydrate and 20% (w/v) PEG 3350)
	<58>

PURIFICATION
PU	#5# <5,14>
PU	#5# (recombinant His-tagged enzyme from strain BL21(DE3) by nickel
	affinity chromatography) <22>
PU	#5# (by nickel affinity chromatography) <44>
PU	#5# (recombinant N-terminally His-tagged enzyme from Escherichia coli
	strain BL21(DE3) by nickel affinity chromatography) <27>
PU	#5# (by nickel chelation affinity chromatography) <48>
PU	#5# (by sonication, centrifugation and on Ni-NTA column) <42>
PU	#9# <1,10>
PU	#14# (recombinant His-tagged enzyme from Escherichia coli strain
	BL21(DE3) by nickel affinity chromatography) <28>
PU	#16# <3,6,15>
PU	#24# (recombinant protein, modified purification protocol) <31>
PU	#26# <49>
PU	#26# (recombinant C-terminally His-tagged enzyme from Escherichia coli
	strain BL21(DE3) by nickel affinity chromatography) <26>
PU	#26# (recombinant His-tagged enzyme from Escherichia coli strain
	BL21(DE3) solubilized from inclusion bodies and refolded is further
	purified by nickel affinity chromatography) <29>
PU	#26# (wild-type and mutants purified to homogeneity using an
	Ni2+-nitrilotriacetic acid affinity column) <43>
PU	#27# <3,7,11>
PU	#29# (Ni-NTA agarose column chromatography and Superdex 200 pg gel
	filtration) <60>
PU	#38# (by nickel chelation affinity chromatography) <46>
PU	#41# (recombinant His-tagged enzyme from strain BL21(DE3) by nickel
	affinity chromatography) <22>
PU	#42# (recombinant His10-tagged enzyme from Escherichia coli by nickel
	affinity chromatography and gel filtration) <23>
PU	#43# (recombinant protein) <30>
PU	#44# (by nickel-affinity chromatography) <50>
PU	#46# (by gel filtration and ion exchange chromatography, to
	homogeneity) <40>
PU	#53# (using Ni-NTA chromatography) <51>
PU	#55# (His-Bind resin column chromatography and Superdex 200 pg gel
	filtration) <56>
PU	#56# (Ni-NTA column chromatography and Superdex 200 gel filtration) <61>
PU	#57# (Ni-NTA resin column chromatography and Superdex 200 gel
	filtration) <59>
PU	#58# (nickel Sepharose column chromatography and ENrich SEC 650 gel
	filtration) <58>

RENATURED
REN	#26# (solubilization of overexpressed recombinant His-tagged enzyme
	from Escherichia coli strain BL21(DE3) inclusion bodies by 8 M urea,
	and refolding by dialysis, cation exchange chromatography, and dilution
	in presence of 0.001 mM NADPH in 20 mM sodium acetate, pH 5.3, 10%
	glycerol, and 0.05% Tween 20, the refolded enzyme shows 90-95% of
	soluble enzyme activity) <29>
REN	#26# (study on guanidinium chloride-induced isothermal and thermal
	denaturation. Folding/unfolding is completely reversible and a
	two-state process. Conformational stability, i.e. DELTAGS, and the
	DELTACP value for the protein unfolding, are 22.68 kcal/mole and 5.83
	kcal/(mole K)) <34>

GENERAL_STABILITY
GS	#16,27# (inactivation by dilution can be partly prevented by inclusion
	of NADPH) <6,7>
GS	#42# (the purified recombinant enzyme is stable at room temperature at
	concentrations above 0.2 mg/ml, but unstable at 0.01 mg/ml) <23>

STORAGE_STABILITY
SS	#16# (4°C, 100 mM potassium phosphate, 52% loss of activity after 24 h)
	<6>
SS	#16# (27°C, 100 mM potassium phosphate buffer, 13% loss of activity
	after 24 h) <6>
SS	#27# (27°C, 2 M NaCl, 24 h stable) <7>
SS	#5# (-80°C, 10% glycerol) <42>
SS	#5# (-20°C, phosphate buffer, 10% glycerol) <44>
SS	#5,38# (-80°C, 50% glycerol) <46,48>
SS	#9# (-20°C, stable for 2 months) <1>

TEMPERATURE_STABILITY
TS	#5# 37 (#5# wild-type enzyme: about 40% loss of activity after 15 min,
	mutant enzyme E233K: about 90% loss of activity after 10 min, mutant
	enzyme A164T: about 25% loss of activity after 15 min, mutant enzyme
	A154T/E233K: about 80% loss of activity after 5 min <19>) <19>
TS	#5# 30 (#5# wild-type enzyme: about 15% loss of activity after 15 min,
	mutant enzyme E233K: about 60% loss of activity after 10 min,mutant
	enzyme A164T: about 20% loss of activity after 15 min, mutant enzyme
	A154T/E233K: about 80% loss of activity after 15 min <19>) <19>
TS	#5# 45 (#5# wild-type enzyme: about 70% loss of activity after 15 min,
	mutant enzyme E233K: complete loss of activity after 10 min, mutant
	enzyme A164T: about 60% loss of activity after 15 min, mutant enzyme
	A154T/E233K: complete loss of activity after 5 min <19>) <19>

REFERENCE
RF	<1> Shimakata, T.; Stumpf, P.K.: Purification and characterizations of
	beta-ketoacyl-[acyl-carrier-protein] reductase,
	beta-hydroxyacyl-[acylcarrier-protein] dehydrase, and
	enoyl-[acyl-carrier-protein] reductase from Spinacia oleracea leaves.
	Arch. Biochem. Biophys. (1982) 218, 77-91. {Pubmed:6756317}
RF	<2> Shimakata, T.; Stumpf, P.K.: The procaryotic nature of the fatty
	acid synthetase of developing Carthamus tinctorius L. (Safflower)
	seeds. Arch. Biochem. Biophys. (1982) 217, 144-154. {Pubmed:7125663}
RF	<3> Sheldon, P.S.; Safford, R.; Slabas, A.R.; Kekwick, R.G.O.:
	3-Oxoacyl-[acyl carrier protein] reductase: a component of plant fatty
	acid synthase. Biochem. Soc. Trans. (1988) 16, 392-393. {Pubmed:}
	(review)
RF	<4> Volpe, J.J.; Vagelos, P.R.: Saturated fatty acid biosynthesis and
	its regulation. Annu. Rev. Biochem. (1973) 42, 21-60. {Pubmed:4147183}
	(review)
RF	<5> Toomey, R.E.; Wakil, S.J.: Studies on the mechanism of fatty acid
	synthesis. XV. Preparation and general properties of beta-ketoacyl acyl
	carrier protein reductase from Escherichia coli. Biochim. Biophys. Acta
	(1966) 116, 189-197. {Pubmed:4381013}
RF	<6> Sheldon, P.S.; Kekwick, R.G.O.; Smith, C.G.; Sidebottom, C.;
	Slabas, A.R.: 3-Oxoacyl-[ACP] reductase from oil seed rape (Brassica
	napus). Biochim. Biophys. Acta (1992) 1130, 151-159. {Pubmed:1562581}
RF	<7> Sheldon, P.S.; Kekwick, R.G.O.; Sidebottom, C.; Smith, C.G.;
	Slabas, A.R.: 3-Oxoacyl-(acyl-carrier protein) reductase from avocado
	(Persea americana) fruit mesocarp. Biochem. J. (1990) 271, 713-720.
	{Pubmed:2244875}
RF	<8> Shimakata, T.; Stumpf, P.K.: The purification and function of
	acetyl coenzyme A:acyl carrier protein transacylase. J. Biol. Chem.
	(1983) 258, 3592-3598. {Pubmed:6833216}
RF	<9> Hendren, R.W.; Bloch, K.: Fatty acid synthetases from Euglena
	gracilis. Separation of component activities of the ACP-dependent fatty
	acid synthetase and partial purification of the beta-ketoacyl-ACP
	synthetase. J. Biol. Chem. (1980) 255, 1504-1508. {Pubmed:6766450}
RF	<10> Shimakata, T.; Stumpf, P.K.: Fatty acid synthetase of Spinacia
	oleracea leaves. Plant Physiol. (1982) 69, 1257-1262. {Pubmed:16662382}
RF	<11> Caughey, I.; Kekwick, R.G.O.: The characteristics of some
	components of the fatty acid synthetase system in the plastids from the
	mesocarp of avocado (Persea americana) fruit. Eur. J. Biochem. (1982)
	123, 553-561. {Pubmed:7075600}
RF	<12> Klein, B.; Pawlowski, K.; Höricke-Grandpierre, C.; Schell, J.;
	Töpfer, R.: Isolation and characterization of a cDNA from Cuphea
	lanceolata encoding a beta-ketoacyl-ACP reductase. Mol. Gen. Genet.
	(1992) 233, 122-128. {Pubmed:1376402}
RF	<13> Morbidoni, H.R.; de Mendoza, D.; Cronan, J.E.: Bacillus subtilis
	acyl carrier protein is encoded in a cluster of lipid biosynthesis
	genes. J. Bacteriol. (1996) 178, 4794-4800. {Pubmed:8759840}
RF	<14> Rafferty, J.B.; Fisher, M.; Langridge, S.J.; Martindale, W.;
	Thomas, N.C.; Simon, J.W.; Bithell, S.; Slabas, A.R.; Rice, D.W.:
	Crystallization of the NADP-dependent beta-keto acyl carrier protein
	reductase from Escherichia coli. Acta Crystallogr. Sect. D (1998) 54,
	427-429. {Pubmed:9761917}
RF	<15> Fisher, M.; Sedelnikowa, S.E.; Martindale, W.; Thomas, N.C.;
	Simon, J.W.; Slabas, A.R.; Rafferty, J.B.: Crystallization of the
	NADP-dependent beta-keto acyl-carrier protein reductase from Brassica
	napus. Acta Crystallogr. Sect. D (2000) 56, 86-88. {Pubmed:10666637}
RF	<16> Fisher, M.; Kroon, J.T.M.; Martindale, W.; Stuitje, A.R.; Slabas,
	A.R.; Rafferty, J.B.: The x-ray structure of Brassica napus beta-keto
	acyl carrier protein reductase and its implications for substrate
	binding and catalysis. Structure (2000) 8, 339-347. {Pubmed:10801480}
RF	<17> Pillai, S.; Rajagopal, C.; Kapoor, M.; Kumar, G.; Gupta, A.;
	Surolia, N.: Functional characterization of beta-ketoacyl-ACP reductase
	(FabG) from Plasmodium falciparum. Biochem. Biophys. Res. Commun.
	(2003) 303, 387-392. {Pubmed:12646215} (c)
RF	<18> Wang, H.; Cronan, J.E.: Only one of the two annotated Lactococcus
	lactis fabG genes encodes a functional beta-ketoacyl-acyl carrier
	protein reductase. Biochemistry (2004) 43, 11782-11789.
	{Pubmed:15362862} (c)
RF	<19> Lai, C.Y.; Cronan, J.E.: Isolation and characterization of
	beta-ketoacyl-acyl carrier protein reductase (fabG) mutants of
	Escherichia coli and Salmonella enterica serovar typhimurium. J.
	Bacteriol. (2004) 186, 1869-1878. {Pubmed:14996818} (c)
RF	<20> Hoang, T.T.; Sullivan, S.A.; Cusick, J.K.; Schweizer, H.P.:
	beta-Ketoacyl acyl carrier protein reductase (FabG) activity of the
	fatty acid biosynthetic pathway is a determining factor of
	3-oxo-homoserine lactone acyl chain lengths. Microbiology (2002) 148,
	3849-3856. {Pubmed:12480888} (c)
RF	<21> Poletto, S.S.; da Fonseca, I.O.; de Carvalho, L.P.; Basso, L.A.;
	Santos, D.S.: Selection of an Escherichia coli host that expresses
	mutant forms of Mycobacterium tuberculosis 2-trans enoyl-ACP(CoA)
	reductase and 3-ketoacyl-ACP(CoA) reductase enzymes. Protein Expr.
	Purif. (2004) 34, 118-125. {Pubmed:14766307} (c)
RF	<22> Nomura, C.T.; Taguchi, K.; Gan, Z.; Kuwabara, K.; Tanaka, T.;
	Takase, K.; Doi, Y.: Expression of 3-ketoacyl-acyl carrier protein
	reductase (fabG) genes enhances production of polyhydroxyalkanoate
	copolymer from glucose in recombinant Escherichia coli JM109. Appl.
	Environ. Microbiol. (2005) 71, 4297-4306. {Pubmed:16085817}
RF	<23> Wickramasinghe, S.R.; Inglis, K.A.; Urch, J.E.; Mueller, S.; van
	Aalten, D.M.; Fairlamb, A.H.: Kinetic, inhibition and structural
	studies on 3-oxoacyl-ACP reductase from Plasmodium falciparum, a key
	enzyme in fatty acid biosynthesis. Biochem. J. (2006) 393, 447-457.
	{Pubmed:16225460}
RF	<24> Patel, M.P.; Liu, W.S.; West, J.; Tew, D.; Meek, T.D.; Thrall,
	S.H.: Kinetic and chemical mechanisms of the fabG-encoded Streptococcus
	pneumoniae beta-ketoacyl-ACP reductase. Biochemistry (2005) 44,
	16753-16765. {Pubmed:16342966}
RF	<25> Silva, R.G.; de Carvalho, L.P.; Blanchard, J.S.; Santos, D.S.;
	Basso, L.A.: Mycobacterium tuberculosis beta-ketoacyl-acyl carrier
	protein (ACP) reductase: kinetic and chemical mechanisms. Biochemistry
	(2006) 45, 13064-13073. {Pubmed:17059223}
RF	<26> Karmodiya, K.; Surolia, N.: Analyses of co-operative transitions
	in Plasmodium falciparum beta-ketoacyl acyl carrier protein reductase
	upon co-factor and acyl carrier protein binding. FEBS J. (2006) 273,
	4093-4103. {Pubmed:16934037}
RF	<27> Li, B.H.; Ma, X.F.; Wu, X.D.; Tian, W.X.: Inhibitory activity of
	chlorogenic acid on enzymes involved in the fatty acid synthesis in
	animals and bacteria. IUBMB Life (2006) 58, 39-46. {Pubmed:16540431}
RF	<28> Miller, D.J.; Zhang, Y.M.; Rock, C.O.; White, S.W.: Structure of
	RhlG, an essential beta-ketoacyl reductase in the rhamnolipid
	biosynthetic pathway of Pseudomonas aeruginosa. J. Biol. Chem. (2006)
	281, 18025-18032. {Pubmed:16624803}
RF	<29> Karmodiya, K.; Srivastav, R.K.; Surolia, N.: Production and
	purification of refolded recombinant Plasmodium falciparum
	beta-ketoacyl-ACP reductase from inclusion bodies. Protein Expr. Purif.
	(2005) 42, 131-136. {Pubmed:15939298}
RF	<30> Mao, Q.; Duax, W.L.; Umland, T.C.: Crystallization and X-ray
	diffraction analysis of the beta-ketoacyl-acyl carrier protein
	reductase FabG from Aquifex aeolicus VF5. Acta Crystallogr. Sect. F
	(2007) 63, 106-109. {Pubmed:17277451}
RF	<31> Silva, R.G.; Rosado, L.A.; Santos, D.S.; Basso, L.A.:
	Mycobacterium tuberculosis beta-ketoacyl-ACP reductase: alpha-secondary
	kinetic isotope effects and kinetic and equilibrium mechanisms of
	substrate binding. Arch. Biochem. Biophys. (2008) 471, 1-10.
	{Pubmed:18155153}
RF	<32> Zhang, F.; Luo, S.Y.; Ye, Y.B.; Zhao, W.H.; Sun, X.G.; Wang, Z.Q.;
	Li, R.; Sun, Y.H.; Tian, W.X.; Zhang, Y.X.: The antibacterial efficacy
	of aceraceous plant may be related to inhibition of bacterial
	beta-ketoacyl-ACP reductase (FabG). Biotechnol. Appl. Biochem. (2008)
	51, 73-78. {Pubmed:18208374}
RF	<33> Nomura, C.T.; Tanaka, T.; Eguen, T.E.; Appah, A.S.; Matsumoto, K.;
	Taguchi, S.; Ortiz, C.L.; Doi, Y.: FabG mediates polyhydroxyalkanoate
	production from both related and nonrelated carbon sources in
	recombinant Escherichia coli LS5218. Biotechnol. Prog. (2008) 24,
	342-351. {Pubmed:18215055}
RF	<34> Karmodiya, K.; Sajad, S.; Sinha, S.; Maity, K.; Suguna, K.;
	Surolia, N.: Conformational stability and thermodynamic
	characterization of homotetrameric Plasmodium falciparum
	beta-ketoacyl-ACP reductase. IUBMB Life (2007) 59, 441-449.
	{Pubmed:17654120}
RF	<35> Karioti, A.; Skaltsa, H.; Zhang, X.; Tonge, P.J.; Perozzo, R.;
	Kaiser, M.; Franzblau, S.G.; Tasdemir, D.: Inhibiting enoyl-ACP
	reductase (FabI) across pathogenic microorganisms by linear
	sesquiterpene lactones from Anthemis auriculata. Phytomedicine (2008)
	15, 1125-1129. {Pubmed:18424102}
RF	<36> OHara, P.; Slabas, A.R.; Fawcett, T.: Antisense expression of
	3-oxoacyl-ACP reductase affects whole plant productivity and causes
	collateral changes in activity of fatty acid synthase components. Plant
	Cell Physiol. (2007) 48, 736-744. {Pubmed:17401135}
RF	<37> Zaccai, N.R.; Carter, L.G.; Berrow, N.S.; Sainsbury, S.;
	Nettleship, J.E.; Walter, T.S.; Harlos, K.; Owens, R.J.; Wilson, K.S.;
	Stuart, D.I.; Esnouf, R.M.: Crystal structure of a 3-oxoacyl-(acyl
	carrier protein) reductase (BA3989) from Bacillus anthracis at
	2.4-.ANG. resolution. Proteins Struct. Funct. Bioinform. (2007) 70,
	562-567. {Pubmed:}
RF	<38> Vo, M.T.; Lee, K.W.; Jung, Y.M.; Lee, Y.H.: Comparative effect of
	overexpressed phaJ and fabG genes supplementing (R)-3-hydroxyalkanoate
	monomer units on biosynthesis of mcl-polyhydroxyalkanoate in
	Pseudomonas putida KCTC1639. J. Biosci. Bioeng. (2008) 106, 95-98.
	{Pubmed:18691538}
RF	<39> Beaudoin, F.; Wu, X.; Li, F.; Haslam, R.P.; Markham, J.E.; Zheng,
	H.; Napier, J.A.; Kunst, L.: Functional characterization of the
	Arabidopsis beta-ketoacyl-coenzyme A reductase candidates of the fatty
	acid elongase. Plant Physiol. (2009) 150, 1174-1191. {Pubmed:19439572}
RF	<40> Hoelsch, K.; Havel, J.; Haslbeck, M.; Weuster-Botz, D.:
	Identification, cloning, and characterization of a novel ketoreductase
	from the cyanobacterium Synechococcus sp. strain PCC 7942. Appl.
	Environ. Microbiol. (2008) 74, 6697-6702. {Pubmed:18791006}
RF	<41> Han, J.; Lu, Q.; Zhou, L.; Liu, H.; Xiang, H.: Identification of
	the polyhydroxyalkanoate (PHA)-specific acetoacetyl coenzyme A
	reductase among multiple FabG paralogs in Haloarcula hispanica and
	reconstruction of the PHA biosynthetic pathway in Haloferax volcanii.
	Appl. Environ. Microbiol. (2009) 75, 6168-6175. {Pubmed:19648370}
RF	<42> Kristan, K.; Bratkovic, T.; Sova, M.; Gobec, S.; Prezelj, A.;
	Urleb, U.: Novel inhibitors of beta-ketoacyl-ACP reductase from
	Escherichia coli. Chem. Biol. Interact. (2009) 178, 310-316.
	{Pubmed:18977209}
RF	<43> Karmodiya, K.; Modak, R.; Sahoo, N.; Sajad, S.; Surolia, N.:
	Deciphering the key residues in Plasmodium falciparum beta-ketoacyl
	acyl carrier protein reductase responsible for interactions with
	Plasmodium falciparum acyl carrier protein. FEBS J. (2008) 275,
	4756-4766. {Pubmed:18721141}
RF	<44> Sun, Y.H.; Cheng, Q.; Tian, W.X.; Wu, X.D.: A substitutive
	substrate for measurements of beta-ketoacyl reductases in two fatty
	acid synthase systems. J. Biochem. Biophys. Methods (2008) 70, 850-856.
	{Pubmed:18201766}
RF	<45> Gurvitz, A.: Caenorhabditis elegans F09E10.3 encodes a putative
	3-oxoacyl-thioester reductase of mitochondrial type 2 fatty acid
	synthase FASII that is functional in yeast. J. Biomed. Biotechnol.
	(2009) 2009, 235868. {Pubmed:19746209}
RF	<46> Huang, H.; Wu, D.; Tian, W.X.; Ma, X.F.; Wu, X.D.: Antimicrobial
	effect by extracts of rhizome of Alpinia officinarum Hance may relate
	to its inhibition of beta-ketoacyl-ACP reductase. J. Enzyme Inhib. Med.
	Chem. (2008) 23, 362-368. {Pubmed:18569341}
RF	<47> Gurvitz, A.: The essential mycobacterial genes, fabG1 and fabG4,
	encode 3-oxoacyl-thioester reductases that are functional in yeast
	mitochondrial fatty acid synthase type 2. Mol. Genet. Genomics (2009)
	282, 407-416. {Pubmed:19685079}
RF	<48> Wu, D.; Wu, X.D.; You, X.F.; Ma, X.F.; Tian, W.X.: Inhibitory
	effects on bacterial growth and b-ketoacyl-ACP reductase by different
	species of maple leaf extracts and tannic acid. Phytother. Res. (2009)
	24, 535-541. {Pubmed:}
RF	<49> Karmodiya, K.; Surolia, N.: A unique and differential effect of
	denaturants on cofactor mediated activation of Plasmodium falciparum
	beta-ketoacyl-ACP reductase. Proteins Struct. Funct. Genet. (2008) 70,
	528-538. {Pubmed:17879351}
RF	<50> Zaccai, N.; Carter, L.; Berrow, N.; Sainsbury, S.; Nettleship, J.;
	Walter, T.; Harlos, K.; Owens, R.; Wilson, K.; Stuart, D.; Esnouf, R.:
	Crystal structure of a 3-oxoacyl-(acyl carrier protein) reductase
	(BA3989) from Bacillus anthracis at 2.4 A resolution. Proteins Struct.
	Funct. Genet. (2008) 70, 562-567. {Pubmed:17894349}
RF	<51> Subramanian, S.; Abendroth, J.; Phan, I.Q.; Olsen, C.; Staker,
	B.L.; Napuli, A.; Van Voorhis, W.C.; Stacy, R.; Myler, P.J.: Structure
	of 3-ketoacyl-(acyl-carrier-protein) reductase from Rickettsia
	prowazekii at 2.25 A resolution. Acta Crystallogr. Sect. F (2011) 67,
	1118-1122. {Pubmed:21904060}
RF	<52> Rosado, L.A.; Caceres, R.A.; de Azevedo, W.F.; Basso, L.A.;
	Santos, D.S.: Role of Serine140 in the mode of action of Mycobacterium
	tuberculosis beta-ketoacyl-ACP Reductase (MabA). BMC Res. Notes (2012)
	5, 526. {Pubmed:23006410}
RF	<53> Zhao, W.; Wang, Y.; Hao, W.; Zhao, M.; Peng, S.: In vitro
	inhibition of fatty acid synthase by
	1,2,3,4,6-penta-O-galloyl-beta-D-glucose plays a vital role in
	anti-tumour activity. Biochem. Biophys. Res. Commun. (2014) 445,
	346-351. {Pubmed:24508804}
RF	<54> Liang, Y.; Tian, W.; Ma, X.: Inhibitory effects of grape skin
	extract and resveratrol on fatty acid synthase. BMC Complement. Altern.
	Med. (2013) 13, 361. {Pubmed:24341420}
RF	<55> Cukier, C.D.; Hope, A.G.; Elamin, A.A.; Moynie, L.; Schnell, R.;
	Schach, S.; Kneuper, H.; Singh, M.; Naismith, J.H.; Lindqvist, Y.;
	Gray, D.W.; Schneider, G.: Discovery of an allosteric inhibitor binding
	site in 3-oxo-acyl-ACP reductase from Pseudomonas aeruginosa. ACS Chem.
	Biol. (2013) 8, 2518-2527. {Pubmed:24015914}
RF	<56> Matsumoto, K.; Tanaka, Y.; Watanabe, T.; Motohashi, R.; Ikeda, K.;
	Tobitani, K.; Yao, M.; Tanaka, I.; Taguchi, S.: Directed evolution and
	structural analysis of NADPH-dependent acetoacetyl coenzyme A
	(acetoacetyl-CoA) reductase from Ralstonia eutropha reveals two
	mutations responsible for enhanced kinetics. Appl. Environ. Microbiol.
	(2013) 79, 6134-6139. {Pubmed:23913421}
RF	<57> Dutta, D.; Bhattacharyya, S.; Roychowdhury, A.; Biswas, R.; Das,
	A.: Crystal structure of hexanoyl-CoA bound to beta-ketoacyl reductase
	FabG4 of Mycobacterium tuberculosis. Biochem. J. (2013) 450, 127-139.
	{Pubmed:23163771}
RF	<58> Blaise, M.; Van Wyk, N.; Baneres-Roquet, F.; Guerardel, Y.;
	Kremer, L.: Binding of NADP+ triggers an open-to-closed transition in a
	mycobacterial FabG beta-ketoacyl-ACP reductase. Biochem. J. (2017) 474,
	907-921. {Pubmed:28126742}
RF	<59> Zhang, Y.; Ning, F.; Li, X.; Teng, M.: Structural insights into
	cofactor recognition of yeast mitochondria 3-oxoacyl-ACP reductase
	OAR1. IUBMB Life (2013) 65, 154-162. {Pubmed:23300157}
RF	<60> Hou, J.; Zheng, H.; Chruszcz, M.; Zimmerman, M.D.; Shumilin, I.A.;
	Osinski, T.; Demas, M.; Grimshaw, S.; Minor, W.: Dissecting the
	structural elements for the activation of beta-ketoacyl-(acyl carrier
	protein) reductase from Vibrio cholerae. J. Bacteriol. (2015) 198,
	463-476. {Pubmed:26553852}
RF	<61> Venkatesan, R.; Sah-Teli, S.K.; Awoniyi, L.O.; Jiang, G.; Prus,
	P.; Kastaniotis, A.J.; Hiltunen, J.K.; Wierenga, R.K.; Chen, Z.:
	Insights into mitochondrial fatty acid synthesis from the structure of
	heterotetrameric 3-ketoacyl-ACP reductase/3R-hydroxyacyl-CoA
	dehydrogenase. Nat. Commun. (2014) 5, 4805. {Pubmed:25203508}
RF	<62> Medina, F.E.; Neves, R.P.; Ramos, M.J.; Fernandes, P.A.: A QM/MM
	study of the reaction mechanism of human beta-ketoacyl reductase. Phys.
	Chem. Chem. Phys. (2016) 19, 347-355. {Pubmed:27905606}

KI_VALUE
KI	#42# 0.0102 {3-hydroxybutyryl-CoA}  (#42# pH 6.8, 25°C, recombinant
	enzyme <23>) <23>
KI	#5,24# -999 {more}  (#5# inhibition kinetic analysis <27>; #24# product
	inhibition kinetics, overview <25>) <25,27>

IC50_VALUE
IC50	#2# -999 {resveratrol}  (#2# IC50 value is 21.9 microg/ml, pH 7.0, 37°C
	<54>) <54>
IC50	#2# -999 {grape skin extract}  (#2# IC50 value is 20.3 microg/ml, pH
	7.0, 37°C <54>) <54>
IC50	#38# 0.0212 {kaempferol}  (#38# pH 7.0 <46>) <46>
IC50	#38# -999 {more}  (#38# IC(50) value of 4.47 microg/ml for extract of
	galangal, pH 7.0 <46>) <46>
IC50	#38# 0.3048 {quercetin}  (#38# pH 7.0 <46>) <46>
IC50	#42# 0.002 {Hexachlorophene}  (#42# an anthelmintic and antimicrobial
	agent, over 75% inhibition at 0.02 mM, IC50: 0.002 mM <23>) <23>
IC50	#42# 0.01 {bithionol}  (#42# over 75% inhibition at 0.02 mM, IC50:
	0.010 mM <23>) <23>
IC50	#42# 0.0038 {di-resorcinol sulfide}  (#42# over 75% inhibition at 0.02
	mM, IC50: 0.0038 mM <23>) <23>
IC50	#42# 0.0154 {bromochlorophen}  (#42# an anthelmintic agent, over 75%
	inhibition at 0.02 mM, IC50: 0.0154 mM <23>) <23>
IC50	#49# 1 {anthecotulide}  (#49# pH 7.0, 25°C <35>) <35>
IC50	#49# 0.5 {4-acetoxyanthecotulide}  (#49# pH 7.0, 25°C <35>) <35>
IC50	#49# 0.75 {4-hydroxyanthecotulide}  (#49# pH 7.0, 25°C <35>) <35>
IC50	#5# 0.18 {(E)-phenyl 3-(benzo[d][1,3]dioxol-5-yl)acrylate}  (#5# pH 7.0
	<42>) <42>
IC50	#5# 0.18 {(E)-4-cyanophenyl 3-(benzo[d][1,3]dioxol-5-yl)acrylate}  (#5#
	pH 7.0 <42>) <42>
IC50	#5# 0.45 {(E)-2-nitrophenyl cinnamate}  (#5# pH 7.0 <42>) <42>
IC50	#5# 0.12 {epigallocatechin gallate}  (#5# at pH 9.0 <44>) <44>
IC50	#5# 0.00078 {Tannic acid}  <48>
IC50	#5# 0.0084 {epigallocatechin gallate}  (#5# at pH 8.3 <44>) <44>
IC50	#5# 0.0105 {epigallocatechin gallate}  (#5# at pH 7.5 <44>) <44>
IC50	#5# 0.881-0.948 {chlorogenic acid}  (#5# IC50: 0.881-0.948 mM <27>) <27>
IC50	#5# 0.215
	{N-(1,3-dioxoisoindolin-2-yl)-2-oxo-2H-chromene-3-carboxamide}  (#5# pH
	7.0 <42>) <42>
IC50	#5# 0.0578 {epigallocatechin gallate}  (#5# at pH 7.0 <44>) <44>
IC50	#5# 0.0336 {epigallocatechin gallate}  (#5# at pH 8.5 <44>) <44>
IC50	#5# 0.00554 {epigallocatechin gallate}  (#5# at pH 8.0 <44>) <44>
IC50	#5# 0.1223 {epigallocatechin gallate}  (#5# at pH 6.5 <44>) <44>

KCAT_KM_VALUE
KKM	#55# 18000 (#55# wild type enzyme, at pH 8.0 and 30°C <56>) <56>
KKM	#55# 26500 (#55# mutant enzyme Q47L, at pH 8.0 and 30°C <56>) <56>
KKM	#55# 685 (#55# wild type enzyme, at pH 8.0 and 30°C <56>) <56>
KKM	#55# 862 (#55# mutant enzyme Q47L, at pH 8.0 and 30°C <56>) <56>
KKM	#55# 15200 (#55# mutant enzyme Q47L, at pH 8.0 and 30°C <56>) <56>
KKM	#55# 585 (#55# mutant enzyme Q47L, at pH 8.0 and 30°C <56>) <56>

GENERAL_INFORMATION
GI	#11,18,40# malfunction (#40# DELTAfabG1 cells lose the ability to
	accumulate poly(3-hydroxybutyrate-co-3-hydroxyvalerate). When the
	DELTAfabG1 strain is transformed with the fabG1 expression plasmid
	pWLG1, the capability of polyhydroxyalkanoate accumulation is restored.
	When the fabG1 gene is disrupted or knocked out, the NADPH-dependent
	activity of acetoacetyl-CoA reductase in the mutant, the DELTAfabG1 or
	fabG1-1 strain, is greatly decreased <41>; #11# loss of KCR1 function
	results in embryo lethality, which cannot be rescued by KCR2 expression
	using the KCR1 promoter. Disruption of the KCR2 gene has no obvious
	phenotypic effect <39>; #18# polyhydroxyalkanoate-defective
	haloarchaeon <41>) <39,41>
GI	#11,40# physiological function (#40# FabG1 has the function of
	supplying precursors for polyhydroxyalkanoate biosynthesis <41>; #11#
	only KCR1 is a functional KCR isoform involved in microsomal fatty acid
	elongation <39>) <39,41>

///
ID	1.1.1.101
********************************************************************************
*                                                                              *
* Copyrighted by Dietmar Schomburg, Techn. University Braunschweig, GERMANY    *
* Distributed under the License as stated at http:/www.brenda-enzymes.org      *
*                                                                              *
********************************************************************************

PROTEIN
PR	#1# Cavia porcellus   <1,5,7,9>
PR	#2# Mus musculus   <5,13>
PR	#3# Homo sapiens   <6>
PR	#4# Rattus norvegicus   <1,2,3,5>
PR	#5# Saccharomyces cerevisiae   <8,10,11,12>
PR	#6# Trypanosoma brucei   <4>

RECOMMENDED_NAME
RN	acylglycerone-phosphate reductase


SYSTEMATIC_NAME
SN	1-palmitoylglycerol-3-phosphate:NADP+ oxidoreductase


SYNONYMS
SY	 reductase, palmitoyl dihydroxyacetone phosphate
SY	 palmitoyl-dihydroxyacetone-phosphate reductase
SY	 acyldihydroxyacetone phosphate reductase
SY	 palmitoyl dihydroxyacetone phosphate reductase
SY	 palmitoyldihydroxyacetone-phosphate reductase
SY	 acyldihydroxyacetone-phosphate:NADPH oxidoreductase
SY	 acyldihydroxyacetone-phosphate oxidoreductase
SY	 1-acylglycerol-3-phosphate:NADP+ oxidoreductase
SY	 acyl/alkyl dihydroxyacetone-phosphate reductase

REACTION
RE	1-palmitoylglycerol 3-phosphate + NADP+ = palmitoylglycerone phosphate
	+ NADPH + H+

REACTION_TYPE
RT	oxidation
RT	reduction

SOURCE_TISSUE
ST	#1# spleen <1>
ST	#1# lung <1>
ST	#1,2,4# liver <1,2,3,5,7,9>
ST	#1,4# testis <1>
ST	#1,4# ascites tumor cell (#1,4# grown in the abdomen of swiss white
	mice <1>) <1>
ST	#2# preadipocyte (#2# 3T3-L1, fibroblast-like cell <13>) <13>
ST	#3# skin fibroblast (#3# Zellweger syndrome cell lines GM0228 and
	GM4340 and normal control cells <6>) <6>
ST	#4# kidney <1>
ST	#4# heart <1>
ST	#4# brain <1>
ST	#4# adipose tissue <1>

NATURAL_SUBSTRATE_PRODUCT
NSP	#1,2,3,4,5# acyldihydroxyacetone phosphate + NADPH = 1-acyl-sn-glycerol
	3-phosphate + NADP+ (#3,5# acyldihydroxyacetone phosphate pathway
	<6,8,10>; #2# reaction involved during conversion of 3T3-L1
	preadipocytes to adipocytes <13>; #1# enzyme links acyldihydroxyacetone
	phosphate pathway intermediates to cellular glycerolipid biosynthesis
	<7>; #1,2,4,5# reaction in non-ether lipids biosynthesis
	<1,2,5,8,10,11,12>) <1,2,5,6,7,8,10,11,12,13>
NSP	#1,2,3,4,5# alkyldihydroxyacetone phosphate + NADPH + H+ =
	1-alkyl-sn-glycerol 3-phosphate + NADP+ (#3,5# acyldihydroxyacetone
	phosphate pathway <6,8>; #2# reaction involved during conversion of
	3T3-L1 preadipocytes to adipocytes <13>; #1# enzyme links
	acyldihydroxyacetone phosphate pathway intermediates to cellular
	glycerolipid biosynthesis <7>; #1,2,4,5# reaction in ether lipids
	biosynthesis <1,2,5,8>) <1,2,5,6,7,8,13>

SUBSTRATE_PRODUCT
SP	#1,2,3,4,5,6# acyldihydroxyacetone phosphate + NADPH =
	1-acyl-sn-glycerol 3-phosphate + NADP+ (#3,5# acyldihydroxyacetone
	phosphate pathway <6,8,10>; #2# reaction involved during conversion of
	3T3-L1 preadipocytes to adipocytes <13>; #1# enzyme links
	acyldihydroxyacetone phosphate pathway intermediates to cellular
	glycerolipid biosynthesis <7>; #1,2,4,5# reaction in non-ether lipids
	biosynthesis <1,2,5,8,10,11,12>) |#5# i.e. lysophosphatidic acid
	<10,11>| <1,2,3,4,5,6,7,8,9,10,11,12,13>
SP	#1,2,3,4,5,6# alkyldihydroxyacetone phosphate + NADPH + H+ =
	1-alkyl-sn-glycerol 3-phosphate + NADP+ (#1,4# ether analog of acyl
	dihydroxyacetone phosphate <5>; #3,5# acyldihydroxyacetone phosphate
	pathway <6,8>; #2# reaction involved during conversion of 3T3-L1
	preadipocytes to adipocytes <13>; #1# enzyme links acyldihydroxyacetone
	phosphate pathway intermediates to cellular glycerolipid biosynthesis
	<7>; #1,2,4,5# reaction in ether lipids biosynthesis <1,2,5,8>)
	<1,2,3,4,5,6,7,8,9,13>
SP	#1,3,4,5,6# hexadecyldihydroxyacetone phosphate + NADPH =
	1-hexadecyl-sn-glycerol 3-phosphate + NADP+ <1,2,3,4,5,6,7,8,9,10>
SP	#1,4,5,6# palmitoylglycerone phosphate + NADPH = 1-palmitoylglycerol
	3-phosphate + NADP+ (#1,4,5,6# i.e. palmitoyldihydroxyacetone phosphate
	<1,2,3,4,5,7,8,9>) <1,2,3,4,5,7,8,9>

TURNOVER_NUMBER
TN	#1# 100 {NADPH}  <7>

KM_VALUE
KM	#1# 0.05 {NADPH}  (#1# hexadecyldihydroxyacetone phosphate, peroxisomal
	enzyme <5>; #1# liver mitochondria <1>) <1,5>
KM	#1# 0.06 {NADPH}  (#1# cosubstrate palmitoyldihydroxyacetone phosphate,
	peroxisomal enzyme <5>) <5>
KM	#1# 1.7 {NADH}  <7,9>
KM	#1# 0.021 {Hexadecyldihydroxyacetone phosphate}  (#1# cosubstrate NADPH
	<9>) <7,9>
KM	#1# 0.07 {NADPH}  (#1# in presence of NADP+, microsomal enzyme <5>) <5>
KM	#1# 0.8 {NADH}  (#1# cosubstrate hexadecyldihydroxyacetone phosphate,
	peroxisomal enzyme <5>) <5>
KM	#1# 0.08 {NADH}  (#1# cosubstrate hexadecyldihydroxyacetone phosphate,
	microsomal enzyme, NADPH, cosubstrate hexadecyldihydroxyacetone
	phosphate, peroxisomal enzyme <5>) <5>
KM	#1# 0.13 {NADPH}  (#1# in presence of NADP+, peroxisomal enzyme <5>) <5>
KM	#1# 0.0154 {Palmitoyldihydroxyacetone phosphate}  <7>
KM	#1,4# 0.01 {NADPH}  (#1# Km-value below: hexadecyldihydroxyacetone
	phosphate + NADPH, microsomal enzyme <5>; #1,4# ascites microsomes <1>)
	<1,5>
KM	#1,5# 0.015 {NADPH}  (#1# cosubstrate palmitoydihydroxyacetone
	phosphate <9>; #5# cosubstrate hexadecyldihydroxyacetone phosphate <8>)
	<8,9>
KM	#1,5# 0.02 {NADPH}  (#1# cosubstrate hexadecyldihydroxyacetone
	phosphate <9>; #1# cosubstrate palmitoyldihydroxyacetone phosphate,
	microsomal enzyme <5>; #1# ,cosubstrate hexadecyldihydroxyacetone
	phosphate, microsomal enzyme <5>) <5,7,8,9>
KM	#3# 0.0054 {NADPH}  (#3# skin Zellwenger syndrome fibroblasts <6>) <6>
KM	#3# 0.0051 {NADPH}  (#3# skin fibroblasts, normal cells <6>) <6>
KM	#4# 0.005 {NADPH}  (#4# cosubstrate hexadecyldihydroxyacetone
	phosphate, brain <1>) <1>
KM	#4# 0.007 {NADPH}  (#4# cosubstrate palmitoyldihydroxyacetone
	phosphate, brain <1>) <1>

PH_OPTIMUM
PHO	#1# 6.5 <5>
PHO	#1,4# 6.5-7.5 (#1,4# broad optimum <1,9>) <1,9>
PHO	#5# 6.7-7.2 (#5# broad optimum <8>) <8>

PH_RANGE
PHR	#1# 5.5-8.2 (#1# about half-maximal activity at pH 5.5 and 8.2 <5>) <5>

SPECIFIC_ACTIVITY
SA	#1# 62.5 <7,9>
SA	#2# 0.0186 (#2# light mitochondrial fraction <5>) <5>
SA	#2# 0.0296 (#2# light mitochondrial fraction, clofibrate-fed animals
	<5>) <5>
SA	#2# 0.0101 (#2# at day 0 during differentiation induced by insulin,
	dexamethasone, and methylisobutylxanthine <13>) <13>
SA	#4# 0.00158 <3>
SA	#4# 0.00546 (#4# light mitochondrial fraction <2>) <2>
SA	#5# 0.00393 (#5# glucose grown cells <10>) <10>

TEMPERATURE_OPTIMUM
TO	#5# 40 <8>

TEMPERATURE_RANGE
TR	#5# 28-43 (#5# about half-maximal activity at 28°C and 43°C <8>) <8>

COFACTOR
CF	#1,2,3,4,5,6# NADPH (#1,4,5# specific for NADPH <1,8,11,12>;
	#1,2,3,4,5,6# hydrogen from B-side of nicotinamide ring is transferred
	to reduce keto substrates <1,2,3,4,5,6,7,8,9,10,11,12,13>)
	<1,2,3,4,5,6,7,8,9,10,11,12,13>
CF	#1,4# NADH (#4# at high concentrations, rat liver <1>; #1# can
	substitute for NADPH with very low activity and affinity <9>; #1# can
	substitute for NADPH <7>) <1,5,7,9>

ACTIVATING_COMPOUND
AC	#1# phosphatidylcholine (#1# micelles, activation, in presence of
	Triton X-100, slight stimulation at low concentrations <7>) <7>
AC	#1# phosphatidylglycerol (#1# micelles, activation, in presence of
	Triton X-100, slight stimulation at low concentrations <7>) <7>
AC	#1,4# Triton X-100 (#4# activation <3>; #1# destabilizes during
	solubilization <7>) <3,7>
AC	#1,4# EDTA (#1,4# activation, acyldihydroxyacetone phosphate as
	substrate <1>) <1>
AC	#2# Clofibrate (#2# activation <5>) <5>
AC	#5# glycerol (#5# activation, used as nonfermentable carbon source in
	wild type cell cultures, greater activity compared to activity in
	glucose-grown cells <10>) <10>
AC	#5# glycerol/ethanol (#5# activation, used as nonfermentable carbon
	source in wild type cell cultures, greater activity compared to
	activity in glucose-grown cells <10>) <10>
AC	#5# ethanol (#5# activation, used as nonfermentable carbon source in
	wild type and tpa1 mutant cell cultures, greater activity compared to
	activity in glucose-grown cells <10>) <10>
AC	#5# dihydroxyacetone (#5# activation, used as carbon source in wild
	type cell cultures, greater activity compared to activity in
	glucose-grown cells <10>) <10>

INHIBITORS
IN	#1# NADP+ (#1# competitive to NADPH <5>) <5,7>
IN	#1# PCMB <7>
IN	#1# palmitoyl-CoA (#1# competitive to NADPH, not to
	alkyldihydroxyacetone phosphate <7>) <5,7>
IN	#1# phosphatidylinositol <7>
IN	#1# phosphatidylethanolamine <7>
IN	#1# phosphatidylcholine (#1# at high concentrations <7>) <7>
IN	#1# phosphatidylglycerol (#1# at high concentrations <7>) <7>
IN	#1# alkyldihydroxyacetone phosphate (#1# at high concentrations <5>) <5>
IN	#1# Palmitoyldihydroxyacetone phosphate (#1# competitive to
	hexadecyldihydroxyacetone phosphate <7>) <7>
IN	#1# more (#1# stable to N-ethylmaleimide <5,7>; #1# DTNB and thiols
	<5>) <5,7>
IN	#1,4# Trypsin (#1,4# inactivation <3,5>) <3,5>
IN	#1,5# N-ethylmaleimide (#1# not inhibitory <7>; #5# strong inhibitor
	<8>) <7,8>
IN	#4# chymotrypsin (#4# inactivation <3>) <3>
IN	#5# EDTA (#5# weak inhibition <8>) <8>
IN	#5# F- (#5# weak inhibition <8>) <8>
IN	#5# divalent cations (#5# i.e. Cu2+, Co2+, Ca2+, Mg2+, Mn2+, Ni2+,
	Zn2+, strong inhibition <8>) <8>

MOLECULAR_WEIGHT
MW	#1# 75000 (#1# liver peroxisomes, gel filtration in the presence of
	octylglucoside <9>) <9>
MW	#1# 60000 (#1# 1 * 60000, SDS-PAGE <7,9>) <7,9>
MW	#1# 70000-75000 (#1# gel filtration <7>) <7>
MW	#5# 33000 (#5# lipid particles from wild type, systematic amino acid
	sequence analysis by mass spectrometry <12>) <12>

SUBUNITS
SU	#1# monomer (#1# 1 * 60000, SDS-PAGE <7,9>) <7,9>
SU	#1# More (#1# 27% hydrophobic amino acids by amino acid analysis <7>)
	<7>

CLONED
CL	#5# (expression in Escherichia coli, YIL124w is the structural gene of
	the enzyme) <12>

PURIFICATION
PU	#1# (affinity chromatography on NADPH-agarose gel matrix) <7,9>
PU	#1# (partial, solubilization) <5>

GENERAL_STABILITY
GS	#1# (freeze-thawing leads to rapid loss of activity) <7>
GS	#1# (NADPH enhances thermal stability) <5>
GS	#1# (Triton X-100, stable to solubilization in the presence of high
	salt concentrations) <5>
GS	#1# (stable toward high concentrations of N-ethylmaleimide or DTNB) <5>
GS	#1# (thiols stabilize solubilized enzyme) <5>
GS	#1# (NADPH stabilizes during storage and solubilization) <7>
GS	#1# (DTT stabilizes during storage) <7>
GS	#1# (high ionic strength facilitates solubilization with neutral or
	anionic detergents) <7>
GS	#1# (Triton X-100, enzyme becomes unstable during solubilization unless
	NADPH and 1 M KCl are present) <7>
GS	#1# (unstable in the absence of NADPH) <9>
GS	#1# (unstable on freezing and thawing) <9>
GS	#1,4# (trypsin inactivates) <3,5>
GS	#1,4# (freeze-thawing, stable after several cycles) <1>
GS	#4# (chymotrypsin inactivates) <3>

ORGANIC_SOLVENT_STABILITY
OSS	#1# Glycerol (#1# stabilizes <7>) <7>

STORAGE_STABILITY
SS	#1# (4°C, stable in the presence of DTT and NADPH, 1 month) <7>
SS	#5# (-80°C, membrane fraction stable) <8>
SS	#5# (-20°C, membrane fraction stable) <8>

TEMPERATURE_STABILITY
TS	#1# 55 (#1# 10% loss of activity after 15 min, NADPH enhances thermal
	stability <5>) <5>
TS	#1# 4 (#1# stable for 4-6 weeks in the presence of octylglucoside and
	NADPH <9>) <9>
TS	#1,4# 100 (#1,4# complete inactivation after 10 min <1>) <1>
TS	#3# 50 (#3# t1/2: 15 min, control fibroblasts, t1/2: 20 min, Zellweger
	syndrome fibroblasts <6>) <6>
TS	#5# 30 (#5# 10 min stable below <8>) <8>
TS	#5# 45 (#5# t1/2: 10 min <8>) <8>

REFERENCE
RF	<1> LaBelle, E.F.; Hajra, A.K.: Enzymatic reduction of alkyl and acyl
	derivatives of dihydroxyacetone phosphate by reduced pyridine
	nucleotides. J. Biol. Chem. (1972) 247, 5825-5834. {Pubmed:4403490}
RF	<2> Hajra, A.K.; Burke, C.L.; Jones, C.L.: Subcellular localization of
	acyl coenzyme A: dihydroxyacetone phosphate acyltransferase in rat
	liver peroxisomes (microbodies). J. Biol. Chem. (1979) 254,
	10896-10900. {Pubmed:500614}
RF	<3> Ballas, L.M.; Bell, R.M.: Topography of glycerolipid synthetic
	enzymes. Synthesis of phosphatidylserine, phosphatidylinositol and
	glycerolipid intermediates occurs on the cytoplasmic surface of rat
	liver microsomal vesicles. Biochim. Biophys. Acta (1981) 665, 586-595.
	{Pubmed:6271231}
RF	<4> Opperdoes, F.R.: Localization of the initial steps in
	alkoxyphospholipid biosynthesis in glycosomes (microbodies) of
	Trypanosoma brucei. FEBS Lett. (1984) 169, 35-39. {Pubmed:6562019}
RF	<5> Ghosh, M.K.; Hajra, A.K.: Subcellular distribution and properties
	of acyl/alkyl dihydroxyacetone phosphate reductase in rodent livers.
	Arch. Biochem. Biophys. (1986) 245, 523-530. {Pubmed:3954368}
RF	<6> Webber, K.O.; Datta, N.S.; Hajra, A.K.: Properties of the enzymes
	catalyzing the biosynthesis of lysophosphatidate and its ether analog
	in cultured fibroblasts from Zellweger syndrome patients and normal
	controls. Arch. Biochem. Biophys. (1987) 254, 611-620. {Pubmed:3646870}
RF	<7> Datta, S.C.; Ghosh, M.K.; Hajra, A.K.: Purification and properties
	of acyl/alkyl dihydroxyacetone-phosphate reductase from guinea pig
	liver peroxisomes. J. Biol. Chem. (1990) 265, 8268-8274.
	{Pubmed:2335525}
RF	<8> Racenis, P.V.; Lai, J.L.; Das, A.K.; Mullick, P.C.; Hajra, A.K.;
	Greenberg, M.L.: The acyl dihydroxyacetone phosphate pathway enzymes
	for glycerolipid biosynthesis are present in the yeast Saccharomyces
	cerevisiae. J. Bacteriol. (1992) 174, 5704-5710. {Pubmed:}
RF	<9> Hajra, A.K.; Datta, S.C.; Ghosh, M.K.: Acyl/alkyldihydroxyacetone
	phosphate reductase from guinea pig liver peroxisomes. Methods Enzymol.
	(1992) 209, 402-407. {Pubmed:1495422}
RF	<10> Minskoff, S.A.; Racenis, P.V.; Granger, J.; Larkins, L.; Hajra,
	A.K.; Greenberg, M.L.: Regulation of phosphatidic acid biosynthetic
	enzymes in Saccharomyces cerevisiae. J. Lipid Res. (1994) 35,
	2254-2262. {Pubmed:7897322}
RF	<11> Athenstaedt, K.; Weys, S.; Paltauf, F.; Daum, G.: Redundant
	systems of phosphatidic acid biosynthesis via acylation of
	glycerol-3-phosphate or dihydroxyacetone phosphate in the yeast
	Saccharomyces cerevisiae. J. Bacteriol. (1999) 181, 1458-1463.
	{Pubmed:10049376}
RF	<12> Athenstaedt, K.; Daum, G.: 1-Acyldihydroxyacetone-phosphate
	reductase (Ayr1p) of the yeast Saccharomyces cerevisiae encoded by the
	open reading frame YIL124w is a major component of lipid particles. J.
	Biol. Chem. (2000) 275, 235-240. {Pubmed:10617610}
RF	<13> Hajra, A.K.; Larkins, L.K.; Das, A.K.; Hemati, N.; Erickson, R.L.;
	MacDougald, O.A.: Induction of the peroxisomal
	glycerolipid-synthesizing enzymes during differentiation of 3T3-L1
	adipocytes. Role in triacylglycerol synthesis. J. Biol. Chem. (2000)
	275, 9441-9446. {Pubmed:10734090}

///